Processing 00000000.tx.1: Regulation of Amyloid Precursor Protein Secretion by Glutamate Receptors in Human Ntera 2Neurons (NT2N)* Camille Jolly-Tornetta, Zhi-yong Gao, Virginia M.-Y. 

Phrase: "Regulation of Amyloid Precursor Protein Secretion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C1327618:regulation of protein secretion [Cell Function]
   820   C1523071:regulation of secretion [Cell Function]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "by Glutamate Receptors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0061465:Receptors, Glutamate [Amino Acid, Peptide, or Protein,Receptor]
   861   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   861   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "in Human Ntera 2Neurons (NT2N)"

Phrase: "* Camille Jolly-Tornetta,"

Phrase: "Zhi-yong Gao,"

Phrase: "Virginia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042753:Virginia [Geographic Area]
  1000   C1256310:Virginia [Reptile]

Phrase: "M.-"

Phrase: "Y."
Processing 00000000.tx.2: Lee, and Bryan A. 

Phrase: "Lee,"

Phrase: "and"

Phrase: "Bryan A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.3: Wolf From the Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104  ABSTRACT Top Abstract Introduction Procedures Results Discussion References The amyloid precursor protein (APP) can be cleaved by a -secretase to generate a -amyloid peptide, which has been implicated in the pathogenesis of Alzheimer's disease. 

Phrase: "Wolf From the Department of Pathology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0325001:Wolf [Mammal]

Phrase: "and"

Phrase: "Laboratory Medicine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013227:Medicine, NOS [Pharmacologic Substance]
   861   C0025118:Medicine [Biomedical Occupation or Discipline]

Phrase: "University of Pennsylvania School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0036375:School [Manufactured Object,Organization]

Phrase: "Philadelphia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031525:Philadelphia [Geographic Area]

Phrase: "Pennsylvania 19104  ABSTRACT Top Abstract Introduction Procedures Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The amyloid precursor protein (APP)"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "can"

Phrase: "be"

Phrase: "cleaved by a -secretase to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0205242:Cleaved [Spatial Concept]
   760   C0333853:Cleaved [Cell]

Phrase: "generate"

Phrase: "a -amyloid peptide,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "has"

Phrase: "been"

Phrase: "implicated in the pathogenesis of Alzheimer's disease."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0543483:pathogenesis [Functional Concept]
   748   C0699748:Pathogenesis [Pathologic Function]
Processing 00000000.tx.4: However, APP can also be cleaved by an -secretase to form a non-amyloidogenic secreted form of APP (APP-S). 

Phrase: "However,"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "can"

Phrase: "also"

Phrase: "be"

Phrase: "cleaved by an -secretase to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0205242:Cleaved [Spatial Concept]
   760   C0333853:Cleaved [Cell]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a non-amyloidogenic secreted form of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0348078:Form [Qualitative Concept]
   742   C0376315:Form [Manufactured Object]
   742   C1522492:Form [Functional Concept]

Phrase: "(APP-S"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.5: APP-S secretion can be physiologically regulated. 

Phrase: "APP-S secretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "can"

Phrase: "be"

Phrase: "physiologically"

Phrase: "regulated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]
Processing 00000000.tx.6: This study examined the glutamatergic regulation of APP in the human neuronal Ntera 2(NT2N) cell line. 

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the glutamatergic regulation of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "in the human neuronal Ntera 2"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0086418:Human [Human]
   812   C0521390:Neuronal [Immunologic Factor]
   741 E C0027882:Neuron [Cell]

Phrase: "(NT2N"

Phrase: ")"

Phrase: "cell line."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0007600:Cell Line [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:Line [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.7: Metabotropic glutamate receptor subtypes 1/ and 5 were identified in the NT2N neurons by reverse transcription-polymerase chain reaction. 

Phrase: "Metabotropic glutamate receptor subtypes 1/"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   888   C1415287:GLUTAMATE RECEPTOR 1 [Gene or Genome]
   884   C0206529:Metabotropic Glutamate Receptor [Amino Acid, Peptide, or Protein,Receptor]
   853   C1178976:Metabotropic receptor [Amino Acid, Peptide, or Protein,Receptor]
   840   C0061465:Glutamate Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   804   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0449560:subtypes [Classification]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "were"

Phrase: "identified in the NT2N neurons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0027882:Neurons [Cell]
   753   C0205396:Identified [Qualitative Concept]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]

Phrase: "by reverse transcription-polymerase chain reaction."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0814037:reverse transcription polymerase chain reaction [Genetic Function]
   884   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   840   C0035380:Reverse Transcription [Genetic Function]
   804   C0040649:Transcription [Genetic Function]
   804   C0337112:Chain [Manufactured Object]
   804   C0443286:Reaction [Functional Concept]
   804   C1114821:Reaction [Clinical Attribute]
   804   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1524075:Chain [Idea or Concept]
   804   C1555029:Reverse [Idea or Concept]
Processing 00000000.tx.8: Stimulation of these phosphatidylinositol-linked receptors with glutamate or specific receptor agonists resulted in a dose- and time-dependent increase in the secretion of the amyloid precursor protein (APP-S), measured by the immunoprecipitation of APP-S from the medium of [35S]methionine-labeled NT2N neurons. 

Phrase: "Stimulation of these phosphatidylinositol-linked receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   753   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "with glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "specific receptor agonists"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0243192:agonists [Pharmacologic Substance]
   827   C2987634:agonists [Pharmacologic Substance]

Phrase: "resulted in a dose-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0178602:Dose [Quantitative Concept]
   770   C0869039:Dose [Quantitative Concept]
   770   C1114758:Dose # [Clinical Attribute]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "and"

Phrase: "time-dependent increase in the secretion of the amyloid precursor protein (APP-S),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0442805:Increase [Functional Concept]

Phrase: "measured by the immunoprecipitation of APP-S"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0021069:Immunoprecipitation [Laboratory Procedure]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0444706:Measured [Qualitative Concept]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1709634:Precursor [Idea or Concept]
   744   C3541902:MEASURED [Diagnostic Procedure]
   711 E C0079809:Measure [Quantitative Concept]
   711 E C0242485:Measure [Functional Concept]

Phrase: "from the medium of [35S"

Phrase: "]methionine-labeled NT2N neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0027882:Neurons [Cell]
   721 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.9: The glutamate-induced APP-S secretion was maximal at 30min and at a concentration of 1mM glutamate. 

Phrase: "The glutamate-induced APP-S secretion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   895   C1817648:glutamate secretion [Cell Function]
   827   C1159339:Protein Secretion [Cell Function]
   799   C0036536:secretion [Biologic Function]
   799   C0036537:Secretion [Body Substance]

Phrase: "was"

Phrase: "maximal at 30min"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0205289:Maximal [Qualitative Concept]
   790   C0806909:Maximal [Quantitative Concept]
   718 E C1552615:maximum [Quantitative Concept]
   718 E C2826546:MAXIMUM [Quantitative Concept]

Phrase: "and at a concentration of 1mM glutamate."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   748   C0086045:Concentration [Mental Process]
   748   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1446561:Concentration [Quantitative Concept]
   748   C1515981:And [Idea or Concept]
Processing 00000000.tx.10: Glutamate-induced APP-S secretion required activation of phospholipase C, which resulted in inositol 1,4,5-trisphosphate production, as shown by the rapid glutamate-induced accumulation of inositol 1,4,5-trisphosphate. 

Phrase: "Glutamate-induced APP-S secretion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   895   C1817648:glutamate secretion [Cell Function]
   827   C1159339:Protein Secretion [Cell Function]
   799   C0036536:secretion [Biologic Function]
   799   C0036537:Secretion [Body Substance]

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "activation of phospholipase C,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   881   C1155436:phospholipase C activation [Molecular Function]
   770   C1879547:Activation [Activity]

Phrase: "which"

Phrase: "resulted in inositol 1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "4,"

Phrase: "5-trisphosphate production,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033268:production [Occupational Activity]

Phrase: "as"

Phrase: "shown by the rapid glutamate-induced accumulation of inositol 1,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   739   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   739   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]
   739   C0205263:Induced [Functional Concept]
   739   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0439831:Rapid [Qualitative Concept]
   706   C1547282:Show [Intellectual Product]

Phrase: "4,"

Phrase: "5-trisphosphate."
Processing 00000000.tx.11: Glutamate also caused an increase in intracellular Ca2+. 

Phrase: "Glutamate also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   861   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "an increase in intracellular Ca2+."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]
Processing 00000000.tx.12: The protein kinase C activator phorbol 12-myristate 13-acetate, a phorbol ester, as well as 1-oleoyl-2-acetoyl-3-glycerol, a cell-permeable diacylglycerol analog, also stimulated APP-S secretion. 

Phrase: "The protein kinase C activator phorbol 12-myristate 13-acetate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   843   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   791   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]

Phrase: "a phorbol ester,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031586:Phorbol Ester [Hazardous or Poisonous Substance,Organic Chemical]
   861   C0014898:Ester [Organic Chemical]
   861   C0031588:phorbol [Organic Chemical]
   861   C0070750:Phorbol [Organic Chemical]

Phrase: "as well as"

Phrase: "1-oleoyl-2-acetoyl-3-glycerol,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   919   C0089700:1-oleoyl-2-glycerol [Lipid]
   799   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "a cell-permeable diacylglycerol analog,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0243071:Analog [Chemical Viewed Structurally]
   704 E C0679213:analogies [Idea or Concept]

Phrase: "also stimulated APP-S secretion."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1159339:Protein Secretion [Cell Function]
   799   C0036536:secretion [Biologic Function]
   799   C0036537:Secretion [Body Substance]
Processing 00000000.tx.13: These findings suggest that APP-S secretion from NT2N neurons can be regulated by the activation of phosphatidylinositol-linked metabotropic glutamate receptor signaling pathway.  

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that APP-S secretion from NT2N neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1159339:Protein Secretion [Cell Function]
   742   C0036536:secretion [Biologic Function]
   742   C0036537:Secretion [Body Substance]

Phrase: "can"

Phrase: "be"

Phrase: "regulated by the activation of phosphatidylinositol-linked metabotropic glutamate receptor signaling pathway."
Meta Candidates (Total=28; Excluded=2; Pruned=0; Remaining=26)
   820   C3545986:activation of glutamate receptor signaling pathway [Molecular Function]
   810   C1155442:metabotropic glutamate receptor signaling pathway [Molecular Function]
   798   C3548191:activation of glutamate signaling pathway [Molecular Function]
   790   C1155441:glutamate receptor signaling pathway [Molecular Function]
           glutamate signaling pathway
   770   C0206529:Metabotropic Glutamate Receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C0037083:signaling pathway [Cell Function]
           Signaling
   753   C0061465:Glutamate Receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C0086982:Signaling Pathway [Molecular Function]
   753   C1514762:Receptor Signaling [Molecular Function]
   751 E C0037080:pathway signaling [Molecular Function]
   751   C0070807:receptor, phosphatidylinositol [Amino Acid, Peptide, or Protein,Receptor]
   751   C1178976:Metabotropic receptor [Amino Acid, Peptide, or Protein,Receptor]
   751   C1514758:Receptor Activation [Cell Function]
   736   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   736   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   736   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   736   C0851285:Regulated [Governmental or Regulatory Activity]
   736   C1704259:Pathway [Molecular Function]
   736   C1705987:Pathway [Conceptual Entity]
   736   C1879547:Activation [Activity]
   736   C2348046:Phosphatidylinositol [Lipid]
   736   C3537152:signaling [Biologic Function]
   703   C1517892:Link [Intellectual Product]
   703   C1704666:Link [Intellectual Product]
   703 E C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.14: INTRODUCTION Top Abstract Introduction Procedures Results Discussion References Alzheimer's disease is characterized by the deposition of -amyloid (A)1 into senile plaques, the formation of neurofibrillary tangles, and neuronal death. 

Phrase: "INTRODUCTION Top Abstract Introduction Procedures Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "characterized by the deposition of -amyloid (A)1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C0011560:Amyloid deposition [Pathologic Function]
           Amyloid
   774   C1705760:Amyloid Deposition [Finding]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0333562:Deposition [Functional Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1880022:Characterized [Activity]

Phrase: "into senile plaques,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "the formation of neurofibrillary tangles,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "neuronal death."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C2754100:neuron death [Cell Function]
   861   C0011065:Death [Organism Function]
   861   C1306577:Death, NOS [Finding]
Processing 00000000.tx.15: Senile plaques consist of a A protein surrounded by dystrophic neuritic processes, astrocytes, and microglia. 

Phrase: "Senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "consist of a A protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   835   C0002722:Amyloid A Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   797   C0002723:Amyloid A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   797   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332529:CONSIST [Qualitative Concept]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "surrounded by dystrophic neuritic processes,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0333607:Dystrophic [Functional Concept]
   760   C1282914:Surrounded [Spatial Concept]
   726   C1184743:Process [Body Part, Organ, or Organ Component]
   726   C1522240:Process [Phenomenon or Process]

Phrase: "astrocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "and"

Phrase: "microglia."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206116:Microglia [Cell]
   928 E C0521398:Microglial [Body Location or Region]
Processing 00000000.tx.16: The -amyloid protein is a 39-43-amino acid cleavage product of -amyloid precursor proteins (APP) (1-4). 

Phrase: "The -amyloid protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "a 39-43-amino acid cleavage product of -amyloid precursor proteins"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   855   C1874187:amino acid protein [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   813   C1456454:Amyloid Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0011560:Amyloid [Pathologic Function]
   790   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1709634:Precursor [Idea or Concept]
   787   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   787   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   787   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "(APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "(1-4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.17: APP is a family of transmembrane glycoproteins with a large extracytoplasmic domain, a membrane-spanning domain containing the A peptide, and a short intracytoplasmic domain (4). 

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "a family of transmembrane glycoproteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0015576:Family [Family Group]
   760   C1704727:Family [Conceptual Entity]

Phrase: "with a large extracytoplasmic domain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "a membrane-spanning domain"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   827   C0025255:Membrane [Tissue]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]
   793   C1711300:Span [Conceptual Entity]
   793   C2700613:Span [Quantitative Concept]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the A peptide,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "a short intracytoplasmic domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.18: APP exists as three alternatively spliced isoforms, ranging from 695to 770amino acids in length and is expressed in mammalian neuronal and nonneuronal cells and tissues (5). 

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "exists as three alternatively spliced isoforms,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205449:Three [Quantitative Concept]
   753   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
   753   C2987476:Exist [Conceptual Entity]

Phrase: "ranging from 695to 770amino acids"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0001128:Acids [Chemical]
   726 E C0202406:Acid [Laboratory Procedure]
   726   C1514721:Range [Quantitative Concept]
   726   C2348147:Range [Quantitative Concept]
   726   C3542016:Range [Intellectual Product]

Phrase: "in length"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1444754:Length [Quantitative Concept]
  1000   C1706316:LENGTH [Research Activity]
   928 E C0205166:Long [Qualitative Concept]
   928 E C1522425:Longest [Qualitative Concept]
   928 E C1706317:Long [Qualitative Concept]

Phrase: "and"

Phrase: "is"

Phrase: "expressed in mammalian neuronal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0024660:Mammalian [Mammal]
   770   C0521390:Neuronal [Immunologic Factor]

Phrase: "and"

Phrase: "nonneuronal cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0027836:Non-neuronal cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.19: APP is most abundant in the brain and APP695 is the major APP in the human neuronal cell line NTera 2/cl.D1 (NT2) (6). 

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "most abundant in the brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2346714:Abundant [Qualitative Concept]

Phrase: "and"

Phrase: "APP695"

Phrase: "is"

Phrase: "the major APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "in the human neuronal cell line NTera 2/cl.D1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1416886:D1 [Gene or Genome]

Phrase: "(NT2"

Phrase: ")"

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.20: APP is thought to be processed through various pathways. 

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "processed through various pathways."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   770   C1522240:Processed [Phenomenon or Process]
   770   C1704259:Pathways [Molecular Function]
   770   C1705987:Pathways [Conceptual Entity]
   737 E C1184743:Process [Body Part, Organ, or Organ Component]
Processing 00000000.tx.21: APP processed by a constitutive secretory pathway (or -secretase) results in a large secreted form (APP-S) excluding A formation (7, 8). 

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "processed by a constitutive secretory pathway"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C1159343:constitutive secretory pathway [Cell Function]
   790   C1159342:Secretory Pathway [Cell Function]
           Secretory Process
   753   C1327616:Secretory [Cell Function]
   753   C1522240:Processed [Phenomenon or Process]
   753   C1704259:Pathway [Molecular Function]
   753   C1705987:Pathway [Conceptual Entity]
   719 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "(or -secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "results in a large secreted form"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C0549177:Large [Quantitative Concept]
   753   C1274040:Result [Functional Concept]
   753   C1327616:Secreted [Cell Function]
   753   C1522492:Form [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]

Phrase: "(APP-S"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "excluding A formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "(7,"

Phrase: "8"

Phrase: ")."
Processing 00000000.tx.22: Processing by a -secretase or by an endosomal and lysosomal pathway produces the 4-kDa A protein (9, 10). 

Phrase: "Processing by a -secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709694:Processing [Activity]

Phrase: "or by an endosomal"

Phrase: "and"

Phrase: "lysosomal pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "produces"

Phrase: "the 4-kDa A protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.23: Mutations in the APP gene have been shown to result in the abnormal processing of APP, which may lead to subsequent A deposition and accumulation (11, 12). 

Phrase: "Mutations in the APP gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   774   C0596611:gene mutations [Genetic Function]
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "result in the abnormal processing of APP,"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0033666:protein processing [Molecular Function]
   762   C0311448:Abnormal protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0459424:Abnormal result [Finding]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205161:Abnormal [Qualitative Concept]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1274040:Result [Functional Concept]
   742   C1546471:Result [Idea or Concept]
   742   C1709634:Precursor [Idea or Concept]
   742   C1709694:Processing [Activity]
   742   C2347472:% Abnormal [Quantitative Concept]
   742   C2699333:ABNORMAL [Intellectual Product]
   742   C2825142:Result [Finding]

Phrase: "which"

Phrase: "may"

Phrase: "lead to subsequent A deposition"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C0011560:Amyloid deposition [Pathologic Function]
           Amyloid
   806   C1705760:Amyloid Deposition [Finding]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0332282:Subsequent [Temporal Concept]
   760   C0333562:Deposition [Functional Concept]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "accumulation"

Phrase: "(11,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.24: Recent evidence for this was provided by a human familial Alzheimer's disease mutant APP transgenic mouse that expresses high levels of APP, as well as A, which increases in an age-dependent manner. 

Phrase: "Recent evidence for this"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]

Phrase: "was"

Phrase: "provided by a human familial Alzheimer's disease mutant APP transgenic mouse"
Meta Candidates (Total=38; Excluded=1; Pruned=0; Remaining=37)
   777   C0611285:Alzheimer's Disease Amyloid Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Amyloid
   766   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   766   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   766   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   763   C1955168:Alzheimer precursor protein [Amino Acid, Peptide, or Protein]
   762   C0002722:Amyloid A Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0002723:Amyloid A Precursor [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Amyloid A
   750   C0002395:Alzheimer's Disease [Disease or Syndrome]
   750   C0025936:Mouse, Transgenic [Mammal]
   750   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   750   C1521724:Alzheimer's Disease [Pathologic Function]
   749   C0002726:amyloid disease [Disease or Syndrome]
   749   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   749   C0277558:Familial disease [Disease or Syndrome]
   749   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   749   C1334805:Mouse Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   749   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   749   C1564139:Mutant Protein [Amino Acid, Peptide, or Protein]
   744   C1451672:MAL protein, human [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1451673:Mal protein, mouse [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   735   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   735   C0003069:Transgenic [Animal]
   735   C0011560:Amyloid [Pathologic Function]
   735   C0012634:Disease [Disease or Syndrome]
   735   C0015576:familial [Family Group]
   735   C0025914:Mouse [Mammal]
   735   C0025929:mouse [Mammal]
   735   C0026809:Mouse [Mammal]
   735   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   735   C0086418:Human [Human]
   735   C0241888:Familial [Functional Concept]
   735   C0596988:Mutant [Cell or Molecular Dysfunction]
   735   C1709634:Precursor [Idea or Concept]
   735   C1999230:Provided [Activity]
   713 E C0344339:disease family [Finding]
   713   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "expresses"

Phrase: "high levels of APP,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C0428479:Protein level [Laboratory or Test Result]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "as well as"

Phrase: "A,"

Phrase: "which"

Phrase: "increases in an age-dependent manner."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0001779:Age [Organism Attribute]
   753   C0442805:Increase [Functional Concept]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]
Processing 00000000.tx.25: This results in the formation of amyloid plaques, dendritic and synaptic loss, and astrocytosis, as seen in Alzheimer's disease (13, 14). 

Phrase: "This results in the formation of amyloid plaques,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711   C2825142:Result [Finding]

Phrase: "dendritic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011305:Dendritic [Cell Component]
  1000   C0439640:Dendritic [Qualitative Concept]

Phrase: "and"

Phrase: "synaptic loss,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517945:Loss [Quantitative Concept]

Phrase: "and"

Phrase: "astrocytosis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0751171:Astrocytosis [Pathologic Function]

Phrase: "as"

Phrase: "seen in Alzheimer's disease"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0205397:Seen [Qualitative Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "(13,"

Phrase: "14"

Phrase: ")."
Processing 00000000.tx.26: Mutations in the presenilin 1and 2genes (responsible for many cases of familial Alzheimer's disease) alter APP processing by increasing A generation (15-18). 

Phrase: "Mutations in the presenilin 1and 2genes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(responsible for many cases of familial Alzheimer's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1273518:Responsible [Finding]

Phrase: ")"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "APP processing by increasing A generation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0033666:protein processing [Molecular Function]
   744   C1709694:Processing [Activity]

Phrase: "(15-18"

Phrase: ")."
Processing 00000000.tx.27: This supports the idea of a primary role for APP and A in the pathogenesis of Alzheimer's disease. 

Phrase: "This"

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the idea of a primary role"

Phrase: "for APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "A in the pathogenesis of Alzheimer's disease."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0002726:amyloid disease [Disease or Syndrome]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.28: Many populations of neurons are affected in Alzheimer's disease, in particular the cholinergic and glutamatergic neurons of the hippocampus and cerebral cortex, therefore it is important to examine these receptor signaling pathways. 

Phrase: "Many populations of neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0032659:Population [Quantitative Concept]
   770   C1257890:Population [Population Group]

Phrase: "are"

Phrase: "affected in Alzheimer's disease,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0392760:Affected [Functional Concept]
   770   C1314939:Affected [Functional Concept]
   737 E C0001721:Affect [Mental Process]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "in particular"

Phrase: "the cholinergic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599668:cholinergic [Functional Concept]

Phrase: "and"

Phrase: "glutamatergic neurons of the hippocampus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0027882:Neurons [Cell]

Phrase: "and"

Phrase: "cerebral cortex,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "therefore"

Phrase: "it"

Phrase: "is"

Phrase: "important to"

Phrase: "examine"

Phrase: "these receptor signaling pathways."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0037080:Signal Pathways [Molecular Function]
   884   C0037083:signaling pathway [Cell Function]
   884   C0086982:Signaling Pathway [Molecular Function]
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]
   734   C1514762:Receptor Signaling [Molecular Function]
Processing 00000000.tx.29: The m1 and m3 muscarinic receptors have been shown previously to stimulate the secretion of APP, and recently the activation of metabotropic glutamate receptors was shown to cause an increase in APP secretion (19, 20). 

Phrase: "The m1"

Phrase: "and"

Phrase: "m3 muscarinic receptors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034826:Receptors, Muscarinic [Amino Acid, Peptide, or Protein,Receptor]
   896   C0289799:M3 receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0026815:muscarinic [Pharmacologic Substance]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "previously to"

Phrase: "stimulate"

Phrase: "the secretion of APP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1159339:Protein Secretion [Cell Function]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]

Phrase: "and"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "the activation of metabotropic glutamate receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1514758:Receptor Activation [Cell Function]
   753   C1879547:Activation [Activity]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "an increase in APP secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "(19,"

Phrase: "20"

Phrase: ")."
Processing 00000000.tx.30: Metabotropic glutamate receptors are seven transmembrane-spanning proteins that consist of eight receptor subtypes. 

Phrase: "Metabotropic glutamate receptors"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0206529:Receptors, Metabotropic Glutamate [Amino Acid, Peptide, or Protein,Receptor]
   901   C0061465:Receptors, Glutamate [Amino Acid, Peptide, or Protein,Receptor]
   896   C1178976:Metabotropic receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   827   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "seven transmembrane-spanning proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0021699:Transmembrane protein [Amino Acid, Peptide, or Protein]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "consist of eight receptor subtypes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205454:Eight [Quantitative Concept]
   760   C0332529:CONSIST [Qualitative Concept]
   760   C0449560:subtypes [Classification]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.31: The mGluR1 and R5 subtypes are linked to phosphatidylinositol (PI) hydrolysis, whereas the other six subtypes are negatively coupled to adenylate cyclase. 

Phrase: "The mGluR1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0535210:mGluR1 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1333711:MGLUR1 [Gene or Genome]
  1000   C1706579:MGLUR1 [Gene or Genome]

Phrase: "and"

Phrase: "R5 subtypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449560:subtypes [Classification]

Phrase: "are"

Phrase: "linked to phosphatidylinositol (PI) hydrolysis,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0020291:Hydrolysis [Natural Phenomenon or Process]
   770   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   770   C2348046:Phosphatidylinositol [Lipid]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "whereas"

Phrase: "the other six subtypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449560:subtypes [Classification]

Phrase: "are"

Phrase: "negatively"

Phrase: "coupled to adenylate cyclase."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0001492:Adenylate Cyclase [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1382029:Adenylate Cyclase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0597765:adenylate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1948027:Coupled [Functional Concept]
   737 E C0010222:couple [Family Group]
Processing 00000000.tx.32: The degeneration and loss of neurons seen in Alzheimer's disease and a recent study demonstrating the involvement of metabotropic glutamate receptors in the regulation of APP secretion suggest that a defect in the receptors or in their signaling pathways might lead to abnormal processing of APP and subsequent A deposition. 

Phrase: "The degeneration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011164:Degeneration [Pathologic Function]
  1000   C1880269:Degeneration [Functional Concept]

Phrase: "and"

Phrase: "loss of neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0598940:Loss of neurons [Finding]
           neuron loss
   816 E C1850496:Neuronal loss [Finding]
   790   C1517945:Loss [Quantitative Concept]

Phrase: "seen in Alzheimer's disease"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0205397:Seen [Qualitative Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "a recent study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "demonstrating"

Phrase: "the involvement of metabotropic glutamate receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1314939:Involvement [Functional Concept]

Phrase: "in the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of APP secretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a defect in the receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1457869:Defect [Functional Concept]
   760   C1861101:DEFECT [Disease or Syndrome]

Phrase: "or in their signaling pathways"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   797   C0037080:pathways signaling [Molecular Function]
   790 E C0037083:signaling pathway [Cell Function]
           Signaling
   790 E C0086982:Signaling Pathway [Molecular Function]
   760   C1704259:Pathways [Molecular Function]
   760   C1705987:Pathways [Conceptual Entity]
   760   C3537152:signaling [Biologic Function]
   726 E C1710082:Signal [Phenomenon or Process]

Phrase: "might"

Phrase: "lead to abnormal processing of APP"
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0033666:protein processing [Molecular Function]
   767   C0311448:Abnormal protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205161:Abnormal [Qualitative Concept]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1522538:Lead [Functional Concept]
   744   C1709634:Precursor [Idea or Concept]
   744   C1709694:Processing [Activity]
   744   C2347472:% Abnormal [Quantitative Concept]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C2699333:ABNORMAL [Intellectual Product]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "subsequent A deposition."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0011560:Amyloid deposition [Pathologic Function]
   901   C1705760:Amyloid Deposition [Finding]
   827   C0333562:Deposition [Functional Concept]
Processing 00000000.tx.33: The regulatory mechanism of APP processing and secretion is unknown; 

Phrase: "The regulatory mechanism of APP processing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0441712:Mechanism [Functional Concept]
   744   C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]

Phrase: "is"

Phrase: "unknown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.34: however, recent findings suggest that the control is through neurotransmitter receptor coupling to signal transduction pathways (21). 

Phrase: "however,"

Phrase: "recent findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "is through neurotransmitter receptor coupling"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0034828:Neurotransmitter Receptor [Amino Acid, Peptide, or Protein,Receptor]
   806   C0597359:receptor coupling [Molecular Function]
   760   C0027908:Neurotransmitter [Neuroreactive Substance or Biogenic Amine]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C1948027:Coupling [Functional Concept]

Phrase: "to signal transduction pathways"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0086982:Signal Transduction Pathways [Molecular Function]
   913   C0037080:Signal Pathways [Molecular Function]
   901   C0037083:Signal Transduction [Cell Function]
   827   C1160185:transduction [Organism Function]
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.35: In order to examine the glutamatergic signaling pathway, the human teratocarcinoma cell line NTera 2/cl.D1 (NT2N) was used. 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "examine"

Phrase: "the glutamatergic signaling pathway,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0037083:signaling pathway [Cell Function]
   901   C0086982:Signaling Pathway [Molecular Function]
   884 E C0037080:Signal Pathway [Molecular Function]
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "the human teratocarcinoma cell line NTera 2/cl.D1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1416886:D1 [Gene or Genome]

Phrase: "(NT2N"

Phrase: ")"

Phrase: "was"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.36: NT2N cells are post-mitotic, terminally differentiated neurons that possess cell surface markers consistent with neurons of the central nervous system. 

Phrase: "NT2N cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "post-mitotic, terminally differentiated neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0027882:Neurons [Cell]
   721 E C0521390:Neuronal [Immunologic Factor]

Phrase: "that"

Phrase: "possess"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "cell surface markers"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0699040:Cell surface [Cell Component]
   827   C0007634:Cell [Cell]
   827   C0205148:Surface [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793   C0005516:Marker [Clinical Attribute]

Phrase: "consistent with neurons of the central nervous system."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.37: Pure cultures of neurons are obtained through differentiation of the stem cell population with retinoic acid and treatment of the replated neuronal population with mitotic inhibitors to clear any contaminating nonneuronal cells. 

Phrase: "Pure cultures of neurons"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0010453:Cultures [Idea or Concept]
   770   C2247561:PurE [Molecular Function]
   737 E C0220814:culture [Functional Concept]
   737 E C0430400:Culture [Laboratory Procedure]
   737 E C2242979:Culture [Laboratory Procedure]

Phrase: "are"

Phrase: "obtained through differentiation of the stem cell population"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   793   C1514964:Stem Cell Differentiation [Cell Function]
   770   C0038250:Stem cell [Cell]
   767   C0007589:Cell Differentiation [Cell Function]
           Differentiation
   744   C0007634:Cell [Cell]
   744   C0032659:Population [Quantitative Concept]
   744   C0242767:Stem [Plant]
   744   C1186763:Stem [Body Part, Organ, or Organ Component]
   744   C1257890:Population [Population Group]
   744   C1269647:Cell [Cell]
   744   C1301820:Obtained [Functional Concept]
   744   C1511938:Differentiation [Clinical Attribute]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   744   C2945687:Differentiation [Functional Concept]
   711 E C1706701:Obtain [Activity]

Phrase: "with retinoic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "treatment of the replated neuronal population"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "with mitotic inhibitors to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0003379:Mitotic Inhibitors [Pharmacologic Substance]
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   827   C1513354:Mitotic [Qualitative Concept]
   793 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "any contaminating nonneuronal cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   884   C0027836:Non-neuronal cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.38: NT2N neurons provide a strong model for examining APP secretion because they endogenously express APP and secrete both APP and A in response to physiological stimuli. 

Phrase: "NT2N neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a strong model for examining APP secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C3161035:Model [Intellectual Product]

Phrase: "because"

Phrase: "they endogenously"

Phrase: "express"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "secrete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:secrete [Cell Function]

Phrase: "both APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "A in response"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0011560:Amyloid [Pathologic Function]
   790   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "to physiological stimuli."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0234402:Stimuli [Phenomenon or Process]
Processing 00000000.tx.39: In contrast to non-neuronal cells, NT2N neurons express APP695, the major APP isoform expressed in the brain, and NT2N neurons process APP differently (6, 22). 

Phrase: "In contrast to non-neuronal cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   988   C0027836:Non-neuronal cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "NT2N neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "express"

Phrase: "APP695,"

Phrase: "the major APP isoform"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0597298:protein isoform [Amino Acid, Peptide, or Protein]
           Isoform
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "expressed in the brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "NT2N neurons process APP differently"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   836   C0033666:process protein [Molecular Function]
   835   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   835   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   822   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0011560:Amyloid [Pathologic Function]
   793   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C1709634:Precursor [Idea or Concept]

Phrase: "(6,"

Phrase: "22"

Phrase: ")."
Processing 00000000.tx.40: For this study, NT2N neurons were used to determine if glutamate is involved in the regulation of APP secretion.  

Phrase: "For this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "NT2N neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "if"

Phrase: "glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "involved in the regulation of APP secretion."
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   807   C1327618:regulation of protein secretion [Cell Function]
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   784   C1523071:regulation of secretion [Cell Function]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1159339:Protein Secretion [Cell Function]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0036536:secretion [Biologic Function]
   742   C0036537:Secretion [Body Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0851285:Regulation [Governmental or Regulatory Activity]
   742   C1314939:Involved [Functional Concept]
   742   C1327622:Regulation [Biologic Function]
   742   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.41: EXPERIMENTAL PROCEDURES Top Abstract Introduction Procedures Results Discussion References Materials-- The media and serum used to maintain the NT2N culture were from Life Technologies, Inc., and all of the mitotic inhibitors and antibiotics used in the cell culture were purchased from Sigma. 

Phrase: "EXPERIMENTAL PROCEDURES Top Abstract Introduction Procedures Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "-"

Phrase: "-"

Phrase: "The media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "the NT2N culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C2242979:Culture [Laboratory Procedure]

Phrase: "were from Life Technologies,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0039421:technologies [Occupation or Discipline]
   770   C0376558:Life [Idea or Concept]

Phrase: "Inc.,"

Phrase: "and"

Phrase: "all of the mitotic inhibitors"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0003379:Mitotic Inhibitors [Pharmacologic Substance]
   760   C0243077:inhibitors [Chemical Viewed Functionally]
   760   C0444868:All [Quantitative Concept]
   760   C1513354:Mitotic [Qualitative Concept]
   760   C3539085:All [Idea or Concept]
   726 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "antibiotics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003232:Antibiotics [Antibiotic]

Phrase: "used in the cell culture"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   806   C0007585:Cell Culture [Laboratory Procedure]
   760   C0007634:Cell [Cell]
   760   C0010453:Culture [Idea or Concept]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C1269647:Cell [Cell]
   760   C1273517:used [Finding]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C2242979:Culture [Laboratory Procedure]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "purchased from Sigma."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0869011:purchased [Activity]
   790   C1719918:Sigma [Intellectual Product]
Processing 00000000.tx.42: Matrigel was from Collaborative Research (Bedford, MA). 

Phrase: "Matrigel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0065749:matrigel [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "was from Collaborative Research"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0035168:research [Research Activity]
   770   C0043194:WAS [Disease or Syndrome]
   770   C0242481:Research [Research Activity]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0282116:collaborative [Social Behavior]
   770   C1421478:WAS [Gene or Genome]

Phrase: "(Bedford,"

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.43: The DAG kinase and lipase inhibitors were from Biomol (Plymouth Meeting, PA), and the glutamate receptor agonists and antagonists were purchased from Tocris Cookson (Ballwin, MO). 

Phrase: "The DAG kinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0113519:DAG Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "lipase inhibitors"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C2757059:Lipase Inhibitors [Molecular Function]
   983 E C1268854:Lipase inhibitor [Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "were from Biomol"

Phrase: "(Plymouth Meeting,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0556656:Meeting [Health Care Activity]

Phrase: "PA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541314:PA [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the glutamate receptor agonists"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0242908:Glutamate Agonists [Pharmacologic Substance]
   827   C0243192:agonists [Pharmacologic Substance]
   827   C2987634:agonists [Pharmacologic Substance]
   734   C0061465:Glutamate Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "antagonists"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0243076:antagonists [Chemical Viewed Functionally]
   966 E C0231491:Antagonist [Organ or Tissue Function]
   893 E C0680242:antagonism [Social Behavior]

Phrase: "were"

Phrase: "purchased from Tocris Cookson"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0869011:purchased [Activity]

Phrase: "(Ballwin,"

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.44: The phorbol ester PMA was from Sigma and the calcium ionophore A23187 was from Boehringer Mannheim. 

Phrase: "The phorbol ester PMA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   827   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   827   C2825188:PMA [Intellectual Product]
   734   C0031586:Phorbol Ester [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "was from Sigma"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]
   790   C1719918:Sigma [Intellectual Product]

Phrase: "and"

Phrase: "the calcium ionophore A23187"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521966:Calcium ionophore A23187 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0878412:A23187 [Antibiotic,Organic Chemical]
   734   C0444420:Calcium ionophore [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was from Boehringer Mannheim."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1421478:WAS [Gene or Genome]
Processing 00000000.tx.45: [35S]Methionine (1000-1500 Ci/mmol) was purchased from ICN Biomedicals (Costa Mesa, CA) and myo-[3H]inositol (84Ci/mmol), [3H]inositol 1-phosphate (10Ci/mmol), [3H]inositol 1,4-bisphosphate (10Ci/mmol), [3H]inositol 1,4,5-trisphosphate (21Ci/mmol), and [3H]inositol 1,3,4,5-tetrakisphosphate (21Ci/mmol) were from NEN Life Science Products. 

Phrase: "[35S"

Phrase: "]Methionine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(1000-1500 Ci/mmol)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439190:MMOLE [Quantitative Concept]

Phrase: "was"

Phrase: "purchased from ICN Biomedicals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0869011:purchased [Activity]

Phrase: "(Costa Mesa,"

Phrase: "CA)"

Phrase: "and"

Phrase: "myo-"

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]inositol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]

Phrase: "(84Ci/mmol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439190:MMOLE [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]inositol 1-phosphate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0063574:inositol 1-phosphate [Carbohydrate]
   913   C0021554:inositol phosphate [Carbohydrate]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(10Ci/mmol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439190:MMOLE [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]inositol 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]

Phrase: "4-bisphosphate"

Phrase: "(10Ci/mmol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439190:MMOLE [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]inositol 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]

Phrase: "4,"

Phrase: "5-trisphosphate"

Phrase: "(21Ci/mmol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439190:MMOLE [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and ["

Phrase: "3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]inositol 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4,"

Phrase: "5-tetrakisphosphate"

Phrase: "(21Ci/mmol)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439190:MMOLE [Quantitative Concept]

Phrase: "were from NEN Life Science Products."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0332070:Life Science Products [Health Care Related Organization]
   790   C0005526:Science, Life [Occupation or Discipline]
   753   C0036397:Science [Occupation or Discipline]
   753   C0376558:Life [Idea or Concept]
   753   C1514468:Products [Entity]
   719 E C1704444:Product [Quantitative Concept]
Processing 00000000.tx.46: Trichloroacetic acid, trichlorotrifluorethane, and trioctylamine used in the inositol extraction procedure were also from Sigma. 

Phrase: "Trichloroacetic acid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "trichlorotrifluorethane,"

Phrase: "and"

Phrase: "trioctylamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076985:trioctylamine [Organic Chemical,Pharmacologic Substance]

Phrase: "used in the inositol extraction procedure"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   790   C0185115:extraction procedure [Therapeutic or Preventive Procedure]
           Extraction
   753   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]
   753   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   753   C0684295:extraction [Laboratory Procedure]
   753   C1273517:used [Finding]
   753   C1948041:Procedure [Therapeutic or Preventive Procedure]
   753   C2700391:Procedure [Activity]
   753   C3274430:PROCEDURE [Health Care Activity]
   753   C3538935:Procedure [Idea or Concept]
   753   C3539779:Procedure [Intellectual Product]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "also from Sigma."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1719918:Sigma [Intellectual Product]
Processing 00000000.tx.47: SAX Amprep minicolumns were obtained from Amersham Pharmacia Biotech. 

Phrase: "SAX Amprep minicolumns"

Phrase: "were"

Phrase: "obtained from Amersham Pharmacia Biotech."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0331955:Pharmacia [Health Care Related Organization]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]
Processing 00000000.tx.48: RNA isolation kit was from CLONTECH, RT-PCR reagents were from Promega (Madison, WI), and the mGluR1 primers were from the Wistar Institute (University of Pennsylvania, Philadelphia, PA), and mGluR5 primers were from National Biosciences Inc. 

Phrase: "RNA isolation kit"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0812225:KIT [Medical Device]
   827   C1150635:KIT [Molecular Function]
   827   C1705212:Kit [Medical Device]
   827   C1705213:KIT [Medical Device]
   827   C3273202:Kit [Manufactured Object]

Phrase: "was from CLONTECH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]

Phrase: "RT-PCR reagents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
   734   C0599161:RT-PCR [Molecular Biology Research Technique]

Phrase: "were from Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0072149:Promega [Lipid]

Phrase: "(Madison,"

Phrase: "WI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043193:WI [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the mGluR1 primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were from the Wistar Institute"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0021622:institute [Organization]
   760   C1272753:Institute [Idea or Concept]
   760   C2700262:Wistar [Mammal]

Phrase: "(University of Pennsylvania,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030853:Pennsylvania [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Philadelphia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031525:Philadelphia [Geographic Area]

Phrase: "PA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541314:PA [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "mGluR5 primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were from National Biosciences Inc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3245503:national [Intellectual Product]
Processing 00000000.tx.49: (Beverly, MA). 

Phrase: "(Beverly,"

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.50: Cell Culture of NT2N Neurons-- The human teratocarcinoma NTera2/c1.D1 (NT2) cells were maintained in Opti-MEM supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin (23). 

Phrase: "Cell Culture of NT2N Neurons"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0007585:Cell Culture [Laboratory Procedure]
   753   C0007634:Cell [Cell]
   753   C0010453:Culture [Idea or Concept]
   753   C0220814:culture [Functional Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C2242979:Culture [Laboratory Procedure]

Phrase: "-"

Phrase: "-"

Phrase: "The human teratocarcinoma NTera2/c1.D1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1416886:D1 [Gene or Genome]

Phrase: "(NT2"

Phrase: ")"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "maintained in Opti-MEM"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1314677:Maintained [Functional Concept]
   737 E C0024501:Maintain [Activity]

Phrase: "supplemented with 10% fetal bovine serum"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0007452:Bovine [Mammal]
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0521457:Fetal [Functional Concept]
   753   C1140701:bovine [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "and"

Phrase: "1% penicillin/streptomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.51: 2.3106 cells were seeded into a 75-cm2 flask and treated with 10M retinoic acid (in DMEM medium with 10% fetal bovine serum and 1% penicillin/streptomycin) twice a week for 5weeks. 

Phrase: "2.3106 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "seeded into a 75-cm2 flask"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0439479:cm2 [Quantitative Concept]
   753   C0555206:CM2 [Congenital Abnormality]
   753   C0872171:Flask [Medical Device]
   719   C0036563:Seed [Plant]
   719   C1705192:Seed [Laboratory Procedure]
   719   C1882540:{Seed} [Quantitative Concept]
   719   C2346495:Seed [Conceptual Entity]

Phrase: "and"

Phrase: "treated with 10M retinoic acid"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
   760   C1442446:10M [Temporal Concept]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "("

Phrase: "in DMEM medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "with 10% fetal bovine serum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0007452:Bovine [Mammal]
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0521457:Fetal [Functional Concept]
   812   C1140701:bovine [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "1% penicillin/streptomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: ")"

Phrase: "twice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720725:Twice [Intellectual Product]
  1000   C1948050:Twice [Quantitative Concept]

Phrase: "a week for 5weeks."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332174:/week [Temporal Concept]
   770   C0439230:week [Temporal Concept]
Processing 00000000.tx.52: Cells were then trypsinized and replated (Replate 2) onto poly-D-lysine/Matrigel (Collaborative Research)-coated 10-cm dishes or six-well plates. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "trypsinized"

Phrase: "and"

Phrase: "replated"

Phrase: "("

Phrase: "Replate"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "onto poly-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0747726:POLY [Conceptual Entity]

Phrase: "D-"

Phrase: "lysine/Matrigel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0065749:matrigel [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Collaborative Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]

Phrase: ")"

Phrase: "-"

Phrase: "coated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1522408:Coated [Qualitative Concept]
   966 E C0453946:Coat [Manufactured Object]
   966 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "10-cm dishes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0020498:DISH [Disease or Syndrome]

Phrase: "or"

Phrase: "six-well plates."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1139930:plates [Medical Device]
   793 E C0005971:Plate [Medical Device]
   793 E C3537155:Plate [Manufactured Object]
Processing 00000000.tx.53: Cells were fed once a week with DMEM medium supplemented with 5% fetal bovine serum, 1% penicillin/streptomycin, and mitotic inhibitors (1mM cytosine arabinoside, 10mM fluorodeoxyuridine, 10mM uridine) for 4weeks. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "fed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0342895:FED [Disease or Syndrome]
   966 E C0204695:Feed [Health Care Activity]
   966 E C2987508:Feed [Activity]

Phrase: "once"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720092:Once [Intellectual Product]
  1000   C1948045:Once [Temporal Concept]

Phrase: "a week with DMEM medium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332174:/week [Temporal Concept]
   760   C0439230:week [Temporal Concept]

Phrase: "supplemented with 5% fetal bovine serum,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0007452:Bovine [Mammal]
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0521457:Fetal [Functional Concept]
   753   C1140701:bovine [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "1% penicillin/streptomycin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "and"

Phrase: "mitotic inhibitors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003379:Mitotic Inhibitors [Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1513354:Mitotic [Qualitative Concept]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(1mM cytosine arabinoside,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0010711:Cytosine Arabinoside [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0010843:Cytosine [Biologically Active Substance,Organic Chemical]
   817 E C0591320:Cytosar [Hazardous or Poisonous Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "10mM fluorodeoxyuridine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016343:Fluorodeoxyuridine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "10mM uridine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041984:Uridine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "for 4weeks."
Processing 00000000.tx.54: This yielded a >95% pure culture of differentiated human neurons (NT2N) that could be maintained in culture for 7-8 weeks. 

Phrase: "This yielded a >95% pure culture of differentiated human neurons"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   739   C0010453:Culture [Idea or Concept]
   739   C0220814:culture [Functional Concept]
   739   C0430400:Culture [Laboratory Procedure]
   739   C2242979:Culture [Laboratory Procedure]
   739   C2247561:PurE [Molecular Function]

Phrase: "(NT2N"

Phrase: ")"

Phrase: "that"

Phrase: "could"

Phrase: "be"

Phrase: "maintained in culture"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0010453:Culture [Idea or Concept]
   790   C0220814:culture [Functional Concept]
   790   C0430400:Culture [Laboratory Procedure]
   790   C1314677:Maintained [Functional Concept]
   790   C2242979:Culture [Laboratory Procedure]
   756 E C0024501:Maintain [Activity]

Phrase: "for 7-8 weeks."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439230:weeks [Temporal Concept]
   793 E C0332174:/week [Temporal Concept]
Processing 00000000.tx.55: Pharmacological Treatment of NT2N Neurons-- NT2N 10-cm dishes or six-well plates (240-480 ng of DNA) were washed three times in Krebs-Hepes buffer (25mM Hepes, pH 7.4, 115mM NaCl, 24mM NaHCO3, 5mM KCl, 2.5mM CaCl2, 1mM MgCl2, 0.1% bovine serum albumin, 3mM D-glucose), preincubated 30min under an atmosphere of 95% O2/5% CO2 at 37C, and then incubated for the appropriate time with agonists (glutamate, ACPD, quisqualate, CCG-I, PMA, A23187, OAG). 

Phrase: "Pharmacological Treatment of NT2N Neurons"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0013216:Pharmacological Treatment [Therapeutic or Preventive Procedure]
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "--"

Phrase: "NT2N 10-cm dishes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C0020498:DISH [Disease or Syndrome]

Phrase: "or"

Phrase: "six-well"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205170:Well [Qualitative Concept]
   861   C0205452:Six [Quantitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: "(240-480 ng of DNA"

Phrase: ")"

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times in Krebs-Hepes buffer"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]

Phrase: "(25mM Hepes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "115mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "24mM NaHCO3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0074722:NaHCO3 [Organic Chemical,Pharmacologic Substance]

Phrase: "5mM KCl,"

Phrase: "2.5mM CaCl2,"

Phrase: "1mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "0.1% bovine serum albumin,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   840   C0728877:serum albumin [Laboratory or Test Result]
   804   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0007452:Bovine [Mammal]
   804   C0229671:Serum [Body Substance]
   804   C1140701:bovine [Mammal]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]

Phrase: "3mM"

Phrase: "D-"

Phrase: "glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "preincubated 30min under an atmosphere of 95% O2/5% CO2"

Phrase: "at 37C,"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated for the appropriate time"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0040223:Time [Temporal Concept]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1548787:Appropriate [Qualitative Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "with agonists"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243192:agonists [Pharmacologic Substance]
  1000   C2987634:agonists [Pharmacologic Substance]

Phrase: "(glutamate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "ACPD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0044270:ACPD [Organic Chemical,Pharmacologic Substance]

Phrase: "quisqualate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080073:Quisqualate [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "CCG-I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "PMA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C2825188:PMA [Intellectual Product]

Phrase: "A23187,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878412:A23187 [Antibiotic,Organic Chemical]

Phrase: "OAG"

Phrase: ")."
Processing 00000000.tx.56: To examine the effect of the glutamate receptor antagonists (CNQX, AP5, AIDA, MPPG, MSOPPE) and DAG lipase and kinase inhibitors (RG80267, R59949), the cells were pretreated with the agents for 30min at 37C and then incubated for an additional 30min alone or in presence of glutamate. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the effect of the glutamate receptor antagonists"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "(CNQX,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0099122:CNQX [Organic Chemical,Pharmacologic Substance]

Phrase: "AP5,"

Phrase: "AIDA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1823700:AIDA [Gene or Genome]

Phrase: "MPPG,"

Phrase: "MSOPPE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1100145:MSOPPE [Amino Acid, Peptide, or Protein,Organophosphorus Compound]

Phrase: ")"

Phrase: "and"

Phrase: "DAG lipase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023816:DAG lipase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0023764:Lipase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "kinase inhibitors"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C1152564:Kinase Inhibitors [Molecular Function]
   983 E C1171350:Kinase Inhibitor [Pharmacologic Substance]
   983 E C3537023:kinase inhibitor [Molecular Function]
   983 E C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(RG80267,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0284518:Rg80267 [Organic Chemical,Pharmacologic Substance]

Phrase: "R59949"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072922:R59949 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "pretreated with the agents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0450442:Agent [Chemical Viewed Functionally]
   737   C1254351:Agent [Pharmacologic Substance]
   737   C1521826:Agent [Intellectual Product]

Phrase: "for 30min"

Phrase: "at 37C"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated for an additional 30min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1524062:Additional [Functional Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or in presence of glutamate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   760   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.57: Measurement of APP-S Secretion by Metabolic Labeling and Immunoprecipitation-- In order to metabolically label APP, NT2N cells were serum-starved for 20min in DMEM methionine-free medium and then labeled with 100-400 Ci/ml [35S]methionine in DMEM methionine-free medium (1% penicillin/streptomycin, 5% fetal bovine serum) for 3h. 

Phrase: "Measurement of APP-S Secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0202202:Protein measurement [Laboratory Procedure]
   753   C0242485:Measurement [Functional Concept]

Phrase: "by Metabolic Labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1167624:Labeling [Mental Process]
   861   C1947902:Labeling [Manufactured Object]
   861   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "Immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "-"

Phrase: "-"

Phrase: "In order"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1705175:Order [Intellectual Product]
  1000   C1705176:Order [Qualitative Concept]
  1000   C1705177:Order [Classification]
  1000   C1705178:Order [Activity]
  1000   C1882348:Order [Qualitative Concept]

Phrase: "to metabolically label APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "NT2N cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "serum-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "starved for 20min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C2348531:Starve [Activity]

Phrase: "in DMEM methionine-free medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0009458:Medium [Intellectual Product]
   812   C0439536:Medium [Quantitative Concept]
   812   C1705217:Medium [Substance]
   812   C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "labeled with 100-400 Ci/ml [35S"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   778   C2348025:Ci/mL [Quantitative Concept]
   748   C0439526:/mL [Quantitative Concept]
   748   C1708632:Labeled [Qualitative Concept]
   714 E C0181496:Label [Manufactured Object]
   714 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "]methionine in DMEM methionine-free medium"

Phrase: "(1% penicillin/streptomycin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "5% fetal bovine serum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0007452:Bovine [Mammal]
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0521457:Fetal [Functional Concept]
   812   C1140701:bovine [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: ")"

Phrase: "for 3h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]
Processing 00000000.tx.58: The cells were then treated as described above. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "treated as described above."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0332293:treated [Therapeutic or Preventive Procedure]
   770   C1522326:Treated [Functional Concept]
   770   C1552738:described [Idea or Concept]
   737 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.59: After treatment, the supernatant was removed and centrifuged for 15min at 15,000g to remove any remaining cells. 

Phrase: "After treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "centrifuged for 15min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "at 15,"

Phrase: "000g to"

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "any remaining cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.60: The supernatant was precleared with protein A-Sepharose beads and then immunoprecipitated overnight with 10-20 g of an anti-APP-S polyclonal antibody (Karen) and protein A-Sepharose beads as described previously (6). 

Phrase: "The supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "precleared with protein A-Sepharose beads"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0036681:Sepharose [Carbohydrate]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0991566:Beads [Biomedical or Dental Material]
   719 E C2346972:Bead [Spatial Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "overnight with 10-20 g"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1630409:20/10 [Finding]
   760   C0439267:g% [Quantitative Concept]
   760   C0439583:Overnight [Temporal Concept]

Phrase: "of an anti-APP-S polyclonal antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   895   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   839   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Karen"

Phrase: ")"

Phrase: "and"

Phrase: "protein A-Sepharose beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0991566:Beads [Biomedical or Dental Material]
   779 E C2346972:Bead [Spatial Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.61: Immunoprecipitates were analyzed on 7.5% SDS-PAGE mini-gels, and the radioactivity quantitated using Image Quant software on a Molecular Dynamics PhosphorImager. 

Phrase: "Immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "analyzed on 7.5% SDS-PAGE mini-gels,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   767   C1538570:PAGE-5 [Gene or Genome]
   744   C0017243:Gels [Biomedical or Dental Material]
   744   C0445542:Mini [Organism Attribute]
   744   C0936012:Analyzed [Research Activity]
   744   C1704732:Page [Intellectual Product]
   711 E C1382104:Gel [Substance]

Phrase: "and"

Phrase: "the radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "quantitated"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Image Quant software on a Molecular Dynamics PhosphorImager."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0037585:Software [Intellectual Product,Manufactured Object]
Processing 00000000.tx.62: For data analysis, the control was designated as 100% within each experiment due the differences in radioactive counts between the controls in separate experiments. 

Phrase: "For data analysis,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0010992:Data Analysis [Occupational Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1511726:Data [Idea or Concept]
   861   C1524024:analysis [Functional Concept]
   861   C3245479:data [Medical Device]

Phrase: "the control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "was"

Phrase: "designated as 100%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1524084:Designated [Functional Concept]

Phrase: "within each experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "due"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0678226:due [Functional Concept]
  1000   C3146286:Due [Idea or Concept]

Phrase: "the differences in radioactive counts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "between the controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "in separate experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.63: The glutamate-induced APP-S secretion was determined to be specific for APP after demonstrating that glutamate did not have an effect on the amount of total secreted proteins (data not shown). 

Phrase: "The glutamate-induced APP-S secretion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   895   C1817648:glutamate secretion [Cell Function]
   827   C1159339:Protein Secretion [Cell Function]
   799   C0036536:secretion [Biologic Function]
   799   C0036537:Secretion [Body Substance]

Phrase: "was"

Phrase: "determined"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "specific for APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205369:Specific [Qualitative Concept]
   760   C1552740:specific [Intellectual Product]

Phrase: "after"

Phrase: "demonstrating"

Phrase: "that glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "an effect on the amount of total secreted proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.64: RT-PCR Analysis of Metabotropic Glutamate Receptor Subtypes mGluR1a/b and mGluR5a in NT2N Cells-- 60-90 g of total RNA was isolated from NT2N cells as described previously (24). 

Phrase: "RT-PCR Analysis of Metabotropic Glutamate Receptor Subtypes mGluR1a/b"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0200931:PCR analysis [Laboratory Procedure]
   760   C0599161:RT-PCR [Molecular Biology Research Technique]
   739   C0002778:Analysis [Laboratory Procedure]
   739   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   739   C0677874:pCR [Finding]
   739   C0936012:Analysis [Research Activity]
   739   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "mGluR5a in NT2N Cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1706589:MGLUR5A [Gene or Genome]

Phrase: "--"

Phrase: "60-90 g of total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "isolated from NT2N cells"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C0205409:Isolated [Functional Concept]
   760   C1548221:Isolated [Idea or Concept]
   760   C3282337:Cells [Cell]
   726 E C0370215:Isolate [Substance]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1875400:ISOLATE [Pharmacologic Substance]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.65: Reverse transcription was then performed as follows. 

Phrase: "Reverse transcription"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035380:Reverse Transcription [Genetic Function]
   861   C0040649:Transcription [Genetic Function]
   861   C1555029:Reverse [Idea or Concept]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "follows."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]
Processing 00000000.tx.66: For reverse transcription, RNA was incubated at 65C for 5min and then placed on ice for 10min. 

Phrase: "For reverse transcription,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035380:Reverse Transcription [Genetic Function]
   861   C0040649:Transcription [Genetic Function]
   861   C1555029:Reverse [Idea or Concept]

Phrase: "RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "incubated at 65C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 5min"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "placed on ice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0020746:Ice [Inorganic Chemical]
   756   C0442504:Place [Spatial Concept]
   756   C1704765:Place [Functional Concept]
   756   C1882509:Place [Activity]
   756   C3496241:place [Disease or Syndrome]

Phrase: "for 10min."
Processing 00000000.tx.67: For each reaction of 31l, less than 30g of total RNA was added to the reaction mixture of: RNase inhibitor (40units/ml), first strand cDNA 5 buffer, Moloney murine leukemia virus reverse transcriptase (200units/ml), bovine serum albumin (1mg/ml), 0.1M dithiothreitol, and oligo(dT) (1.5g). 

Phrase: "For each reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "of 31l,"

Phrase: "less than 30g of total RNA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0439092:Less Than [Intellectual Product]
           less
   753   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]
   753   C0547044:Less [Qualitative Concept]

Phrase: "was"

Phrase: "added to the reaction mixture of"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0439962:Mixture [Substance]
   753   C0443286:Reaction [Functional Concept]
   753   C1114821:Reaction [Clinical Attribute]
   753   C1524062:Added [Functional Concept]
   719 E C1883712:Add [Functional Concept]

Phrase: ":"

Phrase: "RNase inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(40units/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "strand"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704972:Strand [Spatial Concept]
  1000   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "cDNA 5 buffer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "Moloney murine leukemia virus reverse transcriptase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C1555029:Reverse [Idea or Concept]
   799   C2257077:transcriptase [Genetic Function]
   734   C0026398:Moloney murine leukemia virus [Virus]
           Moloney Leukemia Virus

Phrase: "(200units/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "bovine serum albumin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   901   C0728877:serum albumin [Laboratory or Test Result]
   827   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0007452:Bovine [Mammal]
   827   C0229671:Serum [Body Substance]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "(1mg/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "0.1M dithiothreitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "oligo(dT) (1.5g"

Phrase: ")."
Processing 00000000.tx.68: The reverse transcription reaction was performed in a thermal cycler for 60min at 42C, followed by a 10-min incubation at 72C. 

Phrase: "The reverse transcription reaction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
   734   C0035380:Reverse Transcription [Genetic Function]

Phrase: "was"

Phrase: "performed in a thermal cycler"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C1611676:Thermal Cycler [Medical Device]
   760   C0884358:Performed [Functional Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "for 60min"

Phrase: "at 42C,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419782:42C [Gene or Genome]
  1000   C3538774:42C [Gene or Genome]

Phrase: "followed by a 10-min incubation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0332283:Followed by [Temporal Concept]
           followed
   790   C0456692:/10 min [Temporal Concept]
   753   C0702093:/min [Temporal Concept]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "at 72C."
Processing 00000000.tx.69: The cDNA generated was then amplified in a 50-l PCR using 8.5l of the cDNA, 10PCR buffer, 1l of dNTP mix (10mM each of dATP, dCTP, dGTP, dTTP), 0.25l of Taq polymerase (5units/l), and 2.5l of each specific primer (20M each) (designed from the published sequence of human mGluR1 (5' CTGCATGTTCACTCCCAAGATGTACAT, 3' CACGCGCCTGTGCACCACCATGGAAG) and mGluR5 (5' TGTGCCCAGCTAGTGATTGC, 3' TGCTCTTCTCATTCTGGGC) (25, 26). 

Phrase: "The cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "amplified in a 50-l PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0677874:pCR [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "8.5l of the cDNA,"

Phrase: "10PCR buffer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "1l of dNTP mix"

Phrase: "(10mM"

Phrase: "each of dATP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0045186:dATP [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C1457900:Each [Quantitative Concept]

Phrase: "dCTP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0045191:dCTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "dGTP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0057430:dGTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "dTTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076582:dTTP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: ","

Phrase: "0.25l of Taq polymerase"

Phrase: "(5units/l),"

Phrase: "and"

Phrase: "2.5l of each specific primer"

Phrase: "(20M"

Phrase: "each"

Phrase: ")"

Phrase: "("

Phrase: "designed from the published sequence of human mGluR1"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   744   C0004793:Sequence [Nucleotide Sequence]
   744   C0034037:Published [Occupational Activity]
   744   C0086418:Human [Human]
   744   C0162326:Sequence [Nucleotide Sequence]
   744   C0162327:Sequence [Nucleotide Sequence]
   744   C0535210:mGluR1 [Amino Acid, Peptide, or Protein,Receptor]
   744   C1333711:MGLUR1 [Gene or Genome]
   744   C1519249:Sequence [Functional Concept]
   744   C1704324:Published [Intellectual Product]
   744   C1706579:MGLUR1 [Gene or Genome]
   711   C1707689:Design [Activity]
   711   C2983265:DESIGN [Intellectual Product]

Phrase: "(5' CTGCATGTTCACTCCCAAGATGTACAT,"

Phrase: "3' CACGCGCCTGTGCACCACCATGGAAG"

Phrase: ")"

Phrase: "and"

Phrase: "mGluR5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1333712:MGLUR5 [Gene or Genome]
  1000   C1706589:MGLUR5 [Gene or Genome]

Phrase: "(5' TGTGCCCAGCTAGTGATTGC,"

Phrase: "3' TGCTCTTCTCATTCTGGGC"

Phrase: ")"

Phrase: "(25,"

Phrase: "26"

Phrase: ")."
Processing 00000000.tx.70: The reaction mixtures were layered with mineral oil, placed in the thermal cycler, and programmed for 2min at 94C, followed by 40cycles at 94C for 1min, 60C for 2min, 72C for 3 min, and then a final 7min at 72C. 

Phrase: "The reaction mixtures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:mixtures [Substance]

Phrase: "were"

Phrase: "layered with mineral oil,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0026156:Mineral Oil [Lipid,Pharmacologic Substance]
   770   C0026162:Mineral [Inorganic Chemical]
   770   C0028908:Oil [Lipid]
   770   C0934502:Layered [Body Part, Organ, or Organ Component]
   770   C1517288:Oil [Food,Lipid]
   737 E C1522408:Layer [Qualitative Concept]
   737 E C1561599:Layer [Intellectual Product]
   715 E C0996956:Olea [Plant]

Phrase: "placed in the thermal cycler,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1611676:Thermal Cycler [Medical Device]
   726   C0442504:Place [Spatial Concept]
   726   C1704765:Place [Functional Concept]
   726   C1882509:Place [Activity]
   726   C3496241:place [Disease or Syndrome]

Phrase: "and"

Phrase: "programmed for 2min"

Phrase: "at 94C,"

Phrase: "followed by 40cycles"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C0332283:Followed by [Temporal Concept]
           followed
   756 E C1719822:Follow [Intellectual Product]

Phrase: "at 94C"

Phrase: "for 1min,"

Phrase: "60C for 2min,"

Phrase: "72C for 3 min,"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "a final 7min at 72C."
Processing 00000000.tx.71: The tubes were placed at 4C until the PCR products were analyzed for purity and size on a 1.5% agarose gels. 

Phrase: "The tubes"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0175730:tubes [Medical Device]
  1000   C1547937:Tubes [Intellectual Product]
  1000   C1704474:Tubes [Quantitative Concept]
   966 E C1561954:tube [Conceptual Entity]
   966 E C1704730:TUBE [Medical Device]

Phrase: "were"

Phrase: "placed at 4C"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0450376:4c [Intellectual Product]
   756   C0442504:Place [Spatial Concept]
   756   C1704765:Place [Functional Concept]
   756   C1882509:Place [Activity]
   756   C3496241:place [Disease or Syndrome]

Phrase: "until the PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "analyzed for purity"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0936012:Analyzed [Research Activity]
   790   C1882508:Purity [Quantitative Concept]
   718 E C2247561:PurE [Molecular Function]

Phrase: "and"

Phrase: "size on a 1.5% agarose gels."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0456389:size [Spatial Concept]
Processing 00000000.tx.72: The products were excised from the gels and purified with the Geneclean II kit and the purified products subjected to a restriction enzyme digest with EcoRI for the identification of mGluR1/ and BglI for mGluR5. 

Phrase: "The products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "excised from the gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0017243:Gels [Biomedical or Dental Material]
   737 E C1382104:Gel [Substance]

Phrase: "and"

Phrase: "purified with the Geneclean II kit"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0812225:KIT [Medical Device]
   753   C1150635:KIT [Molecular Function]
   753   C1705212:Kit [Medical Device]
   753   C1705213:KIT [Medical Device]
   753   C1998793:Purified [Functional Concept]
   753   C3273202:Kit [Manufactured Object]

Phrase: "and"

Phrase: "the purified products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "subjected to a restriction enzyme"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0012906:Restriction Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0443288:Restriction [Functional Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "digest with EcoRI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011516:Eco-RI [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0868946:digest [Physiologic Function]

Phrase: "for the identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020792:Identification [Mental Process]
  1000   C0205396:Identification [Qualitative Concept]

Phrase: "of mGluR1/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0535210:mGluR1 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1333711:MGLUR1 [Gene or Genome]
  1000   C1706579:MGLUR1 [Gene or Genome]

Phrase: "and"

Phrase: "BglI for mGluR5."
Processing 00000000.tx.73: Measurement of IP3 Accumulation-- NT2N cells were labeled for 48h with 10Ci/dish of myo-[3H]inositol, washed three times with Krebs-Hepes buffer (25mM Hepes, pH 7.4,115mM NaCl, 24mM NaHCO3, 5mM KCl, 2.5mM CaCl2, 1mM MgCl2, 0.1% bovine serum albumin, 3mM D-glucose, 10mM LiCl), preincubated 30min under an atmosphere of 95% O2, 5% CO2 at 37C, and then incubated for 2min with fresh Krebs-Hepes buffer1 mM glutamate. 

Phrase: "Measurement of IP3 Accumulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0242485:Measurement [Functional Concept]

Phrase: "--"

Phrase: "NT2N cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "labeled for 48h"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1442464:48H [Temporal Concept]
   790   C1708632:Labeled [Qualitative Concept]
   756 E C0181496:Label [Manufactured Object]
   756 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "with 10Ci/dish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020498:DISH [Disease or Syndrome]

Phrase: "of myo-"

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]inositol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times with Krebs-Hepes buffer"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]

Phrase: "(25mM Hepes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "115mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "24mM NaHCO3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0074722:NaHCO3 [Organic Chemical,Pharmacologic Substance]

Phrase: "5mM KCl,"

Phrase: "2.5mM CaCl2,"

Phrase: "1mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "0.1% bovine serum albumin,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   840   C0728877:serum albumin [Laboratory or Test Result]
   804   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0007452:Bovine [Mammal]
   804   C0229671:Serum [Body Substance]
   804   C1140701:bovine [Mammal]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]

Phrase: "3mM"

Phrase: "D-"

Phrase: "glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "10mM LiCl"

Phrase: ")"

Phrase: ","

Phrase: "preincubated 30min under an atmosphere of 95% O2,"

Phrase: "5% CO2 at 37C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2347816:Co2+ [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated for 2min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "with fresh Krebs-Hepes buffer1 mM glutamate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   799   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.74: Inositol phosphates were extracted with 0.5ml of a 1:5 trichloroacetic acid solution and then neutralized with 1ml of a 3:1 solution of trichlorotrifluoroethane/trioctylamine. 

Phrase: "Inositol phosphates"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021554:Inositol Phosphates [Carbohydrate]
   861   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]
   861   C0031603:Phosphates [Inorganic Chemical,Pharmacologic Substance]
   827 E C0031701:phosphate [Organophosphorus Compound]
   827 E C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "extracted with 0.5ml of a 1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0185115:Extracted [Therapeutic or Preventive Procedure]
   748   C3541890:EXTRACTED [Finding]
   714 E C2828366:Extract [Substance]

Phrase: ":"

Phrase: "5 trichloroacetic acid solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037633:Solution [Substance]
   812   C0525069:Solution [Biomedical or Dental Material]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "neutralized with 1ml of a 3"

Phrase: ":"

Phrase: "1 solution of trichlorotrifluoroethane/trioctylamine."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037633:Solution [Substance]
   760   C0525069:Solution [Biomedical or Dental Material]
Processing 00000000.tx.75: The aqueous layers, as well as commercially available inositol phosphates for standardization of the columns, were loaded onto pre-equilibrated Amprep SAX minicolumns and the inositol phosphate adducts (inositol 1-phosphate (IP), inositol 1,4-bisphosphate (IP2), inositol 1,4,5-trisphosphate (IP3), inositol 1,3,4,5-tetrakisphosphate (IP4)) eluted with a step gradient of 5ml each of 0.05,0.10, 0.16,and 0.17M potassium bicarbonate (KHCO3). 

Phrase: "The aqueous layers,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0934502:layers [Body Part, Organ, or Organ Component]
   827 E C1522408:Layer [Qualitative Concept]
   827 E C1561599:Layer [Intellectual Product]

Phrase: "as well as"

Phrase: "commercially available inositol phosphates for standardization of the columns,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   764   C0021554:Inositol Phosphates [Carbohydrate]
   742   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]
   742   C0031603:Phosphates [Inorganic Chemical,Pharmacologic Substance]
   708 E C0031701:phosphate [Organophosphorus Compound]
   708 E C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "loaded onto"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   833   C1708715:Loaded [Activity]
   799 E C1550025:Load [Idea or Concept]
   799 E C1704782:Load [Manufactured Object]

Phrase: "pre-equilibrated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332152:Pre [Temporal Concept]
   861   C0740175:Pre [Qualitative Concept]
   861   C2257086:PRE [Genetic Function]

Phrase: "Amprep SAX minicolumns"

Phrase: "and"

Phrase: "the inositol phosphate adducts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0596040:adducts [Chemical Viewed Structurally]
   734   C0021554:inositol phosphate [Carbohydrate]

Phrase: "(inositol 1-phosphate (IP),"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0063574:inositol 1-phosphate [Carbohydrate]
   913   C0021554:inositol phosphate [Carbohydrate]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "inositol 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]

Phrase: "4-bisphosphate"

Phrase: "(IP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2697645:IP2 [Gene or Genome]
  1000   C3539932:IP2 [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: ","

Phrase: "inositol 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]

Phrase: "4,"

Phrase: "5-trisphosphate"

Phrase: "(IP3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021549:IP3 [Biologically Active Substance,Carbohydrate]
  1000   C3542924:IP3 [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: ","

Phrase: "inositol 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4,"

Phrase: "5-tetrakisphosphate"

Phrase: "(IP4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3640681:IP4 [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: ")"

Phrase: "eluted with a step gradient of 5ml"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0439182:% gradient [Quantitative Concept]
   748   C0812409:Gradient [Quantitative Concept]
   748   C1261552:Step [Conceptual Entity]
   748   C1704379:Step [Functional Concept]
   748   C1705117:Step [Quantitative Concept]
   748   C2825408:Step [Manufactured Object]

Phrase: "each of 0.05,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1457900:Each [Quantitative Concept]

Phrase: "0.10,"

Phrase: "0.16,"

Phrase: "and"

Phrase: "0.17M potassium bicarbonate"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0071751:potassium bicarbonate [Organic Chemical,Pharmacologic Substance]
   812   C0005367:Bicarbonate [Inorganic Chemical,Pharmacologic Substance]
   812   C0032821:Potassium [Element, Ion, or Isotope]
   812   C0597277:Potassium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C0973231:Bicarbonate [Inorganic Chemical]
   812   C2722820:BICARBONATE [Organic Chemical,Pharmacologic Substance]

Phrase: "(KHCO3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0071751:KHCO3 [Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.76: The fractions were collected and counted in a Wallac scintillation counter. 

Phrase: "The fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "counted in a Wallac scintillation counter."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0036405:Scintillation Counter [Medical Device]
   790   C1710025:Scintillation Counter [Manufactured Object]
   753   C0677601:Counter [Manufactured Object]
   753   C0678573:scintillation [Natural Phenomenon or Process]
   753   C1705206:Counter [Medical Device]
   719   C0750480:Count [Activity]
   719   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.77: Cytosolic Free Ca2+ Measurement-- Cells were loaded with fura-2 during a 40-min incubation at 37C in 2ml of Krebs-Hepes buffer (115mM NaCl, 24mM NaHCO3, 5mM KCl, 1mM MgCl2, 2.5mM CaCl2, 25mM glucose, and 25mM Hepes, pH 7.40) supplemented with 2.5M fura-2 acetoxymethylester (Molecular Probes, Eugene, OR) and 0.2mg/ml pluronic F-127 (Molecular Probes), which was used to increase the loading. 

Phrase: "Cytosolic Free Ca2+ Measurement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0242485:Measurement [Functional Concept]

Phrase: "--"

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "loaded with fura-2"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0079389:Fura-2 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C1708715:Loaded [Activity]
   737 E C1550025:Load [Idea or Concept]
   737 E C1704782:Load [Manufactured Object]

Phrase: "during a 40-min incubation"

Phrase: "at 37C"

Phrase: "in 2ml"

Phrase: "of Krebs-Hepes buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(115mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "24mM NaHCO3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0074722:NaHCO3 [Organic Chemical,Pharmacologic Substance]

Phrase: "5mM KCl,"

Phrase: "1mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "2.5mM CaCl2,"

Phrase: "25mM glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "25mM Hepes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.40"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0439509:/40 [Temporal Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "supplemented with 2.5M fura-2 acetoxymethylester"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0079389:Fura-2 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   714   C0242295:Supplement [Food]
   714   C1947943:Supplement [Intellectual Product]
   714   C2348609:Supplement [Functional Concept]

Phrase: "(Molecular Probes,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "Eugene,"

Phrase: "OR)"

Phrase: "and"

Phrase: "0.2mg/ml pluronic F-127"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0032253:Pluronic F-127 [Organic Chemical,Pharmacologic Substance]
   799   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   799   C0032251:pluronic [Organic Chemical]
   799   C0439133:(f) [Intellectual Product]
   799   C1553038:[f] [Quantitative Concept]

Phrase: "(Molecular Probes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the loading."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708715:Loading [Activity]
Processing 00000000.tx.78: The coverslip with the loaded cells was then mounted in a perifusion chamber placed on the homeothermic platform of an inverted Zeiss microscope. 

Phrase: "The coverslip with the loaded cells"

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "mounted in a perifusion chamber"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0449878:mounted [Finding]
   760   C0935616:Chamber [Body Part, Organ, or Organ Component]
   726 E C0181909:Mount [Medical Device]

Phrase: "placed on the homeothermic platform of an inverted Zeiss microscope."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   739   C0181839:Microscope [Medical Device]
   739   C0443241:Inverted [Qualitative Concept]
   739   C1706379:Microscope [Medical Device]
   739   C1710360:Platform [Research Device]
   706   C0442504:Place [Spatial Concept]
   706   C1704765:Place [Functional Concept]
   706   C1882509:Place [Activity]
   706   C3496241:place [Disease or Syndrome]
Processing 00000000.tx.79: The cells were superfused with Krebs-Hepes buffer at 37C at a flow rate of 1.5ml/min. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "superfused with Krebs-Hepes buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "at 37C"

Phrase: "at a flow rate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2826285:Flow Rate [Quantitative Concept]
   861   C0806140:Flow [Natural Phenomenon or Process]
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "of 1.5ml/min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]
Processing 00000000.tx.80: The microscope was used with a40oil objective. 

Phrase: "The microscope"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0181839:Microscope [Medical Device]
  1000   C1706379:Microscope [Medical Device]

Phrase: "was"

Phrase: "used with a40oil objective."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0018017:Objective [Intellectual Product]
   770   C1273517:used [Finding]
   770   C1571702:Objective [Qualitative Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.81: Fura-2 was successively excited at 334and 380nm by means of two narrow band-pass filters. 

Phrase: "Fura-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079389:Fura-2 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "successively"

Phrase: "excited at 334and 380nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0549255:Excited [Activity]

Phrase: "by means of two narrow band-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0175723:Band [Medical Device]
   827   C0205168:Narrow [Qualitative Concept]
   827   C0332463:Narrow [Spatial Concept]
   827   C0333164:Narrow [Quantitative Concept]
   827   C0439645:Band [Spatial Concept]
   827   C1521913:band [Cell Component]

Phrase: "pass"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828386:Pass [Finding]

Phrase: "filters."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0180860:Filters [Manufactured Object]
   966 E C0581406:Filter [Medical Device]
   966 E C1522664:Filter [Intellectual Product]
   966 E C1704449:Filter [Conceptual Entity]
   966 E C1704684:Filter [Medical Device]
   966 E C1875155:FILTER [Medical Device]
Processing 00000000.tx.82: The emitted fluorescence was filtered through a 520-nm filter, captured with an Attofluor CCD video camera at a resolution of 512480pixels, digitized into 256 gray levels, and analyzed with version 6.00of the Attofluor RatioVision software (Atto Instrument, Rockville, MD). 

Phrase: "The emitted fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "filtered through a 520-nm filter,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0312860:NM [Cell Function]
   719   C0180860:Filter [Manufactured Object]
   719   C0581406:Filter [Medical Device]
   719   C1522664:Filter [Intellectual Product]
   719   C1704449:Filter [Conceptual Entity]
   719   C1704684:Filter [Medical Device]
   719   C1875155:FILTER [Medical Device]

Phrase: "captured with an Attofluor CCD video camera"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0179547:video camera [Medical Device]
   774   C0598124:CCD camera [Manufactured Object]
   748   C0042655:Video [Manufactured Object]
   748   C0179533:Camera [Medical Device]
   748   C1654607:Camera [Eukaryote]
   748   C1706254:CAMERA [Medical Device]
   748   C3463807:Video [Intellectual Product]

Phrase: "at a resolution"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1514893:Resolution [Idea or Concept]
  1000   C1706463:Resolution [Quantitative Concept]
  1000   C2699488:Resolution [Conceptual Entity]

Phrase: "of 512480pixels,"

Phrase: "digitized into 256 gray levels,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0441889:Levels [Qualitative Concept]
   760   C0556636:gray [Quantitative Concept]
   760   C1269776:Gray [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "analyzed with version 6.00of"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0333052:Version [Functional Concept]
   760   C0936012:Analyzed [Research Activity]
   760   C2607870:Version [Spatial Concept]

Phrase: "the Attofluor RatioVision software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(Atto Instrument,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0348000:Instrument [Medical Device]

Phrase: "Rockville,"

Phrase: "MD)."
Processing 00000000.tx.83: The concentration of Ca2+ was calculated by comparing the ratio of fluorescence at each pixel to an in vitro 2-point calibration curve. 

Phrase: "The concentration of Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "was"

Phrase: "calculated by comparing"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0444686:Calculated [Functional Concept]
   790   C1441506:Calculated [Activity]
   790   C1443182:Calculated [Laboratory Procedure]
   756   C1707455:Compare [Activity]

Phrase: "the ratio of fluorescence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0456603:Ratio [Quantitative Concept]
   770   C1547037:Ratio [Intellectual Product]

Phrase: "at each pixel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709558:Pixel [Conceptual Entity]

Phrase: "to an in vitro 2-point calibration curve."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0205134:Curve [Spatial Concept]
Processing 00000000.tx.84: The Ca2+ concentration is presented by averaging the values of all pixels in the body of a differentiated NT2N cell (neuron soma), excluding the Ca2+ data of neurites. 

Phrase: "The Ca2+ concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "is"

Phrase: "presented by averaging"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449450:Presented [Idea or Concept]
   756 E C0150312:Present [Quantitative Concept]
   756   C1510992:Average [Quantitative Concept]
   756   C2825518:AVERAGE [Quantitative Concept]

Phrase: "the values of all pixels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0042295:Values [Qualitative Concept]
   726 E C1522609:Value [Quantitative Concept]

Phrase: "in the body"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242821:body [Human]
  1000   C0460148:Body [Anatomical Structure]
  1000   C1268086:Body [Anatomical Structure]
   916 E C1995017:Bodies [Cell Component]

Phrase: "of a differentiated NT2N cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "(neuron soma"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   922   C2952302:Neuronal somata [Cell Component]
   861   C0599444:soma [Cell Component]
   861   C0702216:Soma [Organic Chemical,Pharmacologic Substance]
   805 E C0007248:Carisoprodol [Organic Chemical,Pharmacologic Substance]
   768 E C2986476:Somatic [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "excluding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0332196:Exclude [Functional Concept]
   966   C2828389:Exclude [Activity]

Phrase: "the Ca2+ data of neurites."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]
Processing 00000000.tx.85: Data points were collected at an interval of 4.5s. 

Phrase: "Data points"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C3176122:Data points [Clinical Attribute]
   983 E C1511726:Data Point [Idea or Concept]
   827   C1552961:Point [Quantitative Concept]
   827   C2347617:point [Quantitative Concept]

Phrase: "were"

Phrase: "collected at an interval of 4.5s."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C1272706:Interval [Temporal Concept]
   748   C1516695:Collected [Idea or Concept]
   748   C1516698:Collected [Functional Concept]
   748   C1552119:5s [Body Part, Organ, or Organ Component]
   748   C1552654:Interval [Idea or Concept]
   748   C1552713:Interval [Intellectual Product]
Processing 00000000.tx.86: Data Analysis-- Student's t test was performed when two groups were compared. 

Phrase: "Data Analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0010992:Data Analysis [Occupational Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1511726:Data [Idea or Concept]
   861   C1524024:analysis [Functional Concept]
   861   C3245479:data [Medical Device]

Phrase: "--"

Phrase: "Student's t test"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0022885:Test [Laboratory Procedure]
   827   C0038492:student [Professional or Occupational Group]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   827   C1551041:student [Idea or Concept]
   827   C1552573:student [Intellectual Product]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "when"

Phrase: "two groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "compared."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]
Processing 00000000.tx.87: Analysis of variance was used, followed by the Student-Newman-Keuls method when multiple groups were compared. 

Phrase: "Analysis of variance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ","

Phrase: "followed by the Student-Newman-Keuls method"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   778   C0332283:Followed by [Temporal Concept]
           followed
   748   C0025663:Method [Intellectual Product]
   748   C0038492:student [Professional or Occupational Group]
   748   C0449851:Method [Functional Concept]
   748   C0871511:METHOD [Intellectual Product]
   748   C1551041:student [Idea or Concept]
   748   C1552573:student [Intellectual Product]
   714 E C1719822:Follow [Intellectual Product]

Phrase: "when"

Phrase: "multiple groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "compared."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]
Processing 00000000.tx.88: In cases where the data did not have a normal distribution, Kruskal-Wallis one-way analysis of variance on ranks was used, followed by Dunn's method of multiple comparison. 

Phrase: "In cases where"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "a normal distribution,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0028377:Normal Distribution [Quantitative Concept]
  1000   C0332617:Normal distribution [Qualitative Concept]
   861   C0205307:Normal [Qualitative Concept]
   861   C0439166:% normal [Quantitative Concept]
   861   C0520511:distribution [Idea or Concept]
   861   C1704711:Distribution [Functional Concept]
   861   C2347086:% Normal [Quantitative Concept]

Phrase: "Kruskal-Wallis one-way analysis of variance"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   897   C1709320:One-way Analysis of Variance [Quantitative Concept]
   814   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "on ranks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0699794:ranks [Intellectual Product]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ","

Phrase: "followed by Dunn's method of multiple comparison."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0332283:Followed by [Temporal Concept]
           followed
   748   C0025663:Method [Intellectual Product]
   748   C0439064:Multiple [Quantitative Concept]
   748   C0449851:Method [Functional Concept]
   748   C0871511:METHOD [Intellectual Product]
   748   C1707455:Comparison [Activity]
   714 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.89: Differences were considered significant for p<0.05.  

Phrase: "Differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "significant for p<0.05."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0237881:significant [Quantitative Concept]
   760   C0750502:Significant [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.90: RESULTS Top Abstract Introduction Procedures Results Discussion References Glutamate Stimulates APP-S Secretion from NT2N Neurons in a Time- and Dose-dependent Manner-- NT2N neurons were metabolically labeled with [35S]methionine and then stimulated with 1mM glutamate for 0-90 min or various concentrations of glutamate for 30min. 

Phrase: "RESULTS Top Abstract Introduction Procedures Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Stimulates"

Phrase: "APP-S Secretion from NT2N Neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1159339:Protein Secretion [Cell Function]
   744   C0036536:secretion [Biologic Function]
   744   C0036537:Secretion [Body Substance]

Phrase: "in a Time-"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "and"

Phrase: "Dose-dependent Manner"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1512045:Dose-dependent [Quantitative Concept]

Phrase: "--"

Phrase: "NT2N neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "metabolically"

Phrase: "labeled with"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   833   C1708632:Labeled [Qualitative Concept]
   799 E C0181496:Label [Manufactured Object]
   799 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "[35S"

Phrase: "]methionine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "stimulated with 1mM glutamate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   770   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "for 0-90 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]

Phrase: "or"

Phrase: "various concentrations of glutamate"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "for 30min."
Processing 00000000.tx.91: APP-S was immunoprecipitated from the medium and the proteins separated on 7.5% SDS-PAGE gels. 

Phrase: "APP-S"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "was"

Phrase: "immunoprecipitated from the medium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0009458:Medium [Intellectual Product]
   770   C0439536:Medium [Quantitative Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]
   737   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "and"

Phrase: "the proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "separated on 7.5% SDS-PAGE gels."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   774   C1538570:PAGE-5 [Gene or Genome]
   748   C0017243:Gels [Biomedical or Dental Material]
   748   C0086972:Separated [Finding]
   748   C0443299:separated [Spatial Concept]
   748   C0687118:Separated [Functional Concept]
   748   C1704732:Page [Intellectual Product]
   714 E C1382104:Gel [Substance]
Processing 00000000.tx.92: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.93: 1 (top panel) shows the resulting APP-S bands. 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(top panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the resulting APP-S bands."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   804   C0175723:Bands [Medical Device]
   771 E C0439645:Band [Spatial Concept]
   771 E C1521913:band [Cell Component]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
Processing 00000000.tx.94: The lower APP-S band is the 695form, while the higher APP-S band is the 751and/or 770form, the result of any remaining non-neuronal cells within the culture. 

Phrase: "The lower APP-S band"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0175723:Band [Medical Device]
   804   C0439645:Band [Spatial Concept]
   804   C1521913:band [Cell Component]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "is"

Phrase: "the 695form,"

Phrase: "while"

Phrase: "the higher APP-S band"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0175723:Band [Medical Device]
   804   C0439645:Band [Spatial Concept]
   804   C1521913:band [Cell Component]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "is"

Phrase: "the 751and/"

Phrase: "or"

Phrase: "770form,"

Phrase: "the result of any"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "remaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1527428:Remaining [Qualitative Concept]

Phrase: "non-neuronal cells within the culture."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   822   C0027836:Non-neuronal cell [Cell]
   783   C0007585:cells culture [Laboratory Procedure]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.95: Glutamate treatment resulted in a 2-fold increase in APP-s secretion between 5and 30min, with maximal secretion at 30min (p<0.05versus control) (Fig. 1, bottom panel). 

Phrase: "Glutamate treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "resulted in a 2-fold increase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0332462:Fold [Spatial Concept]
   753   C0442805:Increase [Functional Concept]
   753   C1880834:FOLD [Phenomenon or Process]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "in APP-s secretion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C1159339:Protein Secretion [Cell Function]
   804   C0036536:secretion [Biologic Function]
   804   C0036537:Secretion [Body Substance]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "between 5and 30min,"

Phrase: "with maximal secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "at 30min"

Phrase: "(p<0.05versus"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "bottom panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.96: Between 30and 90min, glutamate-induced secretion decreased to the control level of secretion. 

Phrase: "Between 30and 90min,"

Phrase: "glutamate-induced secretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1817648:glutamate secretion [Cell Function]
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]

Phrase: "decreased to the control level of secretion."
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]
   748   C0205216:Decreased [Quantitative Concept]
   748   C0243148:control [Qualitative Concept]
   748   C0392756:Decreased [Qualitative Concept]
   748   C0441889:Level [Qualitative Concept]
   748   C0442797:decreased [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C2946261:Level [Pharmacologic Substance]
   748   C3274648:Control [Qualitative Concept]
   714 E C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.97: Glutamate-induced APP-S secretion was dose-dependent (Fig. 2, bottom panel). 

Phrase: "Glutamate-induced APP-S secretion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   895   C1817648:glutamate secretion [Cell Function]
   827   C1159339:Protein Secretion [Cell Function]
   799   C0036536:secretion [Biologic Function]
   799   C0036537:Secretion [Body Substance]

Phrase: "was"

Phrase: "dose-dependent"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1512045:Dose-dependent [Quantitative Concept]
   861   C0178602:Dose [Quantitative Concept]
   861   C0851827:Dependent [Qualitative Concept]
   861   C0869039:Dose [Quantitative Concept]
   861   C1114758:Dose # [Clinical Attribute]
   861   C1701901:Dependent [Qualitative Concept]
   861   C3244310:dependent [Functional Concept]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "bottom panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.98: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.99: 2 (top panel) shows a representative gel depicting an increase in APP-S695 secretion with increasing concentrations of glutamate. 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "(top panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a representative gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017243:Gel [Biomedical or Dental Material]
   861   C1382104:Gel [Substance]

Phrase: "depicting"

Phrase: "an increase in APP-S695 secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "with increasing concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of glutamate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.100: Glutamate also caused a rapid and sustained increase in cytosolic Ca2+ (Fig. 3, top panel). 

Phrase: "Glutamate also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   861   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a rapid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439831:Rapid [Qualitative Concept]

Phrase: "and"

Phrase: "sustained increase in cytosolic Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "top panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.101: Likewise, the glutamate-induced increase in cytosolic Ca2+ was also dose-dependent (Fig. 3, bottom panel). 

Phrase: "Likewise,"

Phrase: "the glutamate-induced increase in cytosolic Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "also dose-dependent"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C1512045:Dose-dependent [Quantitative Concept]
   827   C0178602:Dose [Quantitative Concept]
   827   C0851827:Dependent [Qualitative Concept]
   827   C0869039:Dose [Quantitative Concept]
   827   C1114758:Dose # [Clinical Attribute]
   827   C1701901:Dependent [Qualitative Concept]
   827   C3244310:dependent [Functional Concept]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "bottom panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.102: View larger version (34K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(34K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.103: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.104: Effect of time on glutamate-induced APP-S secretion from NT2N neurons. 

Phrase: "Effect of time"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on glutamate-induced APP-S secretion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   895   C1817648:glutamate secretion [Cell Function]
   827   C1159339:Protein Secretion [Cell Function]
   799   C0036536:secretion [Biologic Function]
   799   C0036537:Secretion [Body Substance]

Phrase: "from NT2N neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.105: Cells were labeled for 3h with [35S]methionine and then treated with1mM glutamate for varying times. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "labeled for 3h"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1442460:3H [Temporal Concept]
   790   C1708632:Labeled [Qualitative Concept]
   756 E C0181496:Label [Manufactured Object]
   756 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "with"

Phrase: "[35S"

Phrase: "]methionine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "then treated with1mM glutamate for varying times."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   748   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.106: APP was immunoprecipitated from the medium and the proteins separated on 7.5% SDS-PAGE gels. 

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "was"

Phrase: "immunoprecipitated from the medium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0009458:Medium [Intellectual Product]
   770   C0439536:Medium [Quantitative Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]
   737   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "and"

Phrase: "the proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "separated on 7.5% SDS-PAGE gels."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   774   C1538570:PAGE-5 [Gene or Genome]
   748   C0017243:Gels [Biomedical or Dental Material]
   748   C0086972:Separated [Finding]
   748   C0443299:separated [Spatial Concept]
   748   C0687118:Separated [Functional Concept]
   748   C1704732:Page [Intellectual Product]
   714 E C1382104:Gel [Substance]
Processing 00000000.tx.107: The gels were dried and quantitated on a PhosphorImager. 

Phrase: "The gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0017243:Gels [Biomedical or Dental Material]
   966 E C1382104:Gel [Substance]

Phrase: "were"

Phrase: "dried"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1512080:Dried [Qualitative Concept]
  1000   C2827485:Dried [Body Substance]
   966 E C0011682:Dry [Natural Phenomenon or Process]
   966 E C0205222:Dry [Qualitative Concept]

Phrase: "and"

Phrase: "quantitated on a PhosphorImager."
Processing 00000000.tx.108: Top panel, representative gel showing the 110-kDa APP-S695 band after treatment with1mM glutamate. 

Phrase: "Top panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "representative gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017243:Gel [Biomedical or Dental Material]
   861   C1382104:Gel [Substance]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the 110-kDa APP-S695 band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0175723:Band [Medical Device]
   795   C0439645:Band [Spatial Concept]
   795   C1521913:band [Cell Component]

Phrase: "after treatment with1mM glutamate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   827   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.109: Bottom panel, APP-S secretion after treatment with1mM glutamate for 5-90 min. 

Phrase: "Bottom panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "APP-S secretion after treatment with1mM glutamate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1159339:Protein Secretion [Cell Function]
   767   C1817648:glutamate secretion [Cell Function]
   744   C0036536:secretion [Biologic Function]
   744   C0036537:Secretion [Body Substance]

Phrase: "for 5-90 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]
Processing 00000000.tx.110: APP-S secretion was quantitated by PhosphorImager as the amount of radioactivity in the APP-S band and is expressed as a percentage of the control within each experiment. 

Phrase: "APP-S secretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "was"

Phrase: "quantitated by PhosphorImager"

Phrase: "as the amount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1265611:Amount [Quantitative Concept]

Phrase: "of radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "in the APP-S band"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0175723:Band [Medical Device]
   812   C0439645:Band [Spatial Concept]
   812   C1521913:band [Cell Component]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "is"

Phrase: "expressed as a percentage of the control"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0243148:control [Qualitative Concept]
   748   C0439165:Percentage [Quantitative Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1550141:Control [Substance]
   748   C1561533:Percentage [Idea or Concept]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: "within each experiment."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.111: Results are shown as the meanS.E. of APP-s secretion from two to four separate observations/condition. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "shown as the meanS.E. of APP-s secretion"
Meta Candidates (Total=20; Excluded=3; Pruned=0; Remaining=17)
   775   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   775   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   772   C0072392:protein S precursor [Amino Acid, Peptide, or Protein]
   756   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0072393:Protein S [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1418948:PROTEIN S [Gene or Genome]
   754   C1159339:Protein Secretion [Cell Function]
   754   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   738   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0011560:Amyloid [Pathologic Function]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0036536:secretion [Biologic Function]
   738   C0036537:Secretion [Body Substance]
   738   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C1704970:Means [Conceptual Entity]
   738   C1709634:Precursor [Idea or Concept]
   704 E C0444504:Mean [Quantitative Concept]
   704   C1547282:Show [Intellectual Product]
   704 E C2347634:Mean [Quantitative Concept]
   704 E C2348143:Mean [Quantitative Concept]

Phrase: "from two to four separate observations/condition."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   799   C0012634:condition [Disease or Syndrome]
   799   C0348080:Condition [Qualitative Concept]
   799   C1705253:Condition [Conceptual Entity]
   727 E C0009647:Conditioned [Mental Process]
   727 E C1701901:Conditional [Qualitative Concept]
   727 E C1963686:Conditional [Functional Concept]
Processing 00000000.tx.112: View larger version (23K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(23K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.113: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.114: Effect of glutamate concentration on APP-S secretion in NT2N neurons. 

Phrase: "Effect of glutamate concentration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on APP-S secretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "in NT2N neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.115: Cells were labeled for 3h with [35S]methionine as in Fig. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "labeled for 3h"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1442460:3H [Temporal Concept]
   790   C1708632:Labeled [Qualitative Concept]
   756 E C0181496:Label [Manufactured Object]
   756 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "with"

Phrase: "[35S"

Phrase: "]methionine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "as in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.116: 1 and stimulated with increasing concentrations of glutamate for 30min. 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "stimulated with increasing concentrations of glutamate"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   753   C0086045:Concentrations [Mental Process]
   753   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0442808:Increasing [Functional Concept]
   753   C1948023:Stimulated [Natural Phenomenon or Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "for 30min."
Processing 00000000.tx.117: Top panel, representative gel showing the 110-kDa APP-S band after treatment with glutamate. 

Phrase: "Top panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "representative gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017243:Gel [Biomedical or Dental Material]
   861   C1382104:Gel [Substance]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the 110-kDa APP-S band after treatment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0175723:Band [Medical Device]
   742   C0439645:Band [Spatial Concept]
   742   C1521913:band [Cell Component]

Phrase: "with glutamate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.118: Bottom panel, APP-S secretion after treatment with 0,100nM, 1M, 10M, 100M, and 1mM glutamate. 

Phrase: "Bottom panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "APP-S secretion after treatment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1159339:Protein Secretion [Cell Function]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]

Phrase: "with 0,"

Phrase: "100nM,"

Phrase: "1M,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470296:1M [Quantitative Concept]

Phrase: "10M,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: "100M,"

Phrase: "and"

Phrase: "1mM glutamate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   861   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.119: APP-S secretion was quantitated by PhosphorImager analysis as the amount of radioactivity in the APP-S band and is expressed as a percentage of the control within each experiment. 

Phrase: "APP-S secretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "was"

Phrase: "quantitated by PhosphorImager analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "as the amount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1265611:Amount [Quantitative Concept]

Phrase: "of radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "in the APP-S band"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0175723:Band [Medical Device]
   812   C0439645:Band [Spatial Concept]
   812   C1521913:band [Cell Component]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "is"

Phrase: "expressed as a percentage of the control"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0243148:control [Qualitative Concept]
   748   C0439165:Percentage [Quantitative Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1550141:Control [Substance]
   748   C1561533:Percentage [Idea or Concept]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: "within each experiment."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.120: Results are shown as the meanS.E. of APP-S secretion from three separate observations/condition. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "shown as the meanS.E. of APP-S secretion"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   782   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   782   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   760   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1159339:Protein Secretion [Cell Function]
   757   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0036536:secretion [Biologic Function]
   739   C0036537:Secretion [Body Substance]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1704970:Means [Conceptual Entity]
   739   C1709634:Precursor [Idea or Concept]
   706 E C0444504:Mean [Quantitative Concept]
   706   C1547282:Show [Intellectual Product]
   706 E C2347634:Mean [Quantitative Concept]
   706 E C2348143:Mean [Quantitative Concept]

Phrase: "from three separate observations/condition."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   812   C0012634:condition [Disease or Syndrome]
   812   C0348080:Condition [Qualitative Concept]
   812   C1705253:Condition [Conceptual Entity]
   741 E C0009647:Conditioned [Mental Process]
   741 E C1701901:Conditional [Qualitative Concept]
   741 E C1963686:Conditional [Functional Concept]
   712 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.121: View larger version (22K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(22K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.122: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.123: Time course and dose dependence of glutamate effects on cytosolic Ca2+ in NT2N neurons. 

Phrase: "Time course"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0449247:Time course [Temporal Concept]
   861   C0040223:Time [Temporal Concept]
   861   C0750729:Course [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "and"

Phrase: "dose dependence of glutamate effects"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1512045:Dose-dependent [Quantitative Concept]
   760   C0011546:Dependence [Mental Process]
   760   C0439857:Dependence [Mental or Behavioral Dysfunction]
   760   C2698668:DEPENDENCE [Regulation or Law]

Phrase: "on cytosolic Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "in NT2N neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.124: NT2N neurons were loaded with fura-2 before they were perifused with Krebs-Hepes buffer. 

Phrase: "NT2N neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "loaded with fura-2"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0079389:Fura-2 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C1708715:Loaded [Activity]
   737 E C1550025:Load [Idea or Concept]
   737 E C1704782:Load [Manufactured Object]

Phrase: "before"

Phrase: "they"

Phrase: "were"

Phrase: "perifused with Krebs-Hepes buffer."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.125: The cells were excited by dual wavelength (334and 380nm), and the emission light was filtered at 520nm before it was captured by a CCD camera. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "excited by dual wavelength"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0449819:Wavelength [Quantitative Concept]
   770   C0549255:Excited [Activity]
   770   C1554184:Dual [Intellectual Product]

Phrase: "(334and 380nm"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the emission light"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0023693:Light [Natural Phenomenon or Process]
   861   C1306462:Light [Functional Concept]
   861   C1881376:Light [Qualitative Concept]

Phrase: "was"

Phrase: "filtered at 520nm"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   756   C0180860:Filter [Manufactured Object]
   756   C0581406:Filter [Medical Device]
   756   C1522664:Filter [Intellectual Product]
   756   C1704449:Filter [Conceptual Entity]
   756   C1704684:Filter [Medical Device]
   756   C1875155:FILTER [Medical Device]
   718 E C0080194:Strain [Injury or Poisoning]
   718 E C0442694:Straining [Physiologic Function]
   718 E C0456178:strain [Intellectual Product]
   718 E C1518614:Strain [Organism]
   718 E C2987481:Strain [Mental Process]

Phrase: "before"

Phrase: "it"

Phrase: "was"

Phrase: "captured by a CCD camera."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0598124:CCD camera [Manufactured Object]
   760   C0179533:Camera [Medical Device]
   760   C1654607:Camera [Eukaryote]
   760   C1706254:CAMERA [Medical Device]
Processing 00000000.tx.126: Ca2+ concentrations are calculated from the ratio of the intensities obtained at the two excitation wavelengths. 

Phrase: "Ca2+ concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "are"

Phrase: "calculated from the ratio of the intensities"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0444686:Calculated [Functional Concept]
   748   C0456603:Ratio [Quantitative Concept]
   748   C0522510:intensities [Qualitative Concept]
   748   C1441506:Calculated [Activity]
   748   C1443182:Calculated [Laboratory Procedure]
   748   C1547037:Ratio [Intellectual Product]

Phrase: "obtained at the two excitation wavelengths."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0205448:Two [Quantitative Concept]
   753   C0449819:wavelengths [Quantitative Concept]
   753   C0549255:Excitation [Activity]
   753   C1301820:Obtained [Functional Concept]
   719 E C1706701:Obtain [Activity]
Processing 00000000.tx.127: Results are shown as the meanS.E. from at least 30cells in three different experiments. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "shown as the meanS.E."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C1704970:Means [Conceptual Entity]
   726 E C0444504:Mean [Quantitative Concept]
   726   C1547282:Show [Intellectual Product]
   726 E C2347634:Mean [Quantitative Concept]
   726 E C2348143:Mean [Quantitative Concept]

Phrase: "from"

Phrase: "at least 30cells"

Phrase: "in three different experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.128: Top panel, time course of glutamate; 

Phrase: "Top panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "time course of glutamate"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0449247:Time course [Temporal Concept]
   770   C0040223:Time [Temporal Concept]
   770   C0750729:Course [Temporal Concept]
   770   C3541383:Time [Temporal Concept]
   715 E C0442043:Temporal [Spatial Concept]
   715 E C2362314:Temporal [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.129: bottom panel, dose curve of glutamate. 

Phrase: "bottom panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "dose curve of glutamate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205134:Curve [Spatial Concept]
Processing 00000000.tx.130: Metabotropic Glutamate Receptor Agonists Stimulate APP-S Secretion from NT2N Neurons-- Glutamate receptors can be categorized into two distinct groups, ionotropic and metabotropic receptors (27, 28). 

Phrase: "Metabotropic Glutamate Receptor Agonists"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C0242908:Glutamate Agonists [Pharmacologic Substance]
   812   C0243192:agonists [Pharmacologic Substance]
   812   C2987634:agonists [Pharmacologic Substance]
   756   C0206529:Metabotropic Glutamate Receptor [Amino Acid, Peptide, or Protein,Receptor]
   708   C1178976:Metabotropic receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "Stimulate"

Phrase: "APP-S Secretion from NT2N Neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1159339:Protein Secretion [Cell Function]
   744   C0036536:secretion [Biologic Function]
   744   C0036537:Secretion [Body Substance]

Phrase: "--"

Phrase: "Glutamate receptors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0061465:Receptors, Glutamate [Amino Acid, Peptide, or Protein,Receptor]
   861   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   861   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "can"

Phrase: "be"

Phrase: "categorized into two distinct groups,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0205448:Two [Quantitative Concept]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C0871968:categorized [Activity]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1552839:groups [Idea or Concept]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "ionotropic"

Phrase: "and"

Phrase: "metabotropic receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1178976:Metabotropic receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(27,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.131: Ionotropic receptors are selectively permeable ion channels and are subdivided into three groups according to agonist selectivity, NMDA, kainate, and AMPA receptors. 

Phrase: "Ionotropic receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1179928:Ionotropic receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "selectively permeable ion channels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0022009:Ion Channels [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   779   C0439799:Channel [Spatial Concept]
   779   C1706095:Channel [Conceptual Entity]

Phrase: "and"

Phrase: "are"

Phrase: "subdivided into three groups"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0205449:Three [Quantitative Concept]
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552839:groups [Idea or Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]

Phrase: "according to agonist selectivity,"

Phrase: "NMDA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079883:NMDA [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "kainate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205812:Kainate [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "AMPA receptors."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0072899:AMPA Receptors [Amino Acid, Peptide, or Protein,Receptor]
   966 E C1819187:AMPA receptor [Cell Component]
   861   C0051318:AMPA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.132: The metabotropic receptors are seven transmembrane-spanning proteins coupled to intracellular second messengers. 

Phrase: "The metabotropic receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1178976:Metabotropic receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "seven transmembrane-spanning proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0021699:Transmembrane protein [Amino Acid, Peptide, or Protein]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "coupled to intracellular second messengers."
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   862   C0036522:Intracellular Second Messengers [Molecular Function]
           second messengers
   806   C1508748:Second Messengers [Biologically Active Substance]
   797   C0815029:intracellular messengers [Biologically Active Substance]
   762   C0175668:Secondary to [Temporal Concept]
   760   C0169911:messengers [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   760   C0175996:intracellular [Cell Component]
   760   C0178719:Intracellular [Spatial Concept]
   760   C0205436:Second [Quantitative Concept]
   760   C0335218:messengers [Professional or Occupational Group]
   760   C0457385:Second [Temporal Concept]
   760   C0565930:/second [Quantitative Concept]
   760   C1561503:second [Idea or Concept]
   760   C1705190:Second [Qualitative Concept]
   760   C1948027:Coupled [Functional Concept]
   726 E C0010222:couple [Family Group]
Processing 00000000.tx.133: The metabotropic receptor family consists of at least eight different subtypes that are subdivided into three groups according to sequence similarities, agonist selectivity, and intracellular signaling machinery. 

Phrase: "The metabotropic receptor family"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0015576:Family [Family Group]
   827   C1704727:Family [Conceptual Entity]
   755 E C0241888:Familial [Functional Concept]
   734   C1178976:Metabotropic receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "consists of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0332529:CONSIST [Qualitative Concept]

Phrase: "at least eight different subtypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0449560:subtypes [Classification]

Phrase: "that"

Phrase: "are"

Phrase: "subdivided into three groups"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0205449:Three [Quantitative Concept]
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552839:groups [Idea or Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]

Phrase: "according to sequence similarities,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1710052:Sequence Similarity [Quantitative Concept]
   827   C2348205:Similarity [Qualitative Concept]

Phrase: "agonist selectivity,"

Phrase: "and"

Phrase: "intracellular signaling machinery."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0337076:machinery [Manufactured Object]
Processing 00000000.tx.134: Therefore, the effects of both metabotropic and ionotropic glutamate receptor agonists and antagonists were examined in NT2N cells. 

Phrase: "Therefore,"

Phrase: "the effects of both metabotropic"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "ionotropic glutamate receptor agonists"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0242908:Glutamate Agonists [Pharmacologic Substance]
   812   C0243192:agonists [Pharmacologic Substance]
   812   C2987634:agonists [Pharmacologic Substance]
   708   C1179928:Ionotropic receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "antagonists"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0243076:antagonists [Chemical Viewed Functionally]
   966 E C0231491:Antagonist [Organ or Tissue Function]
   893 E C0680242:antagonism [Social Behavior]

Phrase: "were"

Phrase: "examined in NT2N cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0007634:Cells [Cell]
   760   C0332128:Examined [Finding]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.135: The effects of both metabotropic and ionotropic glutamate receptor agonists on APP-S secretion are shown in Table I. 

Phrase: "The effects of both metabotropic"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "ionotropic glutamate receptor agonists on APP-S secretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0242908:Glutamate Agonists [Pharmacologic Substance]
   742   C0243192:agonists [Pharmacologic Substance]
   742   C2987634:agonists [Pharmacologic Substance]

Phrase: "are"

Phrase: "shown in Table I."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0021966:I- [Inorganic Chemical]
   770   C0039224:Table [Manufactured Object]
   770   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.136: The ionotropic glutamate receptor agonist NMDA (10M) did not have any effect on APP-S secretion; 

Phrase: "The ionotropic glutamate receptor agonist NMDA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0079883:NMDA [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "any effect on APP-S secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.137: however, the non-NMDA glutamate receptor agonists AMPA (100M) and kainate (100M) caused a 1.5-fold and a 2-fold increase, respectively, in APP-S secretion. 

Phrase: "however,"

Phrase: "the non-NMDA glutamate receptor agonists AMPA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0051318:AMPA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "(100M"

Phrase: ")"

Phrase: "and"

Phrase: "kainate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205812:Kainate [Organic Chemical,Pharmacologic Substance]

Phrase: "(100M"

Phrase: ")"

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a 1.5-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332462:Fold [Spatial Concept]
   812   C1880834:FOLD [Phenomenon or Process]

Phrase: "and"

Phrase: "a 2-fold increase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442805:Increase [Functional Concept]

Phrase: "respectively,"

Phrase: "in APP-S secretion."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.138: AMPA and kainate also caused an increase in intracellular Ca2+ (Fig. 4). 

Phrase: "AMPA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0051318:AMPA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "kainate also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205812:Kainate [Organic Chemical,Pharmacologic Substance]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "an increase in intracellular Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.139: The nonspecific glutamate receptor agonist quisqualate (100M) had a slight effect on APP-S secretion; 

Phrase: "The nonspecific glutamate receptor agonist quisqualate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0080073:Quisqualate [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(100M"

Phrase: ")"

Phrase: "had"

Phrase: "a slight effect on APP-S secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.140: however, the specific metabotropic glutamate receptor group I and II agonists, ACPD (100M) and CCG-I (100M) both resulted in a 1.5-fold increase in APP-S secretion, suggesting the glutamate-induced APP-S secretion is mediated in part by metabotropic glutamate receptors.  

Phrase: "however,"

Phrase: "the specific metabotropic glutamate receptor group I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441843:Group I [Intellectual Product]
   799   C0021966:I- [Inorganic Chemical]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "II agonists,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243192:agonists [Pharmacologic Substance]
   861   C2987634:agonists [Pharmacologic Substance]

Phrase: "ACPD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0044270:ACPD [Organic Chemical,Pharmacologic Substance]

Phrase: "(100M"

Phrase: ")"

Phrase: "and"

Phrase: "CCG-I (100M"

Phrase: ")"

Phrase: "both"

Phrase: "resulted in a 1.5-fold increase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0332462:Fold [Spatial Concept]
   748   C0442805:Increase [Functional Concept]
   748   C1880834:FOLD [Phenomenon or Process]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "in APP-S secretion,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the glutamate-induced APP-S secretion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   895   C1817648:glutamate secretion [Cell Function]
   827   C1159339:Protein Secretion [Cell Function]
   799   C0036536:secretion [Biologic Function]
   799   C0036537:Secretion [Body Substance]

Phrase: "is"

Phrase: "mediated in part"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0086597:mediated [Social Behavior]
   790   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by metabotropic glutamate receptors."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0206529:Receptors, Metabotropic Glutamate [Amino Acid, Peptide, or Protein,Receptor]
   901   C0061465:Receptors, Glutamate [Amino Acid, Peptide, or Protein,Receptor]
   896   C1178976:Metabotropic receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   827   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.141: View this table: [in this window] [in a new window]  Table I Effect of glutamate receptor agonists on APP-S secretion in NT2N cells Cells were labeled for 3h with [35S]methionine as in Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table I Effect of glutamate receptor agonists"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on APP-S secretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "in NT2N cells Cells"

Phrase: "were"

Phrase: "labeled for 3h"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1442460:3H [Temporal Concept]
   790   C1708632:Labeled [Qualitative Concept]
   756 E C0181496:Label [Manufactured Object]
   756 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "with"

Phrase: "[35S"

Phrase: "]methionine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "as in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.142: 1 and then treated with various of glutamate receptor agonists for 30min. 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "treated with various of glutamate receptor agonists"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   778   C0061465:Glutamate Receptor [Amino Acid, Peptide, or Protein,Receptor]
   778   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   774   C0242908:Glutamate Agonists [Pharmacologic Substance]
   748   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   748   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0243192:agonists [Pharmacologic Substance]
   748   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1522326:Treated [Functional Concept]
   748   C2987634:agonists [Pharmacologic Substance]
   714 E C1292734:TREAT [Functional Concept]

Phrase: "for 30min."
Processing 00000000.tx.143: APP-S secretion was quantitated by PhosphorImager analysis as the amount of radioactivity in the APP-S band and is expressed as a percentage of the control within each experiment. 

Phrase: "APP-S secretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "was"

Phrase: "quantitated by PhosphorImager analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "as the amount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1265611:Amount [Quantitative Concept]

Phrase: "of radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "in the APP-S band"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0175723:Band [Medical Device]
   812   C0439645:Band [Spatial Concept]
   812   C1521913:band [Cell Component]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "is"

Phrase: "expressed as a percentage of the control"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0243148:control [Qualitative Concept]
   748   C0439165:Percentage [Quantitative Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1550141:Control [Substance]
   748   C1561533:Percentage [Idea or Concept]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: "within each experiment."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.144: Results are shown as the meanS.E. of APP-S secretion from 4to 13separate observations/condition. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "shown as the meanS.E. of APP-S secretion"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   782   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   782   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   760   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1159339:Protein Secretion [Cell Function]
   757   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0036536:secretion [Biologic Function]
   739   C0036537:Secretion [Body Substance]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1704970:Means [Conceptual Entity]
   739   C1709634:Precursor [Idea or Concept]
   706 E C0444504:Mean [Quantitative Concept]
   706   C1547282:Show [Intellectual Product]
   706 E C2347634:Mean [Quantitative Concept]
   706 E C2348143:Mean [Quantitative Concept]

Phrase: "from 4to 13separate observations/condition."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   812   C0012634:condition [Disease or Syndrome]
   812   C0348080:Condition [Qualitative Concept]
   812   C1705253:Condition [Conceptual Entity]
   741 E C0009647:Conditioned [Mental Process]
   741 E C1701901:Conditional [Qualitative Concept]
   741 E C1963686:Conditional [Functional Concept]
   712 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.145: View larger version (36K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(36K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.146: 4.  

Phrase: "4."
Processing 00000000.tx.147: Effect of glutamate receptor agonists on cytosolic Ca2+ in NT2N neurons. 

Phrase: "Effect of glutamate receptor agonists"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on cytosolic Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "in NT2N neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.148: Cytosolic Ca2+ was measured as in Fig. 

Phrase: "Cytosolic Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "as in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.149: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.150: Metabotropic Glutamate Receptor Antagonists Reduce Glutamate-induced APP-S Secretion in NT2N Cells-- The metabotropic glutamate receptor antagonists AIDA (100M, Group I), MSOPPE (100M, Group II), and MPPG (100M, Group III) decreased glutamate-induced APP-S secretion by 17,27,and 24%, respectively, while NMDA receptor antagonists, CNQX (10M) and AP5 (10M), did not have any effect on glutamate-induced APP-S secretion (Table II) (29-31). 

Phrase: "Metabotropic Glutamate Receptor Antagonists"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   923   C0242910:Glutamate Receptor Antagonists [Pharmacologic Substance]
           Glutamate Antagonists
   812   C0243076:antagonists [Chemical Viewed Functionally]
   779 E C0231491:Antagonist [Organ or Tissue Function]
   756   C0206529:Metabotropic Glutamate Receptor [Amino Acid, Peptide, or Protein,Receptor]
   708   C1178976:Metabotropic receptor [Amino Acid, Peptide, or Protein,Receptor]
   706 E C0680242:antagonism [Social Behavior]

Phrase: "Reduce"

Phrase: "Glutamate-induced APP-S Secretion in NT2N Cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C1159339:Protein Secretion [Cell Function]
   757   C1817648:glutamate secretion [Cell Function]
   741   C1327616:Cell secretion [Cell Function]
   739   C0036536:secretion [Biologic Function]
   739   C0036537:Secretion [Body Substance]

Phrase: "-"

Phrase: "-"

Phrase: "The metabotropic glutamate receptor antagonists AIDA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1823700:AIDA [Gene or Genome]
   717   C0206529:Metabotropic Glutamate Receptor [Amino Acid, Peptide, or Protein,Receptor]
   717   C0242910:Glutamate Receptor Antagonists [Pharmacologic Substance]

Phrase: "(100M,"

Phrase: "Group I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441843:Group I [Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: ","

Phrase: "MSOPPE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1100145:MSOPPE [Amino Acid, Peptide, or Protein,Organophosphorus Compound]

Phrase: "(100M,"

Phrase: "Group II"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "MPPG"

Phrase: "(100M,"

Phrase: "Group III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "decreased glutamate-induced APP-S secretion by 17,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C1159339:Protein Secretion [Cell Function]
   762   C1817648:glutamate secretion [Cell Function]
   742   C0036536:secretion [Biologic Function]
   742   C0036537:Secretion [Body Substance]

Phrase: "27,"

Phrase: "and"

Phrase: "24%,"

Phrase: "respectively,"

Phrase: "while"

Phrase: "NMDA receptor antagonists,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C2916808:NMDA Receptor Antagonists [Molecular Function]
   983 E C0598695:NMDA receptor antagonist [Pharmacologic Substance]
   983 E C3536824:NMDA Receptor Antagonist [Pharmacologic Substance]
   827   C0243076:antagonists [Chemical Viewed Functionally]
   793 E C0231491:Antagonist [Organ or Tissue Function]
   734   C0080093:NMDA receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1152805:NMDA receptor [Molecular Function]
   721 E C0680242:antagonism [Social Behavior]

Phrase: "CNQX"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0099122:CNQX [Organic Chemical,Pharmacologic Substance]

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "AP5"

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "any effect on glutamate-induced APP-S secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "(Table II"

Phrase: ")"

Phrase: "(29-31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.151: These results suggest that glutamate-induced APP-S secretion is mediated in part by metabotropic glutamate receptors.  

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that glutamate-induced APP-S secretion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   895   C1817648:glutamate secretion [Cell Function]
   827   C1159339:Protein Secretion [Cell Function]
   799   C0036536:secretion [Biologic Function]
   799   C0036537:Secretion [Body Substance]

Phrase: "is"

Phrase: "mediated in part"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0086597:mediated [Social Behavior]
   790   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by metabotropic glutamate receptors."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0206529:Receptors, Metabotropic Glutamate [Amino Acid, Peptide, or Protein,Receptor]
   901   C0061465:Receptors, Glutamate [Amino Acid, Peptide, or Protein,Receptor]
   896   C1178976:Metabotropic receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   827   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.152: View this table: [in this window] [in a new window]  Table II Effect of glutamate receptor antagonists on APP-S secretion in NT2N cells Cells were labeled for 3h with [35S]methionine as in Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table II Effect of glutamate receptor antagonists"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on APP-S secretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "in NT2N cells Cells"

Phrase: "were"

Phrase: "labeled for 3h"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1442460:3H [Temporal Concept]
   790   C1708632:Labeled [Qualitative Concept]
   756 E C0181496:Label [Manufactured Object]
   756 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "with"

Phrase: "[35S"

Phrase: "]methionine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "as in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.153: 1 and then pretreated for 30min with various glutamate receptor antagonists. 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "pretreated for 30min"

Phrase: "with various glutamate receptor antagonists."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   923   C0242910:Glutamate Receptor Antagonists [Pharmacologic Substance]
           Glutamate Antagonists
   812   C0243076:antagonists [Chemical Viewed Functionally]
   779 E C0231491:Antagonist [Organ or Tissue Function]
   706 E C0680242:antagonism [Social Behavior]
Processing 00000000.tx.154: The cells were then treated for 30min with the control, 1mM glutamate, the antagonist alone, or 1mM glutamate+the antagonist. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "treated for 30min"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332293:treated [Therapeutic or Preventive Procedure]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "with the control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "1mM glutamate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   861   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the antagonist"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0231491:Antagonist [Organ or Tissue Function]
   900 E C0680242:antagonism [Social Behavior]

Phrase: "alone,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or"

Phrase: "1mM glutamate+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   861   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the antagonist."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0231491:Antagonist [Organ or Tissue Function]
   900 E C0680242:antagonism [Social Behavior]
Processing 00000000.tx.155: APP-S secretion was quantitated by PhosphorImager analysis as the amount of radioactivity in the APP-S band and is expressed as a percentage of the control within each experiment. 

Phrase: "APP-S secretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "was"

Phrase: "quantitated by PhosphorImager analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "as the amount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1265611:Amount [Quantitative Concept]

Phrase: "of radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "in the APP-S band"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0175723:Band [Medical Device]
   812   C0439645:Band [Spatial Concept]
   812   C1521913:band [Cell Component]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "is"

Phrase: "expressed as a percentage of the control"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0243148:control [Qualitative Concept]
   748   C0439165:Percentage [Quantitative Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1550141:Control [Substance]
   748   C1561533:Percentage [Idea or Concept]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: "within each experiment."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.156: Results are shown as the meanS.E. of APP-S secretion from 3to 14separate observations/condition. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "shown as the meanS.E. of APP-S secretion"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   782   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   782   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   760   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1159339:Protein Secretion [Cell Function]
   757   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0036536:secretion [Biologic Function]
   739   C0036537:Secretion [Body Substance]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1704970:Means [Conceptual Entity]
   739   C1709634:Precursor [Idea or Concept]
   706 E C0444504:Mean [Quantitative Concept]
   706   C1547282:Show [Intellectual Product]
   706 E C2347634:Mean [Quantitative Concept]
   706 E C2348143:Mean [Quantitative Concept]

Phrase: "from 3to 14separate observations/condition."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   812   C0012634:condition [Disease or Syndrome]
   812   C0348080:Condition [Qualitative Concept]
   812   C1705253:Condition [Conceptual Entity]
   741 E C0009647:Conditioned [Mental Process]
   741 E C1701901:Conditional [Qualitative Concept]
   741 E C1963686:Conditional [Functional Concept]
   712 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.157: Identification of Metabotropic Glutamate Receptor Subtypes mGluR1/ and mGluR5 in NT2N Neurons-- The metabotropic glutamate receptor subtypes, mGluR1/ and mGluR5, were identified in NT2N cells by RT-PCR analysis. 

Phrase: "Identification of Metabotropic Glutamate Receptor Subtypes mGluR1/"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0020792:Identification [Mental Process]
   748   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "mGluR5 in NT2N Neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1333712:MGLUR5 [Gene or Genome]
   760   C1706589:MGLUR5 [Gene or Genome]

Phrase: "-"

Phrase: "-"

Phrase: "The metabotropic glutamate receptor subtypes,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0449560:subtypes [Classification]
   756   C0206529:Metabotropic Glutamate Receptor [Amino Acid, Peptide, or Protein,Receptor]
   708   C1178976:Metabotropic receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "mGluR1/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0535210:mGluR1 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1333711:MGLUR1 [Gene or Genome]
  1000   C1706579:MGLUR1 [Gene or Genome]

Phrase: "and"

Phrase: "mGluR5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1333712:MGLUR5 [Gene or Genome]
  1000   C1706589:MGLUR5 [Gene or Genome]

Phrase: "were"

Phrase: "identified in NT2N cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   797   C0805527:Cells identified [Laboratory or Test Result]
   760   C0007634:Cells [Cell]
   760   C0205396:Identified [Qualitative Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "by RT-PCR analysis."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0200931:PCR analysis [Laboratory Procedure]
   901   C0599161:RT-PCR [Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0677874:pCR [Finding]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
Processing 00000000.tx.158: For mGluR1/, RT-PCR yielded the expected products of 463and 547 bp, respectively (Fig. 5), while for mGluR5, a PCR product of the expected size of 600bp was obtained (Fig. 5). 

Phrase: "For mGluR1/,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0535210:mGluR1 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1333711:MGLUR1 [Gene or Genome]
  1000   C1706579:MGLUR1 [Gene or Genome]

Phrase: "RT-PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599161:RT-PCR [Molecular Biology Research Technique]
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]

Phrase: "yielded"

Phrase: "the expected products of 463and 547 bp,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1514468:Products [Entity]
   714 E C1704444:Product [Quantitative Concept]

Phrase: "respectively"

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "while for mGluR5,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0750519:while [Idea or Concept]
   790   C1333712:MGLUR5 [Gene or Genome]
   790   C1706589:MGLUR5 [Gene or Genome]

Phrase: "a PCR product of the expected size of 600bp"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1514468:product [Entity]
   742   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.159: The products were excised from the gels, purified with the Geneclean II kit, and subjected to a restriction enzyme digest with EcoRI for the identification of mGluR1/ and BglI for mGluR5. 

Phrase: "The products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "excised from the gels,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0017243:Gels [Biomedical or Dental Material]
   737 E C1382104:Gel [Substance]

Phrase: "purified with the Geneclean II kit,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0812225:KIT [Medical Device]
   753   C1150635:KIT [Molecular Function]
   753   C1705212:Kit [Medical Device]
   753   C1705213:KIT [Medical Device]
   753   C1998793:Purified [Functional Concept]
   753   C3273202:Kit [Manufactured Object]

Phrase: "and"

Phrase: "subjected to a restriction enzyme"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0012906:Restriction Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0443288:Restriction [Functional Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "digest with EcoRI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011516:Eco-RI [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0868946:digest [Physiologic Function]

Phrase: "for the identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020792:Identification [Mental Process]
  1000   C0205396:Identification [Qualitative Concept]

Phrase: "of mGluR1/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0535210:mGluR1 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1333711:MGLUR1 [Gene or Genome]
  1000   C1706579:MGLUR1 [Gene or Genome]

Phrase: "and"

Phrase: "BglI for mGluR5."
Processing 00000000.tx.160: Restriction enzyme analysis yielded the expected size products for mGluR1/ (463,356,and 191bp) and mGluR5 (357and 243bp) (data not shown). 

Phrase: "Restriction enzyme analysis"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0035269:Restriction Enzyme Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   901   C0012906:Restriction Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0443288:Restriction [Functional Concept]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "yielded"

Phrase: "the expected size products for mGluR1/"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1514468:Products [Entity]
   719 E C1704444:Product [Quantitative Concept]

Phrase: "(463,"

Phrase: "356,"

Phrase: "and"

Phrase: "191bp"

Phrase: ")"

Phrase: "and"

Phrase: "mGluR5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1333712:MGLUR5 [Gene or Genome]
  1000   C1706589:MGLUR5 [Gene or Genome]

Phrase: "(357and 243bp"

Phrase: ")"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.161: These results indicate that the metabotropic glutamate receptor subtypes mGluR1/ and mGluR5 are present in NT2N neurons. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "the metabotropic glutamate receptor subtypes mGluR1/"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0535210:mGluR1 [Amino Acid, Peptide, or Protein,Receptor]
   804   C1333711:MGLUR1 [Gene or Genome]
   804   C1706579:MGLUR1 [Gene or Genome]
   717   C0206529:Metabotropic Glutamate Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "mGluR5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1333712:MGLUR5 [Gene or Genome]
  1000   C1706589:MGLUR5 [Gene or Genome]

Phrase: "are"

Phrase: "present in NT2N neurons."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
Processing 00000000.tx.162: View larger version (62K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(62K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.163: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.164: Identification of metabotropic glutamate receptors in NT2N neurons. 

Phrase: "Identification of metabotropic glutamate receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "in NT2N neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.165: RT-PCR was performed with specific primers designed for the amplification of mGluR1 and mGluR5. 

Phrase: "RT-PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599161:RT-PCR [Molecular Biology Research Technique]
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]

Phrase: "was"

Phrase: "performed with specific primers"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0205369:Specific [Qualitative Concept]
   770   C0884358:Performed [Functional Concept]
   770   C1552740:specific [Intellectual Product]
   737   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "designed for the amplification of mGluR1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0535210:mGluR1 [Amino Acid, Peptide, or Protein,Receptor]
   753   C1333711:MGLUR1 [Gene or Genome]
   753   C1517480:Amplification [Molecular Biology Research Technique]
   753   C1521871:Amplification [Phenomenon or Process]
   753   C1705759:Amplification [Cell or Molecular Dysfunction]
   753   C1706579:MGLUR1 [Gene or Genome]
   719   C1707689:Design [Activity]
   719   C2983265:DESIGN [Intellectual Product]

Phrase: "and"

Phrase: "mGluR5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1333712:MGLUR5 [Gene or Genome]
  1000   C1706589:MGLUR5 [Gene or Genome]
Processing 00000000.tx.166: PCR products were analyzed on a 1.5% agarose gel. 

Phrase: "PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "analyzed on a 1.5% agarose gel."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1706746:Agarose Gel [Research Device]
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C0036681:Agarose [Carbohydrate]
   748   C0936012:Analyzed [Research Activity]
   748   C1382104:Gel [Substance]
Processing 00000000.tx.167: Lane 1, DNA ladder; 

Phrase: "Lane 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "DNA ladder"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336762:Ladder [Manufactured Object]

Phrase: ";"
Processing 00000000.tx.168: lane 2, 463-and 548-bp PCR products for mGluR1 and , respectively, lane 3, DNA ladder; 

Phrase: "lane 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "463-"

Phrase: "and"

Phrase: "548-bp PCR products for mGluR1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1514468:Products [Entity]
   719 E C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: ","

Phrase: "respectively,"

Phrase: "lane 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "DNA ladder"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336762:Ladder [Manufactured Object]

Phrase: ";"
Processing 00000000.tx.169: lane 4, 604-bp PCR product for mGluR5. 

Phrase: "lane 4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "604-bp PCR product for mGluR5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1514468:product [Entity]
   753   C1704444:Product [Quantitative Concept]
Processing 00000000.tx.170: Glutamate Stimulates the Rapid Accumulation of Inositol 1,4,5-Trisphosphate in NT2N Neurons-- NT2N neurons were labeled for 48h with myo-[3H]inositol and then stimulated1mM glutamate for 2min. 

Phrase: "Glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Stimulates"

Phrase: "the Rapid Accumulation of Inositol 1,"

Phrase: "4,"

Phrase: "5-Trisphosphate in NT2N Neurons"

Phrase: "--"

Phrase: "NT2N neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "labeled for 48h"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1442464:48H [Temporal Concept]
   790   C1708632:Labeled [Qualitative Concept]
   756 E C0181496:Label [Manufactured Object]
   756 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "with myo-"

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]inositol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]

Phrase: "and"

Phrase: "then stimulated1mM glutamate for 2min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   760   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.171: The inositol phosphates were extracted and purified by strong anion exchange chromatography. 

Phrase: "The inositol phosphates"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021554:Inositol Phosphates [Carbohydrate]
   861   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]
   861   C0031603:Phosphates [Inorganic Chemical,Pharmacologic Substance]
   827 E C0031701:phosphate [Organophosphorus Compound]
   827 E C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "extracted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]

Phrase: "and"

Phrase: "purified by strong anion exchange chromatography."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0003075:Anion [Element, Ion, or Isotope]
   753   C0008550:Chromatography [Laboratory Procedure]
   753   C0442821:Strong [Qualitative Concept]
   753   C0678640:exchange [Social Behavior]
   753   C1998793:Purified [Functional Concept]
Processing 00000000.tx.172: Glutamate caused an increase in inositol 1,4,5-trisphosphate at 2min in NT2N neurons (p<0.05versus control) (Fig. 6). 

Phrase: "Glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "an increase in inositol 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "4,"

Phrase: "5-trisphosphate at 2min"

Phrase: "in NT2N neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(p<0.05versus"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.173: This suggests that glutamate activates the PI-linked metabotropic glutamate receptors resulting in the activation of phospholipase C and the subsequent increase in IP3. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the PI-linked metabotropic glutamate receptors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   897   C0070807:phosphatidylinositol receptors [Amino Acid, Peptide, or Protein,Receptor]
   884   C0206529:Receptors, Metabotropic Glutamate [Amino Acid, Peptide, or Protein,Receptor]
   840   C0061465:Receptors, Glutamate [Amino Acid, Peptide, or Protein,Receptor]
   836   C1178976:Metabotropic receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   804   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "resulting in the activation of phospholipase C"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   804   C1155436:phospholipase C activation [Molecular Function]
   778   C0031669:Phospholipase C [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0332294:Resulting in [Functional Concept]
   748   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0678226:resulting [Functional Concept]
   748   C1879547:Activation [Activity]
   714 E C1274040:Result [Functional Concept]
   714 E C1546471:Result [Idea or Concept]
   714 E C2825142:Result [Finding]

Phrase: "and"

Phrase: "the subsequent increase in IP3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]
Processing 00000000.tx.174: View larger version (11K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(11K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.175: 6.  

Phrase: "6."
Processing 00000000.tx.176: Effect of glutamate on IP3 accumulation in NT2N neurons. 

Phrase: "Effect of glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on IP3 accumulation"

Phrase: "in NT2N neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.177: NT2N neurons were labeled for 48h with myo-[3H]inositol and then treated with1mM glutamate. 

Phrase: "NT2N neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "labeled for 48h"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1442464:48H [Temporal Concept]
   790   C1708632:Labeled [Qualitative Concept]
   756 E C0181496:Label [Manufactured Object]
   756 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "with myo-"

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]inositol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]

Phrase: "and"

Phrase: "then treated with1mM glutamate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   812   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.178: Inositol phosphates were extracted and purified by strong anion exchange chromatography. 

Phrase: "Inositol phosphates"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021554:Inositol Phosphates [Carbohydrate]
   861   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]
   861   C0031603:Phosphates [Inorganic Chemical,Pharmacologic Substance]
   827 E C0031701:phosphate [Organophosphorus Compound]
   827 E C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "extracted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]

Phrase: "and"

Phrase: "purified by strong anion exchange chromatography."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0003075:Anion [Element, Ion, or Isotope]
   753   C0008550:Chromatography [Laboratory Procedure]
   753   C0442821:Strong [Qualitative Concept]
   753   C0678640:exchange [Social Behavior]
   753   C1998793:Purified [Functional Concept]
Processing 00000000.tx.179: [3H]IP3 fractions were quantitated. 

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]IP3 fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "quantitated."
Processing 00000000.tx.180: IP3 accumulation was expressed as a percentage of the control within each experiment. 

Phrase: "IP3 accumulation"

Phrase: "was"

Phrase: "expressed as a percentage of the control"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0243148:control [Qualitative Concept]
   748   C0439165:Percentage [Quantitative Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1550141:Control [Substance]
   748   C1561533:Percentage [Idea or Concept]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: "within each experiment."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.181: Results are shown as the meanS.E. of IP3 accumulation from nine separate observations/ condition. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "shown as the meanS.E. of IP3 accumulation"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   744   C0021549:IP3 [Biologically Active Substance,Carbohydrate]
   744   C1704970:Means [Conceptual Entity]
   744   C3542924:IP3 [Body Part, Organ, or Organ Component]
   711 E C0444504:Mean [Quantitative Concept]
   711   C1547282:Show [Intellectual Product]
   711 E C2347634:Mean [Quantitative Concept]
   711 E C2348143:Mean [Quantitative Concept]

Phrase: "from nine separate observations/ condition."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   812   C0012634:condition [Disease or Syndrome]
   812   C0348080:Condition [Qualitative Concept]
   812   C1705253:Condition [Conceptual Entity]
   741 E C0009647:Conditioned [Mental Process]
   741 E C1701901:Conditional [Qualitative Concept]
   741 E C1963686:Conditional [Functional Concept]
   712 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.182: Increases in Calcium and Diacylglycerol Increase APP-S Secretion-- Because glutamate-induced APP-S secretion involves the phospholipase C pathway, the contribution of downstream signaling events was next examined. 

Phrase: "Increases in Calcium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0442805:increases [Functional Concept]

Phrase: "and"

Phrase: "Diacylglycerol Increase APP-S Secretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1159339:Protein Secretion [Cell Function]
   799   C0036536:secretion [Biologic Function]
   799   C0036537:Secretion [Body Substance]

Phrase: "-"

Phrase: "-"

Phrase: "Because"

Phrase: "glutamate-induced APP-S secretion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   895   C1817648:glutamate secretion [Cell Function]
   827   C1159339:Protein Secretion [Cell Function]
   799   C0036536:secretion [Biologic Function]
   799   C0036537:Secretion [Body Substance]

Phrase: "involves"

Phrase: "the phospholipase C pathway,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]
   734   C0031669:Phospholipase C [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "the contribution of downstream signaling events"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880177:Contribution [Activity]

Phrase: "was"

Phrase: "next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.183: NT2N neurons were treated with the phorbol ester PMA, the cell-permeable DAG analog OAG, the calcium ionophore A23187, thapsigargin, an inhibitor of the endoplasmic reticulum Ca2+-ATPase, the DAG kinase inhibitor R59949, or the DAG lipase inhibitor RG80267. 

Phrase: "NT2N neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "treated with the phorbol ester PMA,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   790   C0031586:Phorbol Ester [Hazardous or Poisonous Substance,Organic Chemical]
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0014898:Ester [Organic Chemical]
   753   C0031588:phorbol [Organic Chemical]
   753   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   753   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   753   C0070750:Phorbol [Organic Chemical]
   753   C1522326:Treated [Functional Concept]
   753   C2825188:PMA [Intellectual Product]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "the cell-permeable DAG analog OAG,"

Phrase: "the calcium ionophore A23187,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521966:Calcium ionophore A23187 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0878412:A23187 [Antibiotic,Organic Chemical]
   734   C0444420:Calcium ionophore [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "thapsigargin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "an inhibitor of the endoplasmic reticulum Ca2+-ATPase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1999216:Inhibitor [Qualitative Concept]

Phrase: "the DAG kinase inhibitor R59949,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0072922:R59949 [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "the DAG lipase inhibitor RG80267."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0284518:Rg80267 [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.184: Both PMA and OAG caused a robust increase in APP-S secretion (p<0.05versus control), comparable with that of glutamate (Fig. 7). 

Phrase: "Both PMA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C2825188:PMA [Intellectual Product]

Phrase: "and"

Phrase: "OAG"

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a robust increase in APP-S secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "(p<0.05versus"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "comparable with that of glutamate"

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.185: These results suggest that protein kinase C is involved in the secretion of APP-S. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that protein kinase C"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "involved in the secretion of APP-S."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1159339:Protein Secretion [Cell Function]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0036536:secretion [Biologic Function]
   744   C0036537:Secretion [Body Substance]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1314939:Involved [Functional Concept]
   744   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.186: Furthermore, the DAG kinase inhibitor R59949, which in other systems increases DAG levels, caused a large increase in the secretion of APP (Table III) (32). 

Phrase: "Furthermore,"

Phrase: "the DAG kinase inhibitor R59949,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0072922:R59949 [Organic Chemical,Pharmacologic Substance]

Phrase: "which in other systems"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0449913:System [Functional Concept]
   737   C1553451:System [Manufactured Object]
   737   C1704459:System [Medical Device]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "DAG levels,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a large increase in the secretion of APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0442805:Increase [Functional Concept]

Phrase: "(Table III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.187: However, DAG metabolism does not seem to be involved in APP-S secretion, since the DAG lipase inhibitor RG80267 did not have any effect on glutamate-induced APP-S secretion (Table III). 

Phrase: "However,"

Phrase: "DAG metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "seem"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "involved in APP-S secretion,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1159339:Protein Secretion [Cell Function]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1314939:Involved [Functional Concept]
   753   C1709634:Precursor [Idea or Concept]

Phrase: "since"

Phrase: "the DAG lipase inhibitor RG80267"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0284518:Rg80267 [Organic Chemical,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "any effect on glutamate-induced APP-S secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "(Table III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.188: The calcium ionophore A23187 also caused an increase in APP-S secretion (3.5-fold), and thapsigargin caused a slight decrease in glutamate-induced APP-S secretion. 

Phrase: "The calcium ionophore A23187 also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C0521966:Calcium ionophore A23187 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   C0878412:A23187 [Antibiotic,Organic Chemical]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "an increase in APP-S secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "(3.5-fold"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]
   734   C0442758:3 5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "thapsigargin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a slight decrease in glutamate-induced APP-S secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0392756:Decrease [Qualitative Concept]
   739   C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.189: These results suggest that both calcium and DAG activation of protein kinase C mediate glutamate-induced APP-S secretion in NT2N neurons. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "both calcium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0006726:Calcium [Inorganic Chemical]
  1000   C2936886:Calcium [Pharmacologic Substance]

Phrase: "and"

Phrase: "DAG activation of protein kinase C"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   864   C3546691:protein kinase C activation [Molecular Function]
   820   C1819041:protein kinase activation [Cell Function]
   783   C0599177:protein activation [Genetic Function]
   753   C1879547:Activation [Activity]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "glutamate-induced APP-S secretion in NT2N neurons."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1159339:Protein Secretion [Cell Function]
   757   C1817648:glutamate secretion [Cell Function]
   739   C0036536:secretion [Biologic Function]
   739   C0036537:Secretion [Body Substance]
Processing 00000000.tx.190: View larger version (26K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(26K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.191: 7.  

Phrase: "7."
Processing 00000000.tx.192: Effect of phorbol ester PMA and diacylglycerol analog OAG on APP-S secretion in NT2N neurons. 

Phrase: "Effect of phorbol ester PMA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "diacylglycerol analog OAG on APP-S secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   767   C1957597:OAG diacylglycerol [Lipid]

Phrase: "in NT2N neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.193: Neurons were labeled for 3h with [35S]methionine as in Fig. 

Phrase: "Neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "labeled for 3h"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1442460:3H [Temporal Concept]
   790   C1708632:Labeled [Qualitative Concept]
   756 E C0181496:Label [Manufactured Object]
   756 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "with"

Phrase: "[35S"

Phrase: "]methionine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "as in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.194: 1 and treated for 30min with the control, 10M PMA, or 200M OAG. 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "treated for 30min"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332293:treated [Therapeutic or Preventive Procedure]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "with the control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "10M PMA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   861   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   861   C2825188:PMA [Intellectual Product]

Phrase: "or"

Phrase: "200M OAG."
Processing 00000000.tx.195: Top panel, representative gel showing the 110-kDa APP-S band. 

Phrase: "Top panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "representative gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017243:Gel [Biomedical or Dental Material]
   861   C1382104:Gel [Substance]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the 110-kDa APP-S band."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0175723:Band [Medical Device]
   799   C0439645:Band [Spatial Concept]
   799   C1521913:band [Cell Component]
Processing 00000000.tx.196: Bottom panel, APP-S secretion after treatment with PMA, OAG, and glutamate. 

Phrase: "Bottom panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "APP-S secretion after treatment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1159339:Protein Secretion [Cell Function]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]

Phrase: "with PMA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C2825188:PMA [Intellectual Product]

Phrase: "OAG,"

Phrase: "and"

Phrase: "glutamate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.197: APP-S secretion was quantitated by PhosphorImager as the amount of radioactivity in the APP-S band and is expressed as a percentage of the control within each experiment. 

Phrase: "APP-S secretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "was"

Phrase: "quantitated by PhosphorImager"

Phrase: "as the amount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1265611:Amount [Quantitative Concept]

Phrase: "of radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "in the APP-S band"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0175723:Band [Medical Device]
   812   C0439645:Band [Spatial Concept]
   812   C1521913:band [Cell Component]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "is"

Phrase: "expressed as a percentage of the control"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0243148:control [Qualitative Concept]
   748   C0439165:Percentage [Quantitative Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1550141:Control [Substance]
   748   C1561533:Percentage [Idea or Concept]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: "within each experiment."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.198: Results are shown as the meanS.E. of APP-S secretion from five to ten separate observations/condition.  

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "shown as the meanS.E. of APP-S secretion"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   782   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   782   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   760   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1159339:Protein Secretion [Cell Function]
   757   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0036536:secretion [Biologic Function]
   739   C0036537:Secretion [Body Substance]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1704970:Means [Conceptual Entity]
   739   C1709634:Precursor [Idea or Concept]
   706 E C0444504:Mean [Quantitative Concept]
   706   C1547282:Show [Intellectual Product]
   706 E C2347634:Mean [Quantitative Concept]
   706 E C2348143:Mean [Quantitative Concept]

Phrase: "from five to ten separate observations/condition."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   799   C0012634:condition [Disease or Syndrome]
   799   C0348080:Condition [Qualitative Concept]
   799   C1705253:Condition [Conceptual Entity]
   727 E C0009647:Conditioned [Mental Process]
   727 E C1701901:Conditional [Qualitative Concept]
   727 E C1963686:Conditional [Functional Concept]
Processing 00000000.tx.199: View this table: [in this window] [in a new window]  Table III Effect of calcium and diacylglycerol metabolism on APP-S secretion in NT2N cells Cells were labeled for 3h with [35S]methionine as in Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table III Effect of calcium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "diacylglycerol metabolism on APP-S secretion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C1327340:amyloid precursor protein metabolism [Molecular Function]
   778   C1158320:diacylglycerol metabolism [Molecular Function]
   774   C0597299:Protein Metabolism [Molecular Function]
   748   C0025519:Metabolism [Organism Function]
   748   C0025520:metabolism [Functional Concept]

Phrase: "in NT2N cells Cells"

Phrase: "were"

Phrase: "labeled for 3h"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1442460:3H [Temporal Concept]
   790   C1708632:Labeled [Qualitative Concept]
   756 E C0181496:Label [Manufactured Object]
   756 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "with"

Phrase: "[35S"

Phrase: "]methionine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "as in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.200: 1 and then pretreated for 30min with thapsigargin, RG80267, or R59949. 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "pretreated for 30min"

Phrase: "with thapsigargin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "RG80267,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0284518:Rg80267 [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "R59949."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072922:R59949 [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.201: The cells were then treated for 30min with the control, 1mM glutamate, A23187, the inhibitor alone, or 1mM glutamate+the inhibitor. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "treated for 30min"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332293:treated [Therapeutic or Preventive Procedure]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "with the control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "1mM glutamate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   861   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "A23187,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878412:A23187 [Antibiotic,Organic Chemical]

Phrase: "the inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999216:Inhibitor [Qualitative Concept]

Phrase: "alone,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or"

Phrase: "1mM glutamate+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   861   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the inhibitor."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.202: APP-S secretion was quantitated by PhosphorImager analysis as the amount of radioactivity in the APP-S band and is expressed as a percentage of the control within each experiment. 

Phrase: "APP-S secretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "was"

Phrase: "quantitated by PhosphorImager analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "as the amount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1265611:Amount [Quantitative Concept]

Phrase: "of radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "in the APP-S band"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0175723:Band [Medical Device]
   812   C0439645:Band [Spatial Concept]
   812   C1521913:band [Cell Component]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "is"

Phrase: "expressed as a percentage of the control"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0243148:control [Qualitative Concept]
   748   C0439165:Percentage [Quantitative Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1550141:Control [Substance]
   748   C1561533:Percentage [Idea or Concept]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: "within each experiment."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.203: Results are shown as the meanS.E. of APP-S secretion from 4to 13separate observations/condition.  

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "shown as the meanS.E. of APP-S secretion"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   782   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   782   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   760   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1159339:Protein Secretion [Cell Function]
   757   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0036536:secretion [Biologic Function]
   739   C0036537:Secretion [Body Substance]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1704970:Means [Conceptual Entity]
   739   C1709634:Precursor [Idea or Concept]
   706 E C0444504:Mean [Quantitative Concept]
   706   C1547282:Show [Intellectual Product]
   706 E C2347634:Mean [Quantitative Concept]
   706 E C2348143:Mean [Quantitative Concept]

Phrase: "from 4to 13separate observations/condition."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   812   C0012634:condition [Disease or Syndrome]
   812   C0348080:Condition [Qualitative Concept]
   812   C1705253:Condition [Conceptual Entity]
   741 E C0009647:Conditioned [Mental Process]
   741 E C1701901:Conditional [Qualitative Concept]
   741 E C1963686:Conditional [Functional Concept]
   712 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.204: DISCUSSION Top Abstract Introduction Procedures Results Discussion References We have shown that the metabotropic glutamate receptors mGluR1 and mGluR5 are present in NT2N cells and that upon stimulation with glutamate, increase the accumulation of the second messenger IP3 and the secretion of APP-S in a time- and dose-dependent manner. 

Phrase: "DISCUSSION Top Abstract Introduction Procedures Results Discussion"

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "We"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the metabotropic glutamate receptors mGluR1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0535210:mGluR1 [Amino Acid, Peptide, or Protein,Receptor]
   812   C1333711:MGLUR1 [Gene or Genome]
   812   C1706579:MGLUR1 [Gene or Genome]
   756   C0206529:Receptors, Metabotropic Glutamate [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "mGluR5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1333712:MGLUR5 [Gene or Genome]
  1000   C1706589:MGLUR5 [Gene or Genome]

Phrase: "are"

Phrase: "present in NT2N cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "that upon stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   790   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "with glutamate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the accumulation of the second messenger IP3"

Phrase: "and"

Phrase: "the secretion of APP-S"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1159339:Protein Secretion [Cell Function]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]

Phrase: "in a time-"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "and"

Phrase: "dose-dependent manner."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1512045:Dose-dependent [Quantitative Concept]
Processing 00000000.tx.205: This is a novel demonstration of glutamatergic regulation of APP-S secretion in a nontransfected human neuronal cell line. 

Phrase: "This"

Phrase: "is"

Phrase: "a novel demonstration of glutamatergic regulation of APP-S secretion"

Phrase: "in a nontransfected human neuronal cell line."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   888   C0682523:Human Cell Line [Cell]
   853   C0427861:human cell [Laboratory or Test Result]
   840   C0007600:Cell Line [Cell]
   804   C0007634:Cell [Cell]
   804   C0205132:Line [Spatial Concept]
   804   C0521390:Neuronal [Immunologic Factor]
   804   C1269647:Cell [Cell]
   804   C1550648:Line [Substance]
   804   C1552960:Line [Quantitative Concept]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   733 E C0027882:Neuron [Cell]
Processing 00000000.tx.206: The regulation of receptor-mediated APP-S secretion has been studied extensively. 

Phrase: "The regulation of receptor-mediated APP-S secretion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   807   C1327618:regulation of protein secretion [Cell Function]
   784   C1523071:regulation of secretion [Cell Function]
   742   C0851285:Regulation [Governmental or Regulatory Activity]
   742   C1327622:Regulation [Biologic Function]

Phrase: "has"

Phrase: "been"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "extensively."
Processing 00000000.tx.207: However, a complete model of the signaling pathway has yet to be developed. 

Phrase: "However,"

Phrase: "a complete model of the signaling pathway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3161035:Model [Intellectual Product]

Phrase: "has"

Phrase: "yet to"

Phrase: "be"

Phrase: "developed."
Processing 00000000.tx.208: APP-S secretion has previously been shown to be regulated by the muscarinic receptor signaling pathway (19). 

Phrase: "APP-S secretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "has"

Phrase: "previously"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "regulated by the muscarinic receptor signaling pathway"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   778   C0034826:Muscarinic Receptor [Amino Acid, Peptide, or Protein,Receptor]
   778   C0037083:signaling pathway [Cell Function]
           Signaling
   778   C0086982:Signaling Pathway [Molecular Function]
   778   C1514762:Receptor Signaling [Molecular Function]
   774 E C0037080:pathway signaling [Molecular Function]
   748   C0026815:muscarinic [Pharmacologic Substance]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0851285:Regulated [Governmental or Regulatory Activity]
   748   C1704259:Pathway [Molecular Function]
   748   C1705987:Pathway [Conceptual Entity]
   748   C3537152:signaling [Biologic Function]
   714 E C1710082:Signal [Phenomenon or Process]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.209: Muscarinic receptor activation results in the activation of a phospholipase C-linked pathway, as seen by increases in intracellular calcium, DAG, and IP3, and subsequent secretion of APP-S (19). 

Phrase: "Muscarinic receptor activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1514758:Receptor Activation [Cell Function]
   827   C1879547:Activation [Activity]
   734   C0034826:Muscarinic Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "results in the activation of a phospholipase C-linked pathway,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   777   C1155436:phospholipase C activation [Molecular Function]
   760   C0031669:Phospholipase C [Amino Acid, Peptide, or Protein,Enzyme]
   757   C0031672:Phospholipase A [Amino Acid, Peptide, or Protein,Enzyme]
   757   C2261240:phospholipase A [Molecular Function]
   739   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1274040:Result [Functional Concept]
   739   C1546471:Result [Idea or Concept]
   739   C1704259:Pathway [Molecular Function]
   739   C1705987:Pathway [Conceptual Entity]
   739   C1879547:Activation [Activity]
   739   C2825142:Result [Finding]
   706   C1517892:Link [Intellectual Product]
   706   C1704666:Link [Intellectual Product]

Phrase: "as"

Phrase: "seen by increases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0205397:Seen [Qualitative Concept]
   790   C0442805:increases [Functional Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "in intracellular calcium,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0006726:Calcium [Inorganic Chemical]
   861   C2936886:Calcium [Pharmacologic Substance]

Phrase: "DAG,"

Phrase: "and"

Phrase: "IP3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021549:IP3 [Biologically Active Substance,Carbohydrate]
  1000   C3542924:IP3 [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "subsequent secretion of APP-S"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1159339:Protein Secretion [Cell Function]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.210: The stimulation of APP-S secretion by glutamate receptors has also been shown recently (20, 33-35). 

Phrase: "The stimulation of APP-S secretion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   835   C2255862:stimulation of protein secretion [Cell Function]
   804   C2259155:stimulation of secretion [Cell Function]
   748   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   748   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "by glutamate receptors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0061465:Receptors, Glutamate [Amino Acid, Peptide, or Protein,Receptor]
   861   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   861   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "(20,"

Phrase: "33-35"

Phrase: ")."
Processing 00000000.tx.211: Glutamate, quisqualate, and ACPD were shown to increase APP-S secretion from rat hippocampal neurons, as well as from rat cortical and hippocampal brain slices. 

Phrase: "Glutamate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "quisqualate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080073:Quisqualate [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "ACPD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0044270:ACPD [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "APP-S secretion from rat hippocampal neurons,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1159339:Protein Secretion [Cell Function]
   744   C0036536:secretion [Biologic Function]
   744   C0036537:Secretion [Body Substance]

Phrase: "as well as from rat"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C0205170:Well [Qualitative Concept]
   760   C3146287:Well [Manufactured Object]

Phrase: "cortical"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0001613:Cortical [Body Part, Organ, or Organ Component]
  1000   C0007776:Cortical [Body Part, Organ, or Organ Component]
  1000   C0022655:Cortical [Body Part, Organ, or Organ Component]
   944 E C0234875:bark [Organism Attribute]
   944 E C2700441:Bark [Plant]
   916 E C0205704:Cascara [Organic Chemical,Pharmacologic Substance]
   916 E C3486388:Cascara [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "hippocampal brain slices."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1519355:Slice [Substance]
Processing 00000000.tx.212: Glutamate, quisqualate, and ACPD have also been shown to increase intracellular IP3 accumulation in cultured rat hippocampal neurons, cortical and hippocampal rat brain slices, and astrocytes (20, 34, 35). 

Phrase: "Glutamate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "quisqualate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080073:Quisqualate [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "ACPD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0044270:ACPD [Organic Chemical,Pharmacologic Substance]

Phrase: "have"

Phrase: "also"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "intracellular IP3 accumulation in cultured rat hippocampal neurons,"

Phrase: "cortical"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0001613:Cortical [Body Part, Organ, or Organ Component]
  1000   C0007776:Cortical [Body Part, Organ, or Organ Component]
  1000   C0022655:Cortical [Body Part, Organ, or Organ Component]
   944 E C0234875:bark [Organism Attribute]
   944 E C2700441:Bark [Plant]
   916 E C0205704:Cascara [Organic Chemical,Pharmacologic Substance]
   916 E C3486388:Cascara [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "hippocampal rat brain slices,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1519355:Slice [Substance]

Phrase: "and"

Phrase: "astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "(20,"

Phrase: "34,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.213: Ionotropic glutamate receptor agonists NMDA, AMPA, and kainate did not have any effect on APP-S secretion from rat hippocampal neurons or from rat cortical and hippocampal brain slices. 

Phrase: "Ionotropic glutamate receptor agonists NMDA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0079883:NMDA [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "AMPA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0051318:AMPA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "kainate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205812:Kainate [Organic Chemical,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "any effect on APP-S secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "from rat hippocampal neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "or from rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034693:Rat, NOS [Mammal]
   790   C0034721:Rat [Mammal]

Phrase: "cortical"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0001613:Cortical [Body Part, Organ, or Organ Component]
  1000   C0007776:Cortical [Body Part, Organ, or Organ Component]
  1000   C0022655:Cortical [Body Part, Organ, or Organ Component]
   944 E C0234875:bark [Organism Attribute]
   944 E C2700441:Bark [Plant]
   916 E C0205704:Cascara [Organic Chemical,Pharmacologic Substance]
   916 E C3486388:Cascara [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "hippocampal brain slices."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1519355:Slice [Substance]
Processing 00000000.tx.214: However, it is not known which glutamate receptors are directly involved in the stimulation of APP-S secretion. 

Phrase: "However,"

Phrase: "it"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "which glutamate receptors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0061465:Receptors, Glutamate [Amino Acid, Peptide, or Protein,Receptor]
   861   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   861   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "involved in the stimulation of APP-S secretion."
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   807   C2255862:stimulation of protein secretion [Cell Function]
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   784   C2259155:stimulation of secretion [Cell Function]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1159339:Protein Secretion [Cell Function]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0036536:secretion [Biologic Function]
   742   C0036537:Secretion [Body Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   742   C1314939:Involved [Functional Concept]
   742   C1709634:Precursor [Idea or Concept]
   742   C1948023:Stimulation [Natural Phenomenon or Process]
Processing 00000000.tx.215: It has been demonstrated that metabotropic glutamate receptors are involved in glutamate-mediated APP-S secretion. 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "demonstrated"

Phrase: "that metabotropic glutamate receptors"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0206529:Receptors, Metabotropic Glutamate [Amino Acid, Peptide, or Protein,Receptor]
   901   C0061465:Receptors, Glutamate [Amino Acid, Peptide, or Protein,Receptor]
   896   C1178976:Metabotropic receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   827   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "involved in glutamate-mediated APP-S secretion."
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1159339:Protein Secretion [Cell Function]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   767   C1817648:glutamate secretion [Cell Function]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0036536:secretion [Biologic Function]
   744   C0036537:Secretion [Body Substance]
   744   C0086597:mediated [Social Behavior]
   744   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   744   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1314939:Involved [Functional Concept]
   744   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.216: These findings support our data and conclusion that metabotropic glutamate receptors are involved in the regulation of APP-S secretion. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "and"

Phrase: "conclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "that metabotropic glutamate receptors"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0206529:Receptors, Metabotropic Glutamate [Amino Acid, Peptide, or Protein,Receptor]
   901   C0061465:Receptors, Glutamate [Amino Acid, Peptide, or Protein,Receptor]
   896   C1178976:Metabotropic receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   827   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "involved in the regulation of APP-S secretion."
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   807   C1327618:regulation of protein secretion [Cell Function]
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   784   C1523071:regulation of secretion [Cell Function]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1159339:Protein Secretion [Cell Function]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0036536:secretion [Biologic Function]
   742   C0036537:Secretion [Body Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0851285:Regulation [Governmental or Regulatory Activity]
   742   C1314939:Involved [Functional Concept]
   742   C1327622:Regulation [Biologic Function]
   742   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.217: For our model, the human neuronal NT2N cells were used. 

Phrase: "For our model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "the human neuronal NT2N cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   897   C0427861:Human cells [Laboratory or Test Result]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.218: NT2N cells provide a unique model system because they are human cells that endogenously express APP and A. 

Phrase: "NT2N cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a unique model system"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0026339:Model System [Intellectual Product,Research Device]
   901   C3161035:Model System [Intellectual Product]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "because"

Phrase: "they"

Phrase: "are"

Phrase: "human cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0427861:Human cells [Laboratory or Test Result]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "that endogenously"

Phrase: "express"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "A."
Processing 00000000.tx.219: These cells also express the muscarinic receptor subtypes m2 and m3 and have been previously shown to express ionotropic glutamate receptors (36, 37). 

Phrase: "These cells also"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "express"

Phrase: "the muscarinic receptor subtypes m2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C0384752:Muscarinic Receptor M2 [Amino Acid, Peptide, or Protein,Receptor]
   812   C0457242:m2 [Quantitative Concept]

Phrase: "and"

Phrase: "m3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1300554:m3 [Quantitative Concept]
  1000   C3484373:M3 [Intellectual Product]

Phrase: "and"

Phrase: "have"

Phrase: "been"

Phrase: "previously"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "express"

Phrase: "ionotropic glutamate receptors"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C2936399:Receptors, Ionotropic Glutamate [Amino Acid, Peptide, or Protein,Receptor]
   901   C0061465:Receptors, Glutamate [Amino Acid, Peptide, or Protein,Receptor]
   896   C1179928:Ionotropic receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   827   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(36,"

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.220: We currently have demonstrated the presence of the metabotropic glutamate receptor subtypes mGluR1 and mGluR5 in NT2N cells. 

Phrase: "We currently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521116:Currently [Temporal Concept]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "the presence of the metabotropic glutamate receptor subtypes mGluR1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "mGluR5 in NT2N cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1333712:MGLUR5 [Gene or Genome]
   760   C1706589:MGLUR5 [Gene or Genome]
Processing 00000000.tx.221: There are at least eight different subtypes of metabotropic glutamate receptors, and these are subdivided into three groups according to sequence similarities, agonist selectivity, and intracellular signaling machinery. 

Phrase: "There"

Phrase: "are at least eight different subtypes of metabotropic glutamate receptors,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   782   C0206529:Receptors, Metabotropic Glutamate [Amino Acid, Peptide, or Protein,Receptor]
   760   C0061465:Receptors, Glutamate [Amino Acid, Peptide, or Protein,Receptor]
   741   C1178976:Metabotropic receptor [Amino Acid, Peptide, or Protein,Receptor]
   739   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   739   C0205454:Eight [Quantitative Concept]
   739   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0449560:subtypes [Classification]
   739   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   739   C1551058:Are [Quantitative Concept]
   739   C1705242:Different [Qualitative Concept]

Phrase: "and"

Phrase: "these"

Phrase: "are"

Phrase: "subdivided into three groups"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0205449:Three [Quantitative Concept]
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552839:groups [Idea or Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]

Phrase: "according to sequence similarities,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1710052:Sequence Similarity [Quantitative Concept]
   827   C2348205:Similarity [Qualitative Concept]

Phrase: "agonist selectivity,"

Phrase: "and"

Phrase: "intracellular signaling machinery."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0337076:machinery [Manufactured Object]
Processing 00000000.tx.222: The metabotropic glutamate receptors mGluR1 and mGluR5 are the group I receptors, coupled to PI hydrolysis, and upon stimulation with specific receptor agonists resulted in an increase in secretion of APP-S from these cells. 

Phrase: "The metabotropic glutamate receptors mGluR1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0535210:mGluR1 [Amino Acid, Peptide, or Protein,Receptor]
   812   C1333711:MGLUR1 [Gene or Genome]
   812   C1706579:MGLUR1 [Gene or Genome]
   756   C0206529:Receptors, Metabotropic Glutamate [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "mGluR5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1333712:MGLUR5 [Gene or Genome]
  1000   C1706589:MGLUR5 [Gene or Genome]

Phrase: "are"

Phrase: "the group I receptors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   734   C0441843:Group I [Intellectual Product]

Phrase: "coupled to PI hydrolysis,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0020291:Hydrolysis [Natural Phenomenon or Process]
   770   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   770   C1948027:Coupled [Functional Concept]
   770   C2348046:Phosphatidylinositol [Lipid]
   737 E C0010222:couple [Family Group]

Phrase: "and upon stimulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   790   C1515981:And [Idea or Concept]
   790   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "with specific receptor agonists"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0243192:agonists [Pharmacologic Substance]
   827   C2987634:agonists [Pharmacologic Substance]

Phrase: "resulted in an increase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0442805:Increase [Functional Concept]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "in secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]

Phrase: "of APP-S"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "from these cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.223: Specific metabotropic glutamate receptor antagonists inhibited receptor-mediated APP-S secretion, suggesting that the agonists were specific for the metabotropic receptors. 

Phrase: "Specific metabotropic glutamate receptor antagonists"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   884   C0242910:Glutamate Receptor Antagonists [Pharmacologic Substance]
           Glutamate Antagonists
   804   C0243076:antagonists [Chemical Viewed Functionally]
   771 E C0231491:Antagonist [Organ or Tissue Function]
   717   C0206529:Metabotropic Glutamate Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "receptor-mediated APP-S secretion,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1159339:Protein Secretion [Cell Function]
   799   C0036536:secretion [Biologic Function]
   799   C0036537:Secretion [Body Substance]
   709   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the agonists"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243192:agonists [Pharmacologic Substance]
  1000   C2987634:agonists [Pharmacologic Substance]

Phrase: "were"

Phrase: "specific for the metabotropic receptors."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205369:Specific [Qualitative Concept]
   760   C1552740:specific [Intellectual Product]
Processing 00000000.tx.224: In addition, but contrary to previous reports in non-neuronal cells and rat neurons, the ionotropic glutamate receptor agonists AMPA and kainate also caused an increase in the secretion of APP-S from NT2N cells. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "but"

Phrase: "contrary to previous reports"

Phrase: "in non-neuronal cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   988   C0027836:Non-neuronal cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "rat neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "the ionotropic glutamate receptor agonists AMPA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0051318:AMPA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "kainate also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205812:Kainate [Organic Chemical,Pharmacologic Substance]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "an increase in the secretion of APP-S"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "from NT2N cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.225: This we believe is the result of the increase in intracellular calcium levels upon activation of these receptors (Fig. 4). 

Phrase: "This"

Phrase: "we"

Phrase: "believe"

Phrase: "is"

Phrase: "the result of the increase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]

Phrase: "in intracellular calcium levels"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   901   C0201925:calcium levels [Laboratory Procedure]
   901   C0428302:calcium levels [Laboratory or Test Result]
   827   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0006726:Calcium [Inorganic Chemical]
   827   C0175996:intracellular [Cell Component]
   827   C0178719:Intracellular [Spatial Concept]
   827   C0441889:Levels [Qualitative Concept]
   827   C2936886:Calcium [Pharmacologic Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "upon activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "of these receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.226: The calcium ionophore A23187, which results in an increase in intracellular calcium concentrations, also caused an increase in the secretion of APP-S, suggesting that calcium is a potentiator of APP-S secretion. 

Phrase: "The calcium ionophore A23187,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521966:Calcium ionophore A23187 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0878412:A23187 [Antibiotic,Organic Chemical]
   734   C0444420:Calcium ionophore [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "which"

Phrase: "results in an increase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0442805:Increase [Functional Concept]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "in intracellular calcium concentrations,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "also"

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "an increase in the secretion of APP-S,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that calcium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0006726:Calcium [Inorganic Chemical]
  1000   C2936886:Calcium [Pharmacologic Substance]

Phrase: "is"

Phrase: "a potentiator of APP-S secretion."
Processing 00000000.tx.227: Furthermore, stimulation of these cells with glutamate resulted in the activation of a phospholipase C-linked pathway, as seen by an increase in IP3 accumulation. 

Phrase: "Furthermore,"

Phrase: "stimulation of these cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "with glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "resulted in the activation of a phospholipase C-linked pathway,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   777   C1155436:phospholipase C activation [Molecular Function]
   760   C0031669:Phospholipase C [Amino Acid, Peptide, or Protein,Enzyme]
   757   C0031672:Phospholipase A [Amino Acid, Peptide, or Protein,Enzyme]
   757   C2261240:phospholipase A [Molecular Function]
   739   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1704259:Pathway [Molecular Function]
   739   C1705987:Pathway [Conceptual Entity]
   739   C1879547:Activation [Activity]
   706   C1274040:Result [Functional Concept]
   706   C1517892:Link [Intellectual Product]
   706   C1546471:Result [Idea or Concept]
   706   C1704666:Link [Intellectual Product]
   706   C2825142:Result [Finding]

Phrase: "as"

Phrase: "seen by an increase"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0205397:Seen [Qualitative Concept]
   770   C0442805:Increase [Functional Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "in IP3 accumulation."
Processing 00000000.tx.228: We also examined the effect of OAG, a cell-permeable DAG analog, and DAG lipase and kinase inhibitors to determine if DAG metabolism or generation is involved in the glutamate-induced APP-S secretion. 

Phrase: "We also"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the effect of OAG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "a cell-permeable DAG analog,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0243071:Analog [Chemical Viewed Structurally]
   704 E C0679213:analogies [Idea or Concept]

Phrase: "and"

Phrase: "DAG lipase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023816:DAG lipase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0023764:Lipase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "kinase inhibitors to"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   901   C1152564:Kinase Inhibitors [Molecular Function]
   884 E C1171350:Kinase Inhibitor [Pharmacologic Substance]
   884 E C3537023:kinase inhibitor [Molecular Function]
   884 E C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   793 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "determine"

Phrase: "if"

Phrase: "DAG metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "or"

Phrase: "generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0079411:Generation [Temporal Concept]
  1000   C3146294:Generation [Activity]
   907 E C1414672:Genesis [Gene or Genome]
   907 E C2984892:Genesis [Gene or Genome]

Phrase: "is"

Phrase: "involved in the glutamate-induced APP-S secretion."
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1159339:Protein Secretion [Cell Function]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   762   C1817648:glutamate secretion [Cell Function]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0036536:secretion [Biologic Function]
   742   C0036537:Secretion [Body Substance]
   742   C0205263:Induced [Functional Concept]
   742   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1314939:Involved [Functional Concept]
   742   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.229: The DAG lipase inhibitor RG80267 did not have any effect on glutamate-induced APP-S secretion, suggesting that DAG metabolism is not involved. 

Phrase: "The DAG lipase inhibitor RG80267"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0284518:Rg80267 [Organic Chemical,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "any effect on glutamate-induced APP-S secretion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that DAG metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "involved."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]
Processing 00000000.tx.230: However, both OAG and the DAG kinase inhibitor R59949, which in other systems has been shown to increase DAG levels (38), caused an increase in glutamate-induced APP-S secretion, suggesting that DAG is a downstream mediator in glutamate receptor signaling. 

Phrase: "However,"

Phrase: "both OAG"

Phrase: "and"

Phrase: "the DAG kinase inhibitor R59949,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0072922:R59949 [Organic Chemical,Pharmacologic Substance]

Phrase: "which in other systems"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0449913:System [Functional Concept]
   737   C1553451:System [Manufactured Object]
   737   C1704459:System [Medical Device]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "DAG levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "(38"

Phrase: ")"

Phrase: ","

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "an increase in glutamate-induced APP-S secretion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that DAG"

Phrase: "is"

Phrase: "a downstream mediator in glutamate receptor signaling."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.231: The effect of the protein kinase C activator PMA on APP-S secretion mimicked the effect seen by glutamate, suggesting that protein kinase C is also involved as a downstream mediator in the regulation of APP-S secretion. 

Phrase: "The effect of the protein kinase C activator PMA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "on APP-S secretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "mimicked"

Phrase: "the effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "seen by glutamate,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   790   C0205397:Seen [Qualitative Concept]
   790   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that protein kinase C"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "also"

Phrase: "involved as a downstream mediator"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0522506:Downstream [Spatial Concept]
   760   C1314939:Involved [Functional Concept]
   760   C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of APP-S secretion."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.232: Protein kinase C has extensively been shown to be involved in the regulation of APP-S secretion (21, 39, 40); 

Phrase: "Protein kinase C"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "extensively"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "involved in the regulation of APP-S secretion"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   807   C1327618:regulation of protein secretion [Cell Function]
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   784   C1523071:regulation of secretion [Cell Function]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1159339:Protein Secretion [Cell Function]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0036536:secretion [Biologic Function]
   742   C0036537:Secretion [Body Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0851285:Regulation [Governmental or Regulatory Activity]
   742   C1314939:Involved [Functional Concept]
   742   C1327622:Regulation [Biologic Function]
   742   C1709634:Precursor [Idea or Concept]

Phrase: "(21,"

Phrase: "39,"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.233: however, it has not been demonstrated how protein kinase C is involved or which isoform is involved in APP-S secretion. 

Phrase: "however,"

Phrase: "it"

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "demonstrated"

Phrase: "how protein kinase C"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   875   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   875   C1168438:Protein C [Laboratory Procedure]
   875   C1418943:PROTEIN C [Gene or Genome]
   875   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "or"

Phrase: "which isoform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "involved in APP-S secretion."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1159339:Protein Secretion [Cell Function]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1314939:Involved [Functional Concept]
   753   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.234: Metabotropic glutamate receptors of Groups II and III are negatively coupled to cAMP, and in astrocytes, forskolin and dibutyryl cyclic AMP inhibited mGluR agonist-induced APP-S secretion and increased APP gene expression and the cellular APP holoprotein. 

Phrase: "Metabotropic glutamate receptors of Groups II"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0206529:Receptors, Metabotropic Glutamate [Amino Acid, Peptide, or Protein,Receptor]
   790   C0061465:Receptors, Glutamate [Amino Acid, Peptide, or Protein,Receptor]
   767   C1178976:Metabotropic receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   753   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: "are"

Phrase: "negatively"

Phrase: "coupled to cAMP,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   790   C1948027:Coupled [Functional Concept]
   756 E C0010222:couple [Family Group]

Phrase: "and in astrocytes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0004112:Astrocytes [Cell]
   790   C1515981:And [Idea or Concept]

Phrase: "forskolin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917964:Forskolin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "dibutyryl cyclic AMP"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0012054:Dibutyryl Cyclic AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   901   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0439596:Cyclic [Temporal Concept]
   827   C1511572:Cyclic [Temporal Concept]
   755 E C0031084:Cyclicities [Temporal Concept]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "mGluR agonist-induced APP-S secretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   818   C1159339:Protein Secretion [Cell Function]
   795   C0036536:secretion [Biologic Function]
   795   C0036537:Secretion [Body Substance]

Phrase: "and"

Phrase: "increased APP gene expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   839   C1171362:protein expression [Genetic Function]
   827   C0017262:Gene Expression [Genetic Function]
   827   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0017337:Gene [Gene or Genome]
   799   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "the cellular APP holoprotein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
Processing 00000000.tx.235: (35). 

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.236: These studies demonstrated an inhibition of both glutamate- and phorbol ester-stimulated APP-S secretion with forskolin, an activator of adenylate cyclase, and dibutyryl cyclic AMP, suggesting that activation of the cAMP pathway inhibits APP-S secretion. 

Phrase: "These studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "demonstrated"

Phrase: "an inhibition of both glutamate-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "and"

Phrase: "phorbol ester-stimulated APP-S secretion with forskolin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1159339:Protein Secretion [Cell Function]
   742   C0036536:secretion [Biologic Function]
   742   C0036537:Secretion [Body Substance]

Phrase: "an activator of adenylate cyclase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   844   C1621896:adenylate cyclase activator [Molecular Function]

Phrase: "and"

Phrase: "dibutyryl cyclic AMP,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0012054:Dibutyryl Cyclic AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   901   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0439596:Cyclic [Temporal Concept]
   827   C1511572:Cyclic [Temporal Concept]
   755 E C0031084:Cyclicities [Temporal Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that activation of the cAMP pathway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "APP-S secretion."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.237: Additionally, activation of adrenergic receptors coupled to cAMP also increased APP gene expression and APP holoprotein in astrocytes (42). 

Phrase: "Additionally,"

Phrase: "activation of adrenergic receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C1514758:Receptor Activation [Cell Function]
   770   C1879547:Activation [Activity]

Phrase: "coupled to cAMP also increased APP gene expression"
Meta Candidates (Total=20; Excluded=1; Pruned=0; Remaining=19)
   782   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   782   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   760   C0017262:Gene Expression [Genetic Function]
   760   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C1171362:expression protein [Genetic Function]
   757   C1413106:CAMP gene [Gene or Genome]
   757   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0017337:Gene [Gene or Genome]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]
   739   C0205217:Increased [Quantitative Concept]
   739   C0442805:Increased [Functional Concept]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1709634:Precursor [Idea or Concept]
   739   C1948027:Coupled [Functional Concept]
   706 E C0010222:couple [Family Group]

Phrase: "and"

Phrase: "APP holoprotein in astrocytes"

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.238: In C6 cells transfected with APP751, forskolin, dibutyryl cyclic AMP, and isoproterenol increased the concentration of cAMP, and forskolin inhibited both the constitutive and phorbol ester-mediated secretion of nexin II, the -secretase cleavage product of APP751 (43). 

Phrase: "In C6 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with APP751,"

Phrase: "forskolin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917964:Forskolin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "dibutyryl cyclic AMP,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0012054:Dibutyryl Cyclic AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   901   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0439596:Cyclic [Temporal Concept]
   827   C1511572:Cyclic [Temporal Concept]
   755 E C0031084:Cyclicities [Temporal Concept]

Phrase: "and"

Phrase: "isoproterenol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0022245:Isoproterenol [Organic Chemical,Pharmacologic Substance]
   944 E C0701452:Norisodrine [Organic Chemical,Pharmacologic Substance]
   944 E C0701454:Isuprel [Organic Chemical,Pharmacologic Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the concentration of cAMP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0009633:Concentration Camp [Manufactured Object]
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "forskolin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917964:Forskolin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "both the constitutive"

Phrase: "and"

Phrase: "phorbol ester-mediated secretion of nexin II,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]

Phrase: "the -secretase cleavage product of APP751"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]
   753   C1514468:product [Entity]
   753   C1704444:Product [Quantitative Concept]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.239: These studies also demonstrate an involvement of cAMP in APP-S secretion. 

Phrase: "These studies also"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "demonstrate"

Phrase: "an involvement of cAMP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1314939:Involvement [Functional Concept]

Phrase: "in APP-S secretion."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.240: In contrast, Xu et al. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "Xu et al."
Processing 00000000.tx.241: (44) showed that forskolin stimulated the secretion of APP-S from PC12 cells. 

Phrase: "(44"

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that forskolin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917964:Forskolin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "the secretion of APP-S"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1159339:Protein Secretion [Cell Function]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]

Phrase: "from PC12 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.242: Therefore, the effect of the cAMP pathway on APP-S secretion still remains unclear and may be cell-specific. 

Phrase: "Therefore,"

Phrase: "the effect of the cAMP pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on APP-S secretion still"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C1159339:Protein Secretion [Cell Function]
   804   C0036536:secretion [Biologic Function]
   804   C0036537:Secretion [Body Substance]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "remains"

Phrase: "unclear"

Phrase: "and"

Phrase: "may"

Phrase: "be"

Phrase: "cell-specific."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205369:Specific [Qualitative Concept]
   861   C1552740:specific [Intellectual Product]
Processing 00000000.tx.243: In NT2N cells, preliminary experiments examining the effect of forskolin on APP-S secretion did not demonstrate a change in APP-S secretion after the addition of forskolin (APP-S secretion of 105%11% of control in the presence of 10M forskolin, n=6). 

Phrase: "In NT2N cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "preliminary experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "examining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332128:examining [Finding]
  1000   C2004054:Examining [Activity]

Phrase: "the effect of forskolin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on APP-S secretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "demonstrate"

Phrase: "a change in APP-S secretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0392747:Change [Functional Concept]
   748   C0443172:change [Quantitative Concept]
   748   C1705241:Change [Quantitative Concept]

Phrase: "after the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of forskolin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917964:Forskolin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "(APP-S secretion of 105%11% of control"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1159339:Protein Secretion [Cell Function]
   742   C0036536:secretion [Biologic Function]
   742   C0036537:Secretion [Body Substance]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 10M forskolin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0917964:Forskolin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "n=6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.244: However, the metabotropic glutamate receptor agonist CCG-I (a Group II agonist) did stimulate APP-S secretion, although this could be due to its reported stimulation of mGluR1 and phosphoinositide hydrolysis (41). 

Phrase: "However,"

Phrase: "the metabotropic glutamate receptor agonist CCG-I ("
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0021966:I- [Inorganic Chemical]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "a Group II agonist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2987634:Agonist [Pharmacologic Substance]

Phrase: ")"

Phrase: "did"

Phrase: "stimulate"

Phrase: "APP-S secretion,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "although"

Phrase: "this"

Phrase: "could"

Phrase: "be due to its reported stimulation of mGluR1"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   770   C0678226:Due to [Functional Concept]
           due
   744   C0535210:mGluR1 [Amino Acid, Peptide, or Protein,Receptor]
   744   C0684224:Reported [Intellectual Product]
   744   C0700287:Reported [Health Care Activity]
   744   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   744   C1333711:MGLUR1 [Gene or Genome]
   744   C1706579:MGLUR1 [Gene or Genome]
   744   C1948023:Stimulation [Natural Phenomenon or Process]
   744   C2987476:Be [Conceptual Entity]
   744   C3146286:Due [Idea or Concept]
   744   C3496591:Reported [Clinical Attribute]
   711 E C3273238:Report [Intellectual Product]

Phrase: "and"

Phrase: "phosphoinositide hydrolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020291:Hydrolysis [Natural Phenomenon or Process]

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.245: In addition, Group II/III antagonists partially inhibited glutamate-induced APP-S secretion (Table II). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "Group II/III antagonists partially"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0243076:antagonists [Chemical Viewed Functionally]
   771 E C0231491:Antagonist [Organ or Tissue Function]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "glutamate-induced APP-S secretion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   895   C1817648:glutamate secretion [Cell Function]
   827   C1159339:Protein Secretion [Cell Function]
   799   C0036536:secretion [Biologic Function]
   799   C0036537:Secretion [Body Substance]

Phrase: "(Table II"

Phrase: ")."
Processing 00000000.tx.246: These conflicting results suggest that activation of the cAMP pathway may also be an important regulatory mechanism of APP-S secretion in NT2N cells and will require further investigation. 

Phrase: "These conflicting results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that activation of the cAMP pathway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]

Phrase: "may"

Phrase: "also"

Phrase: "be"

Phrase: "an important regulatory mechanism of APP-S secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0441712:Mechanism [Functional Concept]
   742   C1706376:Mechanism [Manufactured Object]

Phrase: "in NT2N cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "will"

Phrase: "require"

Phrase: "further investigation."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C1261322:Investigation [Health Care Activity]
   861   C1552578:investigation [Idea or Concept]
   789 E C1517586:Investigational [Qualitative Concept]
   789 E C3245491:investigational [Intellectual Product]
Processing 00000000.tx.247: In conclusion, we have demonstrated that glutamate stimulates the metabotropic glutamate receptor signal transduction pathway in human neurons causing an increase in the second messenger IP3 and the secretion of APP-S.  

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "we"

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "stimulates"

Phrase: "the metabotropic glutamate receptor signal transduction pathway in human neurons"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   782   C0086982:Signal Transduction Pathway [Molecular Function]
   760   C0037083:Signal Transduction [Cell Function]
   757   C0037080:Signal Pathway [Molecular Function]
   739   C1160185:transduction [Organism Function]
   739   C1704259:Pathway [Molecular Function]
   739   C1705987:Pathway [Conceptual Entity]
   739   C1710082:Signal [Phenomenon or Process]
   736   C2756001:neuronal signal transduction [Cell Function]

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "an increase in the second messenger IP3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "the secretion of APP-S."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1159339:Protein Secretion [Cell Function]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
Processing 00000000.tx.248: FOOTNOTES * This work was supported in part by National Institutes of Health Grants AG09215 and AG11542 and the Penn Alzheimer's Disease Core Center Pilot Grant Program NIA AG-10124.

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by National Institutes of Health Grants AG09215"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027468:National Institutes of Health [Health Care Related Organization]

Phrase: "and"

Phrase: "AG11542"

Phrase: "and"

Phrase: "the Penn Alzheimer's Disease Core Center Pilot Grant Program NIA AG-10124."
Meta Candidates (Total=25; Excluded=3; Pruned=0; Remaining=22)
   840   C3242129:disease program [Health Care Related Organization]
   840   C3245490:disease program [Health Care Related Organization]
   820   C1516176:Core Grant [Governmental or Regulatory Activity]
   809   C0679722:pilot program [Intellectual Product]
   801   C0002395:Alzheimer's Disease [Disease or Syndrome]
   801   C1521724:Alzheimer's Disease [Pathologic Function]
   788   C0012634:Disease [Disease or Syndrome]
   788   C0018173:Grant [Quantitative Concept]
   788   C0205099:Center [Spatial Concept]
   788   C0444669:Core [Spatial Concept]
   788   C0473169:Pilot [Professional or Occupational Group]
   788   C1074110:Nia [Fungus]
   788   C1167518:core [Cell Component]
   788   C1414316:PILOT [Gene or Genome]
   788   C1548284:Grant [Idea or Concept]
   788   C1706352:Core [Medical Device]
   788   C1709697:Program [Conceptual Entity]
   788   C1882467:Core [Manufactured Object]
   788   C1955974:NIA [Health Care Related Organization]
   788   C2728259:Program [Pharmacologic Substance]
   788   C3274653:Core [Body Substance]
   788   C3484370:Program [Functional Concept]
   733 E C1836721:MALS [Finding]
   733 E C3538764:MALS [Gene or Genome]
   733 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.249: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.250: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.251: Section 1734solely to indicate this fact. 

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.252: Recipient of National Institutes of Health Research Career Development Award K04 DK02217. 

Phrase: "Recipient of National Institutes of Health Research Career Development Award K04 DK02217."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C1709854:Recipient [Human]
Processing 00000000.tx.253: To whom correspondence should be addressed: Dept. of Pathology and Lab Medicine, University of Pennsylvania School of Medicine, 230John Morgan Bldg., 3620Hamilton Walk, Philadelphia, PA 19104-6082. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Dept."

Phrase: "of Pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030664:Pathology [Biomedical Occupation or Discipline]
  1000   C0205469:pathology [Functional Concept]
  1000   C0677042:pathology [Pathologic Function]
   928 E C1521733:Pathologic [Functional Concept]

Phrase: "and"

Phrase: "Lab Medicine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013227:Medicine, NOS [Pharmacologic Substance]
   861   C0025118:Medicine [Biomedical Occupation or Discipline]

Phrase: "University of Pennsylvania School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0036375:School [Manufactured Object,Organization]

Phrase: "230John Morgan Bldg.,"

Phrase: "3620Hamilton Walk,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0080331:Walk [Daily or Recreational Activity]

Phrase: "Philadelphia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031525:Philadelphia [Geographic Area]

Phrase: "PA 19104-6082."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3541314:PA [Idea or Concept]
Processing 00000000.tx.254: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.255: 215-898-0025; 

Phrase: "215-898-0025"

Phrase: ";"
Processing 00000000.tx.256: Fax: 215-573-2266; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "215-573-2266"

Phrase: ";"
Processing 00000000.tx.257: E-mail: wolfb{at}mail.med.upenn.edu . 1 The abbreviations used are: A, -amyloid; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "wolfb{at}mail.med.upenn.edu . 1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   795   C0024492:Mail [Manufactured Object]
   795   C0059804:EDU [Organic Chemical,Pharmacologic Substance]
   795   C1538057:MAIL [Gene or Genome]
   795   C1547565:Mail [Idea or Concept]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "A, -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.258: APP, amyloid precursor protein; 

Phrase: "APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.259: APP-S, non-amyloidogenic secreted form of APP; 

Phrase: "APP-S,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "non-amyloidogenic secreted form of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0348078:Form [Qualitative Concept]
   744   C0376315:Form [Manufactured Object]
   744   C1522492:Form [Functional Concept]

Phrase: ";"
Processing 00000000.tx.260: PI, phosphatidylinositol; 

Phrase: "PI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
  1000   C2348046:Phosphatidylinositol [Lipid]

Phrase: "phosphatidylinositol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
  1000   C2348046:Phosphatidylinositol [Lipid]

Phrase: ";"
Processing 00000000.tx.261: DAG, 1,2-diacyl-sn-glycerol; 

Phrase: "DAG,"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2-diacyl-sn-glycerol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.262: PMA, 12-myristate 13-acetate; 

Phrase: "PMA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C2825188:PMA [Intellectual Product]

Phrase: "12-myristate 13-acetate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.263: ACPD, 1-aminocyclopentane-cis-1,3-dicarboxylic acid; 

Phrase: "ACPD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0044270:ACPD [Organic Chemical,Pharmacologic Substance]

Phrase: "1-aminocyclopentane-cis-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0010575:1-Aminocyclopentane [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C1504308:Cis [Eukaryote]
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "3-dicarboxylic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0012063:dicarboxylic acid [Organic Chemical]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.264: NMDA, N-methyl-D-aspartic acid; 

Phrase: "NMDA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079883:NMDA [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "N-methyl-"

Phrase: "D-"

Phrase: "aspartic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0004015:Aspartic Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.265: CCG-I, (carboxycyclopropyl)glycine; 

Phrase: "CCG-I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(carboxycyclopropyl"

Phrase: ")"

Phrase: "glycine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0522461:Glycine [Plant]

Phrase: ";"
Processing 00000000.tx.266: AIDA, 1-aminoindan-1,5-dicarboxylic acid; 

Phrase: "AIDA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1823700:AIDA [Gene or Genome]

Phrase: "1-aminoindan-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0044284:1-aminoindan [Organic Chemical]
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]

Phrase: "5-dicarboxylic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0012063:dicarboxylic acid [Organic Chemical]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.267: OAG, 1-oleoyl-2-acetyl-sn-glycerol; 

Phrase: "OAG,"

Phrase: "1-oleoyl-2-acetyl-sn-glycerol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0044555:1-oleoyl-2-acetyl-sn-glycerol [Lipid]
           1-oleoyl-2-acetyl-glycerol
   919   C0089700:1-oleoyl-2-glycerol [Lipid]
   799   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.268: CNQX, 6-cyano-7-nitroquinoxaline-2,3-dione; 

Phrase: "CNQX,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0099122:CNQX [Organic Chemical,Pharmacologic Substance]

Phrase: "6-cyano-7-nitroquinoxaline-2,"

Phrase: "3-dione"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1004514:Dione [Eukaryote]
   861   C2304069:Dione [Plant]

Phrase: ";"
Processing 00000000.tx.269: AP5, D-2-amino-5-phosphonopentanoic acid; 

Phrase: "AP5,"

Phrase: "D-2-amino-5-phosphonopentanoic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   858   C2917660:Amino Acid [Pharmacologic Substance]
   799   C0001128:Acid [Chemical]
   799   C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.270: MPPG, -methyl-4-phosphonophenylglycine; 

Phrase: "MPPG, -"

Phrase: "methyl-4-phosphonophenylglycine"

Phrase: ";"
Processing 00000000.tx.271: MSOPPE, -methylserine-O-phosphate monophenyl ester; 

Phrase: "MSOPPE, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1100145:MSOPPE [Amino Acid, Peptide, or Protein,Organophosphorus Compound]

Phrase: "methylserine-O-phosphate monophenyl ester"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0599126:phosphate ester [Organophosphorus Compound]
   804   C0014898:Ester [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.272: AMPA, -amino-3-hydroxy-5-methyl-4-isoxazalepropionic acid; 

Phrase: "AMPA, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0051318:AMPA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "amino-3-hydroxy-5-methyl-4-isoxazalepropionic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   892   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   892   C2917660:Amino Acid [Pharmacologic Substance]
   793   C0001128:Acid [Chemical]
   793   C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.273: NT2, NTera 2/cl.D1; 

Phrase: "NT2,"

Phrase: "NTera 2/cl.D1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1416886:D1 [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.274: NT2N, NTera 2/cl.D1 differentiated neurons; 

Phrase: "NT2N,"

Phrase: "NTera 2/cl.D1 differentiated neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0027882:Neurons [Cell]
   716 E C0521390:Neuronal [Immunologic Factor]

Phrase: ";"
Processing 00000000.tx.275: mGluR1/, metabotropic glutamate receptor subtype 1/; 

Phrase: "mGluR1/,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0535210:mGluR1 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1333711:MGLUR1 [Gene or Genome]
  1000   C1706579:MGLUR1 [Gene or Genome]

Phrase: "metabotropic glutamate receptor subtype 1/"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   888   C1415287:GLUTAMATE RECEPTOR 1 [Gene or Genome]
   884   C0206529:Metabotropic Glutamate Receptor [Amino Acid, Peptide, or Protein,Receptor]
   853   C1178976:Metabotropic receptor [Amino Acid, Peptide, or Protein,Receptor]
   840   C0061465:Glutamate Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   804   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0449560:Subtype [Classification]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ";"
Processing 00000000.tx.276: mGluR5, metabotropic glutamate receptor subtype 5; 

Phrase: "mGluR5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1333712:MGLUR5 [Gene or Genome]
  1000   C1706589:MGLUR5 [Gene or Genome]

Phrase: "metabotropic glutamate receptor subtype 5"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   933   C0530778:metabotropic glutamate receptor 5 [Amino Acid, Peptide, or Protein,Receptor]
   888   C1415293:GLUTAMATE RECEPTOR 5 [Gene or Genome]
   884   C0206529:Metabotropic Glutamate Receptor [Amino Acid, Peptide, or Protein,Receptor]
   853   C1178976:Metabotropic receptor [Amino Acid, Peptide, or Protein,Receptor]
   840   C0061465:Glutamate Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   804   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0449560:Subtype [Classification]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ";"
Processing 00000000.tx.277: RT-PCR, reverse transcription-polymerase chain reaction; 

Phrase: "RT-PCR,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599161:RT-PCR [Molecular Biology Research Technique]
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]

Phrase: "reverse transcription-polymerase chain reaction"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0814037:reverse transcription polymerase chain reaction [Genetic Function]
   884   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   840   C0035380:Reverse Transcription [Genetic Function]
   804   C0040649:Transcription [Genetic Function]
   804   C0337112:Chain [Manufactured Object]
   804   C0443286:Reaction [Functional Concept]
   804   C1114821:Reaction [Clinical Attribute]
   804   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1524075:Chain [Idea or Concept]
   804   C1555029:Reverse [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.278: DMEM, Dulbecco's modified Eagle's medium; 

Phrase: "DMEM,"

Phrase: "Dulbecco's modified Eagle's medium"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0009458:Medium [Intellectual Product]
   812   C0325564:Eagle [Bird]
   812   C0392747:Modified [Functional Concept]
   812   C0439536:Medium [Quantitative Concept]
   812   C1551720:Eagle [Population Group]
   812   C1705217:Medium [Substance]
   812   C3244283:medium [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.279: PAGE, poly- acrylamide gel electrophoresis; 

Phrase: "PAGE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704732:Page [Intellectual Product]

Phrase: "poly- acrylamide gel electrophoresis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   861   C0596607:Gel Electrophoresis [Laboratory Procedure]
   812   C0013855:Electrophoresis [Laboratory Procedure]
   756   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.280: IP, inositol 1-phosphate; 

Phrase: "IP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0063574:inositol 1-phosphate [Carbohydrate]
   913   C0021554:inositol phosphate [Carbohydrate]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "inositol 1-phosphate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0063574:inositol 1-phosphate [Carbohydrate]
   913   C0021554:inositol phosphate [Carbohydrate]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.281: IP2, inositol 1,4-bisphosphate, IP3, inositol 1,4,5-trisphosphate; 

Phrase: "IP2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2697645:IP2 [Gene or Genome]
  1000   C3539932:IP2 [Body Part, Organ, or Organ Component]

Phrase: "inositol 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]

Phrase: "4-bisphosphate,"

Phrase: "IP3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021549:IP3 [Biologically Active Substance,Carbohydrate]
  1000   C3542924:IP3 [Body Part, Organ, or Organ Component]

Phrase: "inositol 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]

Phrase: "4,"

Phrase: "5-trisphosphate"

Phrase: ";"
Processing 00000000.tx.282: IP4, inositol 1,3,4,5-tetrakisphosphate; 

Phrase: "IP4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3640681:IP4 [Body Part, Organ, or Organ Component]

Phrase: "inositol 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4,"

Phrase: "5-tetrakisphosphate"

Phrase: ";"
Processing 00000000.tx.283: bp, base pair(s).  

Phrase: "bp,"

Phrase: "base pair"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0600436:Base Pair [Molecular Function]
   861   C0002055:base [Inorganic Chemical]
   861   C0178499:Base [Chemical Viewed Functionally]
   861   C1709450:Pair [Qualitative Concept]
   861   C1880279:Base [Biomedical or Dental Material]
   789 E C0205112:Basal [Spatial Concept]
   777 E C0016617:Foundation [Organization]
   777 E C1626935:Bases [Quantitative Concept]

Phrase: "("

Phrase: "s)."
Processing 00000000.tx.284: REFERENCES Top Abstract Introduction Procedures Results Discussion References Hardy, J., and Allsop, D. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Procedures Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0557061:Discussion [Therapeutic or Preventive Procedure]
   799   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Allsop,"

Phrase: "D."
Processing 00000000.tx.285: (1991) Trends Pharmacol. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Pharmacol."
Processing 00000000.tx.286: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.287: 12, 383-388[CrossRef][Medline] [OrderarticleviaInfotrieve] Sisodia, S. 

Phrase: "12,"

Phrase: "383-388"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.288: S., and Price, D. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.289: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.290: (1992) Curr. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.291: Opin. 

Phrase: "Opin."
Processing 00000000.tx.292: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.293: 2, 648-652[Medline] [OrderarticleviaInfotrieve] Yankner, B. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "648-652"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Yankner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.294: A., and Mesulam, M. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Mesulam,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.295: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.296: (1991) N. 

Phrase: "(1991"

Phrase: ")"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.297: Engl. 

Phrase: "Engl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414400:ENGL [Gene or Genome]
Processing 00000000.tx.298: J.Med. 

Phrase: "J.Med."
Processing 00000000.tx.299: 325, 1849-1857[Medline] [OrderarticleviaInfotrieve] Selkoe, D. 

Phrase: "325,"

Phrase: "1849-1857"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Selkoe,"

Phrase: "D."
Processing 00000000.tx.300: J., Yamazaki, T., Citron, M., Podlisny, M. 

Phrase: "J.,"

Phrase: "Yamazaki,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Podlisny,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.301: B., Koo, E. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.302: H., Teplow, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.303: B., and Haass, C. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Haass,"

Phrase: "C."
Processing 00000000.tx.304: (1996) Ann. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.305: N.Y.Acad. 

Phrase: "N.Y.Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0268596:ACAD [Disease or Syndrome]
   827   C2700624:ACAD [Cell Function]
Processing 00000000.tx.306: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.307: 777, 57-64[Abstract] Selkoe, D. 

Phrase: "777,"

Phrase: "57-64"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Selkoe,"

Phrase: "D."
Processing 00000000.tx.308: J. 

Phrase: "J."
Processing 00000000.tx.309: (1994) Annu. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.310: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.311: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.312: 17, 489-517[CrossRef][Medline] [OrderarticleviaInfotrieve] Wertkin, A. 

Phrase: "17,"

Phrase: "489-517"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Wertkin,"

Phrase: "A."
Processing 00000000.tx.313: M., Turner, R. 

Phrase: "M."

Phrase: ","

Phrase: "Turner,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.314: S., Pleasure, S. 

Phrase: "S."

Phrase: ","

Phrase: "Pleasure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679105:Pleasure [Mental Process]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.315: J., Golde, T. 

Phrase: "J.,"

Phrase: "Golde,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.316: E., Younkin, S. 

Phrase: "E.,"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.317: G., Trojanowski, J. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.318: Q., and Lee, V. 

Phrase: "Q.,"

Phrase: "and"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.319: M.Y. 

Phrase: "M."

Phrase: "Y."
Processing 00000000.tx.320: (1993) Proc. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.321: Natl. 

Phrase: "Natl."
Processing 00000000.tx.322: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.323: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.324: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0041703:U S [Geographic Area]
Processing 00000000.tx.325: 90, 9513-9517[Abstract] Esch, F. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "9513-9517"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Esch,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.326: S., Keim, P. 

Phrase: "S."

Phrase: ","

Phrase: "Keim,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.327: S., Beattie, E. 

Phrase: "S."

Phrase: ","

Phrase: "Beattie,"

Phrase: "E."
Processing 00000000.tx.328: C., Blacher, R. 

Phrase: "C., Blacher,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.329: W., Culwell, A. 

Phrase: "W., Culwell,"

Phrase: "A."
Processing 00000000.tx.330: R., Oltersdorf, T., McClure, D., and Ward, P. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Oltersdorf,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "McClure,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Ward,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1305702:Ward [Health Care Related Organization,Manufactured Object]
  1000   C1547134:Ward [Idea or Concept]
  1000   C2355574:Ward [Population Group]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.331: J. 

Phrase: "J."
Processing 00000000.tx.332: (1990) Science 248, 1122-1124[Medline] [OrderarticleviaInfotrieve] Sisodia, S. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Science 248,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1122-1124"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.333: S., Koo, E. 

Phrase: "S."

Phrase: ","

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.334: H., Beyreuther, K., Unterbeck, A., and Price, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Unterbeck,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.335: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.336: (1990) Science 248, 492-495[Medline] [OrderarticleviaInfotrieve] Estus, S., Golde, T. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Science 248,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "492-495"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Estus,"

Phrase: "S."

Phrase: ","

Phrase: "Golde,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.337: E., Kunishita, T., Blades, D., Lowery, D., Eisen, M., Usiak, M., Qu, X. 

Phrase: "E.,"

Phrase: "Kunishita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Blades,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0179323:blades [Medical Device]
   966 E C2700402:Blade [Plant]
   966 E C2948008:Blade [Pharmacologic Substance]

Phrase: "D."

Phrase: ","

Phrase: "Lowery,"

Phrase: "D."

Phrase: ","

Phrase: "Eisen,"

Phrase: "M."

Phrase: ","

Phrase: "Usiak,"

Phrase: "M."

Phrase: ","

Phrase: "Qu,"

Phrase: "X."
Processing 00000000.tx.338: M., Tabira, T., and Greenberg, B. 

Phrase: "M."

Phrase: ","

Phrase: "Tabira,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Greenberg,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.339: D. 

Phrase: "D."
Processing 00000000.tx.340: (1992) Science 255, 726-728[Medline] [OrderarticleviaInfotrieve] Golde, T. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Science 255,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "726-728"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Golde,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.341: E., Estus, S., Younkin, L. 

Phrase: "E.,"

Phrase: "Estus,"

Phrase: "S."

Phrase: ","

Phrase: "Younkin,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.342: H., Selkoe, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.343: J., and Younkin, S. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.344: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.345: (1992) Science 255, 728-730[Medline] [OrderarticleviaInfotrieve] Cai, X. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Science 255,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "728-730"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Cai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064494:CAI [Organic Chemical,Pharmacologic Substance]

Phrase: "X."
Processing 00000000.tx.346: D., Golde, T. 

Phrase: "D."

Phrase: ","

Phrase: "Golde,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.347: E., and Younkin, S. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.348: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.349: (1993) Science 259, 514-516[Medline] [OrderarticleviaInfotrieve] Golde, T. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Science 259,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "514-516"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Golde,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.350: E., Cai, X. 

Phrase: "E.,"

Phrase: "Cai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064494:CAI [Organic Chemical,Pharmacologic Substance]

Phrase: "X."
Processing 00000000.tx.351: D., Shoji, M., and Younkin, S. 

Phrase: "D."

Phrase: ","

Phrase: "Shoji,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.352: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.353: (1993) Ann. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.354: N.Y.Acad. 

Phrase: "N.Y.Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0268596:ACAD [Disease or Syndrome]
   827   C2700624:ACAD [Cell Function]
Processing 00000000.tx.355: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.356: 695, 103-108[Abstract] Games, D., Adams, D., Alessandrini, R., Barbour, R., Berthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al.. 

Phrase: "695,"

Phrase: "103-108"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Games,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0150593:games [Daily or Recreational Activity]

Phrase: "D."

Phrase: ","

Phrase: "Adams,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331762:Adams [Health Care Related Organization]

Phrase: "D."

Phrase: ","

Phrase: "Alessandrini,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Barbour,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Berthelette,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Blackwell,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Carr,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Clemens,"

Phrase: "J.,"

Phrase: "Donaldson,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Gillespie,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "et al.."
Processing 00000000.tx.357: (1995) Nature 373, 523-527[CrossRef][Medline] [OrderarticleviaInfotrieve] Johnson-Wood, K., Lee, M., Motter, R., Hu, K., Gordon, G., Barbour, R., Khan, K., Gordon, M., Tan, H., Games, D., Lieberburg, I., Schenk, D., Seubert, P., and McConlogue, L. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Nature 373,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "523-527"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Johnson-Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0043217:Wood [Substance]
   805 E C0144237:Sylvan [Organic Chemical]
   777 E C0442548:Woods [Geographic Area]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lee,"

Phrase: "M."

Phrase: ","

Phrase: "Motter,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hu,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Gordon,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Barbour,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Khan,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Gordon,"

Phrase: "M."

Phrase: ","

Phrase: "Tan,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302595:tan [Individual Behavior]
  1000   C1537110:Tan [Clinical Attribute]
  1000   C3275241:Tan [Qualitative Concept]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Games,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0150593:games [Daily or Recreational Activity]

Phrase: "D."

Phrase: ","

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Schenk,"

Phrase: "D."

Phrase: ","

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "McConlogue,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.358: (1997) Proc. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.359: Natl. 

Phrase: "Natl."
Processing 00000000.tx.360: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.361: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.362: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0041703:U S [Geographic Area]
Processing 00000000.tx.363: 94, 1550-1555[Abstract/Free FullText] Borchelt, D. 

Phrase: "94,"

Phrase: "1550-1555"

Phrase: "[Abstract/Free FullText"

Phrase: "] Borchelt,"

Phrase: "D."
Processing 00000000.tx.364: R., Thinakaran, G., Eckman, C. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Eckman,"

Phrase: "C."
Processing 00000000.tx.365: B., Lee, M. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Lee,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.366: K., Davenport, F., Ratovitsky, T., Prada, C. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Davenport,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Ratovitsky,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Prada,"

Phrase: "C."
Processing 00000000.tx.367: M., Kim, G., Seekins, S., Yager, D., Slunt, H. 

Phrase: "M."

Phrase: ","

Phrase: "Kim,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Seekins,"

Phrase: "S."

Phrase: ","

Phrase: "Yager,"

Phrase: "D."

Phrase: ","

Phrase: "Slunt,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.368: H., Wang, R., Seeger, M., Levey, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Wang,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Seeger,"

Phrase: "M."

Phrase: ","

Phrase: "Levey,"

Phrase: "A."
Processing 00000000.tx.369: I., Gandy, S. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Gandy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.370: E., Copeland, N. 

Phrase: "E.,"

Phrase: "Copeland,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.371: G., Jenkins, N. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Jenkins,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.372: A., Price, D. 

Phrase: "A.,"

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.373: L., Younkin, S. 

Phrase: "L., Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.374: G., and Sisodia, S. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.375: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.376: (1996) Neuron 17, 1005-1013[Medline] [OrderarticleviaInfotrieve] Citron, M., Westaway, D., Xia, W. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Neuron 17,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "1005-1013"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Westaway,"

Phrase: "D."

Phrase: ","

Phrase: "Xia,"

Phrase: "W."
Processing 00000000.tx.377: M., Carlson, G., Diehl, T., Levesque, G., Johnson-Wood, K., Lee, M., Seubert, P., Davis, A., Kholodenko, D., Motter, R., Sherrington, R., Perry, B., Yao, H., Strome, R., Lieberburg, I., Rommens, J., Kim, S., Schenk, D., Fraser, P., Hyslop, P. 

Phrase: "M."

Phrase: ","

Phrase: "Carlson,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Diehl,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Johnson-Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0043217:Wood [Substance]
   805 E C0144237:Sylvan [Organic Chemical]
   777 E C0442548:Woods [Geographic Area]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lee,"

Phrase: "M."

Phrase: ","

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Davis,"

Phrase: "A.,"

Phrase: "Kholodenko,"

Phrase: "D."

Phrase: ","

Phrase: "Motter,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Perry,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Yao,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Strome,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Rommens,"

Phrase: "J.,"

Phrase: "Kim,"

Phrase: "S."

Phrase: ","

Phrase: "Schenk,"

Phrase: "D."

Phrase: ","

Phrase: "Fraser,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hyslop,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.378: S., and Selkoe, D. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.379: J. 

Phrase: "J."
Processing 00000000.tx.380: (1997) Nat. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.381: Med. 

Phrase: "Med."
Processing 00000000.tx.382: 3, 67-72[Medline] [OrderarticleviaInfotrieve] Hardy, J. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "67-72"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hardy,"

Phrase: "J."
Processing 00000000.tx.383: (1997) Trends Neurosci. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci."
Processing 00000000.tx.384: 20, 154-159[CrossRef][Medline] [OrderarticleviaInfotrieve] Xia, W., Zhang, J., Kholodenko, D., Citron, M., Podlisny, M. 

Phrase: "20,"

Phrase: "154-159"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Xia,"

Phrase: "W.,"

Phrase: "Zhang,"

Phrase: "J.,"

Phrase: "Kholodenko,"

Phrase: "D."

Phrase: ","

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Podlisny,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.385: B., Teplow, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.386: B., Haass, C., Seubert, P., Koo, E. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.387: H., and Selkoe, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.388: J. 

Phrase: "J."
Processing 00000000.tx.389: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.390: Biol. 

Phrase: "Biol."
Processing 00000000.tx.391: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.392: 272, 7977-7982[Abstract/Free FullText] Wolf, B. 

Phrase: "272,"

Phrase: "7977-7982"

Phrase: "[Abstract/Free FullText"

Phrase: "] Wolf,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325001:Wolf [Mammal]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.393: A., Wertkin, A. 

Phrase: "A.,"

Phrase: "Wertkin,"

Phrase: "A."
Processing 00000000.tx.394: M., Jolly, Y. 

Phrase: "M."

Phrase: ","

Phrase: "Jolly,"

Phrase: "Y."
Processing 00000000.tx.395: C., Yasuda, R. 

Phrase: "C., Yasuda,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.396: P., Wolfe, B. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wolfe,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.397: B., Konrad, R. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Konrad,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.398: J., Manning, D., Ravi, S., Williamson, J. 

Phrase: "J.,"

Phrase: "Manning,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0024554:MAN [Finding]
   966   C0025266:Man [Population Group]
   966   C0086418:Man [Human]

Phrase: "D."

Phrase: ","

Phrase: "Ravi,"

Phrase: "S."

Phrase: ","

Phrase: "Williamson,"

Phrase: "J."
Processing 00000000.tx.399: R., and Lee, V. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.400: M.-Y. 

Phrase: "M.-"

Phrase: "Y."
Processing 00000000.tx.401: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.402: Biol. 

Phrase: "Biol."
Processing 00000000.tx.403: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.404: 270, 4916-4922[Abstract/Free FullText] Lee, R. 

Phrase: "270,"

Phrase: "4916-4922"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lee,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.405: K., Wurtman, R. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Wurtman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.406: J., Cox, A. 

Phrase: "J.,"

Phrase: "Cox,"

Phrase: "A."
Processing 00000000.tx.407: J., and Nitsch, R. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Nitsch,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.408: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.409: (1995) Proc. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.410: Natl. 

Phrase: "Natl."
Processing 00000000.tx.411: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.412: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.413: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0041703:U S [Geographic Area]
Processing 00000000.tx.414: 92, 8083-8087[Abstract] Nitsch, R. 

Phrase: "92,"

Phrase: "8083-8087"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Nitsch,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.415: M., Slack, B. 

Phrase: "M."

Phrase: ","

Phrase: "Slack,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1425836:SLACK [Gene or Genome]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.416: E., Wurtman, R. 

Phrase: "E.,"

Phrase: "Wurtman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.417: J., and Growdon, J. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Growdon,"

Phrase: "J."
Processing 00000000.tx.418: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.419: (1992) Science 258, 304-307[Medline] [OrderarticleviaInfotrieve] Arai, H., Lee, V. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Science 258,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "304-307"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Arai,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.420: M.Y., Messinger, M. 

Phrase: "M."

Phrase: "Y.,"

Phrase: "Messinger,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.421: L., Greenberg, B. 

Phrase: "L., Greenberg,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.422: D., Lowery, D. 

Phrase: "D."

Phrase: ","

Phrase: "Lowery,"

Phrase: "D."
Processing 00000000.tx.423: E., and Trojanowski, J. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.424: Q. 

Phrase: "Q."
Processing 00000000.tx.425: (1991) Ann. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.426: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.427: 30, 686-693[Medline] [OrderarticleviaInfotrieve] Pleasure, S. 

Phrase: "30,"

Phrase: "686-693"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Pleasure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679105:Pleasure [Mental Process]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.428: J., Page, C., and Lee, V. 

Phrase: "J.,"

Phrase: "Page,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704732:Page [Intellectual Product]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.429: M.Y. 

Phrase: "M."

Phrase: "Y."
Processing 00000000.tx.430: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.431: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.432: 12, 1802-1815[Abstract] Chomczynski, P., and Sacchi, N. 

Phrase: "12,"

Phrase: "1802-1815"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Chomczynski,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Sacchi,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.433: (1987) Anal. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Anal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003461:Anal [Body Part, Organ, or Organ Component]
  1000   C2939124:Anal [Spatial Concept]
Processing 00000000.tx.434: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.435: 162, 156-159[CrossRef][Medline] [OrderarticleviaInfotrieve] Desai, M. 

Phrase: "162,"

Phrase: "156-159"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Desai,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.436: A., Burnett, J. 

Phrase: "A.,"

Phrase: "Burnett,"

Phrase: "J."
Processing 00000000.tx.437: P., Mayne, N. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Mayne,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.438: G., and Schoepp, D. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Schoepp,"

Phrase: "D."
Processing 00000000.tx.439: D. 

Phrase: "D."
Processing 00000000.tx.440: (1995) Mol. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.441: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.442: 48, 648-657[Abstract] Minakami, R., Katsuki, F., Yamamoto, T., Nakamura, K., and Sugiyama, H. 

Phrase: "48,"

Phrase: "648-657"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Minakami,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Katsuki,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Nakamura,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Sugiyama,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.443: (1994) Biochem. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.444: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.445: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.446: Commun. 

Phrase: "Commun."
Processing 00000000.tx.447: 199, 1136-1143[CrossRef][Medline] [OrderarticleviaInfotrieve] Westbrook, G. 

Phrase: "199,"

Phrase: "1136-1143"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Westbrook,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.448: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.449: (1994) Curr. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.450: Opin. 

Phrase: "Opin."
Processing 00000000.tx.451: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.452: 4, 337-346[CrossRef][Medline] [OrderarticleviaInfotrieve] Barnard, E. 

Phrase: "4,"

Phrase: "337-346"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Barnard,"

Phrase: "E."
Processing 00000000.tx.453: A. 

Phrase: "A."
Processing 00000000.tx.454: (1997) Trends Pharmacol. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Pharmacol."
Processing 00000000.tx.455: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.456: 18, 141-148[CrossRef][Medline] [OrderarticleviaInfotrieve] Pellicciari, R., Luneia, R., Costantino, G., Marinozzi, M., Natalini, B., Jakobsen, P., Kanstrup, A., Lombardi, G., Moroni, F., and Thomsen, C. 

Phrase: "18,"

Phrase: "141-148"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Pellicciari,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Luneia,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Costantino,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Marinozzi,"

Phrase: "M."

Phrase: ","

Phrase: "Natalini,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Jakobsen,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Kanstrup,"

Phrase: "A.,"

Phrase: "Lombardi,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Moroni,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Thomsen,"

Phrase: "C."
Processing 00000000.tx.457: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.458: Med. 

Phrase: "Med."
Processing 00000000.tx.459: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.460: 38, 3717-3719[Medline] [OrderarticleviaInfotrieve] Thomas, P., Ye, Y., and Lightner, E. 

Phrase: "38,"

Phrase: "3717-3719"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Thomas,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Ye,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043402:YE [Geographic Area]

Phrase: "Y.,"

Phrase: "and"

Phrase: "Lightner,"

Phrase: "E."
Processing 00000000.tx.461: (1996) Hum. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Hum."
Processing 00000000.tx.462: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.463: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.464: 5, 1809-1812[Abstract/Free FullText] Jane, D. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "1809-1812"

Phrase: "[Abstract/Free FullText"

Phrase: "] Jane,"

Phrase: "D."
Processing 00000000.tx.465: E., Pittaway, K., Sunter, D. 

Phrase: "E.,"

Phrase: "Pittaway,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sunter,"

Phrase: "D."
Processing 00000000.tx.466: C., Thomas, N. 

Phrase: "C., Thomas,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.467: K., and Watkins, J. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Watkins,"

Phrase: "J."
Processing 00000000.tx.468: C. 

Phrase: "C."
Processing 00000000.tx.469: (1995) Neuropharmacology 34, 851-856[CrossRef][Medline] [OrderarticleviaInfotrieve] Konrad, R. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Neuropharmacology 34,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027896:Neuropharmacology [Biomedical Occupation or Discipline]

Phrase: "851-856"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Konrad,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.470: J., Major, C. 

Phrase: "J.,"

Phrase: "Major,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205164:Major [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.471: D., and Wolf, B. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Wolf,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325001:Wolf [Mammal]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.472: A. 

Phrase: "A."
Processing 00000000.tx.473: (1994) Biochemistry 33, 13284-13294[Medline] [OrderarticleviaInfotrieve] Kirazov, L., Lffler, T., Schliebs, R., and Bigl, V. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Biochemistry 33,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "13284-13294"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kirazov,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Lffler,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Schliebs,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Bigl,"

Phrase: "V."
Processing 00000000.tx.474: (1997) Neurochem. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Neurochem."
Processing 00000000.tx.475: Int. 

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.476: 30, 557-563[CrossRef][Medline] [OrderarticleviaInfotrieve] Ulus, I. 

Phrase: "30,"

Phrase: "557-563"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ulus,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.477: H., and Wurtman, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Wurtman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.478: J. 

Phrase: "J."
Processing 00000000.tx.479: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.480: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.481: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.482: Ther. 

Phrase: "Ther."
Processing 00000000.tx.483: 281, 149-154[Abstract/Free FullText] Lee, R. 

Phrase: "281,"

Phrase: "149-154"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lee,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.484: K.K., and Wurtman, R. 

Phrase: "K.K.,"

Phrase: "and"

Phrase: "Wurtman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.485: J. 

Phrase: "J."
Processing 00000000.tx.486: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.487: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.488: 68, 1830-1835[Medline] [OrderarticleviaInfotrieve] Younkin, D. 

Phrase: "68,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: "1830-1835"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Younkin,"

Phrase: "D."
Processing 00000000.tx.489: P., Tang, C. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Tang,"

Phrase: "C."
Processing 00000000.tx.490: M., Hardy, M., Reddy, U. 

Phrase: "M."

Phrase: ","

Phrase: "Hardy,"

Phrase: "M."

Phrase: ","

Phrase: "Reddy,"

Phrase: "U."
Processing 00000000.tx.491: R., Shi, Q. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Shi,"

Phrase: "Q."
Processing 00000000.tx.492: Y., Pleasure, S. 

Phrase: "Y.,"

Phrase: "Pleasure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679105:Pleasure [Mental Process]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.493: J., Lee, V. 

Phrase: "J.,"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.494: M., and Pleasure, D. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Pleasure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679105:Pleasure [Mental Process]

Phrase: "D."
Processing 00000000.tx.495: (1993) Proc. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.496: Natl. 

Phrase: "Natl."
Processing 00000000.tx.497: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.498: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.499: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0041703:U S [Geographic Area]
Processing 00000000.tx.500: 90, 2174-2178[Abstract] Hardy, M., Younkin, D., Tang, C. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "2174-2178"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hardy,"

Phrase: "M."

Phrase: ","

Phrase: "Younkin,"

Phrase: "D."

Phrase: ","

Phrase: "Tang,"

Phrase: "C."
Processing 00000000.tx.501: M., Pleasure, J., Shi, Q. 

Phrase: "M."

Phrase: ","

Phrase: "Pleasure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679105:Pleasure [Mental Process]

Phrase: "J.,"

Phrase: "Shi,"

Phrase: "Q."
Processing 00000000.tx.502: Y., and Williams, M. 

Phrase: "Y.,"

Phrase: "and"

Phrase: "Williams,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.503: X.P.D. 

Phrase: "X.P.D."
Processing 00000000.tx.504: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.505: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.506: 63, 482-489[Medline] [OrderarticleviaInfotrieve] Wolf, B. 

Phrase: "63,"

Phrase: "482-489"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Wolf,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325001:Wolf [Mammal]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.507: A., Easom, R. 

Phrase: "A.,"

Phrase: "Easom,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.508: A., Hughes, J. 

Phrase: "A.,"

Phrase: "Hughes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551730:Hughes [Population Group]

Phrase: "J."
Processing 00000000.tx.509: H., McDaniel, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "McDaniel,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.510: L., and Turk, J. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Turk,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337911:Turk [Population Group]

Phrase: "J."
Processing 00000000.tx.511: (1989) Biochemistry 28, 4291-4301[Medline] [OrderarticleviaInfotrieve] Suzuki, T., Nishio, K., Sasaki, H., Ikeuchi, T., Tanabe, S., Terada, M., and Saijo, N. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Biochemistry 28,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "4291-4301"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Nishio,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sasaki,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ikeuchi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tanabe,"

Phrase: "S."

Phrase: ","

Phrase: "Terada,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Saijo,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.512: (1997) Biochem. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.513: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.514: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.515: Commun. 

Phrase: "Commun."
Processing 00000000.tx.516: 238, 790-794[CrossRef][Medline] [OrderarticleviaInfotrieve] Horsburgh, K., Mackay, K. 

Phrase: "238,"

Phrase: "790-794"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Horsburgh,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Mackay,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.517: B., and McCulloch, J. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "McCulloch,"

Phrase: "J."
Processing 00000000.tx.518: (1997) Exp. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.519: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.520: 143, 207-218[CrossRef][Medline] [OrderarticleviaInfotrieve] Hayashi, Y., Tanabe, Y., Aramori, I., Masu, M., Shimamoto, K., Ohfune, Y., and Nakanishi, S. 

Phrase: "143,"

Phrase: "207-218"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hayashi,"

Phrase: "Y.,"

Phrase: "Tanabe,"

Phrase: "Y.,"

Phrase: "Aramori,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Masu,"

Phrase: "M."

Phrase: ","

Phrase: "Shimamoto,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ohfune,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Nakanishi,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.521: (1992) Br. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Br."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704648:Br. [Conceptual Entity]
Processing 00000000.tx.522: J.

Phrase: "J."
Processing 00000000.tx.523: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.524: 107, 539-543[Abstract] Lee, R. 

Phrase: "107,"

Phrase: "539-543"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Lee,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.525: K.K., Araki, W., and Wurtman, R. 

Phrase: "K.K.,"

Phrase: "Araki,"

Phrase: "W.,"

Phrase: "and"

Phrase: "Wurtman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.526: J. 

Phrase: "J."
Processing 00000000.tx.527: (1997) Proc. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.528: Natl. 

Phrase: "Natl."
Processing 00000000.tx.529: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.530: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.531: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0041703:U S [Geographic Area]
Processing 00000000.tx.532: 94, 5422-5426[Abstract/Free FullText] Efthimiopoulos, S., Punj, S., Manolopoulos, V., Pangalos, M., Wang, G. 

Phrase: "94,"

Phrase: "5422-5426"

Phrase: "[Abstract/Free FullText"

Phrase: "] Efthimiopoulos,"

Phrase: "S."

Phrase: ","

Phrase: "Punj,"

Phrase: "S."

Phrase: ","

Phrase: "Manolopoulos,"

Phrase: "V.,"

Phrase: "Pangalos,"

Phrase: "M."

Phrase: ","

Phrase: "Wang,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.533: P., Refolo, L. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Refolo,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.534: M., and Robakis, N. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Robakis,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.535: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.536: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.537: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.538: 67, 872-875[Medline] [OrderarticleviaInfotrieve] Xu, H., Sweeney, D., Greengard, P., and Gandy, S. 

Phrase: "67,"

Phrase: "872-875"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Xu,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sweeney,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0270811:Sweeney [Disease or Syndrome]

Phrase: "D."

Phrase: ","

Phrase: "Greengard,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Gandy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.539: (1996) Proc. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.540: Natl. 

Phrase: "Natl."
Processing 00000000.tx.541: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.542: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.543: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0041703:U S [Geographic Area]
Processing 00000000.tx.544: 93, 4081-4084[Abstract/Free FullText] Copyright  1998 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "93,"

Phrase: "4081-4084"

Phrase: "[Abstract/Free FullText"

Phrase: "] Copyright  1998 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009993:Copyright [Intellectual Product]
   753   C0037455:society [Organization]
   753   C0596070:American [Population Group]
   753   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

